Predictors of Veteran PTSD Symptom Reduction by Use of Accelerated Resolution Therapy by Witt, Ann
Walden University
ScholarWorks
Walden Dissertations and Doctoral Studies Walden Dissertations and Doctoral StudiesCollection
2019
Predictors of Veteran PTSD Symptom Reduction
by Use of Accelerated Resolution Therapy
Ann Witt
Walden University
Follow this and additional works at: https://scholarworks.waldenu.edu/dissertations
Part of the Quantitative Psychology Commons
This Dissertation is brought to you for free and open access by the Walden Dissertations and Doctoral Studies Collection at ScholarWorks. It has been
accepted for inclusion in Walden Dissertations and Doctoral Studies by an authorized administrator of ScholarWorks. For more information, please
contact ScholarWorks@waldenu.edu.
Walden University 
 
 
 
College of Social and Behavioral Sciences 
 
 
 
 
This is to certify that the doctoral dissertation by 
 
 
Ann Witt 
 
 
has been found to be complete and satisfactory in all respects,  
and that any and all revisions required by  
the review committee have been made. 
 
Review Committee 
Dr. Rodney Ford, Committee Chairperson, Psychology Faculty 
Dr. Craig Marker, Committee Member, Psychology Faculty 
Dr. Jimmy Middlebrook, University Reviewer, Psychology Faculty 
 
 
 
 
 
 
Chief Academic Officer 
Eric Riedel, Ph.D. 
 
 
 
Walden University 
2019 
 
 
 
 
 
Abstract 
Predictors of Veteran PTSD Symptom Reduction by Use of                               
Accelerated Resolution Therapy 
by 
Ann Witt 
 
MS, Walden University, 2012 
BA, Fairleigh Dickinson University, 1985 
 
 
Dissertation Submitted in Partial Fulfillment 
of the Requirements for the Degree of 
Doctor of Philosophy 
Health Psychology 
 
 
Walden University 
February 2019 
 
  
Abstract 
Despite 30 years of research advancements, PTSD treatment remains a trial-and-error 
process as 22 veterans per day commit suicide to relieve their symptoms. Foa and 
Kozak’s emotional processing theory informed this correlational study which included 
secondary data consisting of participants’ self-rated scale scores to examine whether the 
independent variables number of deployments, guilt, depression, and anxiety predicted 
the dependent variable PTSD symptom reduction in a veteran sample with combat 
deployments and associated PTSD symptoms who completed accelerated resolution 
therapy (ART). An analysis of whether mean PTSD symptom reduction amounts differed 
by symptom severity levels was also completed. The study aimed to identify the first 
predictive treatment-matching model for PTSD symptom reduction by use of ART. A 
multiple regression analysis to determine whether the predictor variables predicted PTSD 
symptom reduction by use of ART resulted in nonsignificant findings (p = .517). A 
Welch ANOVA test to determine if mean PTSD symptom reduction differed among the 
low, moderate, and high PTSD symptom severity groups showed significant results         
(p = .002). Games-Howell post hoc analysis showed that mean differences in PTSD 
symptom reduction from the low to high PTSD symptom severity group was significant 
(p = .001) with a 26.1 point mean reduction for the high symptom severity group and a 
greater than 10-point mean PTSD symptom reduction for the low and moderate symptom 
severity groups. The findings confirmed a need for treatment-matching algorithm studies 
to predict which PTSD interventions most benefit veterans suffering with PTSD to reduce 
trial-and-error treatment approaches, associated comorbidities, and high rates of suicides. 
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Chapter 1: Introduction to the Study 
Introduction 
Combat-related posttraumatic stress disorder (PTSD) is a phenomenon known 
over the years by different names including shell shock, battle fatigue, and gross stress 
reaction (Harris, Mayer, & Becker, 1995; Levinson, 2015; Swank & Marchand, 1946; 
Wilson, Friedman, & Lindy, 2001).  PTSD onset results from the damaging effects 
survivors experience after severe, distressing, life-altering traumatic events (Selfridge, 
2014).  Many theorists have debated about the most appropriate assessment, diagnosis, 
and treatment approaches (Bardhoshi et al., 2015; Selfridge, 2014).  These debates have 
led to PTSD research and treatment advances over the decades (Bardhoshi et al., 2015; 
Selfridge, 2014).  However, the etiology of PTSD is still inconclusive (Bardhoshi et al., 
2015; Selfridge, 2014).  This is due to the complex nature of the disorder and the varied 
and unique ways patients recover from their PTSD symptoms (Friedman, 2016; Hoge et 
al., 2014; Ritchie, 2015).   
Empirically supported research informed the Veterans Administration (VA) and 
the Department of Defense (DoD) implementation of clear PTSD treatment guidelines 
(Castro, 2014; Friedman, 2016).  The VA approved the use of cognitive processing 
therapy (CPT), prolonged exposure (PE), eye movement desensitization and reprocessing 
(EMDR), traditional talk therapy, and pharmacotherapy for the treatment of PTSD 
(Castro, 2014; Friedman, 2016; Selfridge, 2014).  These VA-approved approaches, 
however, came with barriers to effective resolution of PTSD symptoms (Bardhoshi et al., 
2015; Selfridge, 2014).  The length and duration of these available treatments often did 
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not align well with veterans’ mobility needs and quick deployment turnarounds (Castro & 
Kintzle, 2014; Hoge et al., 2014; Huan & Kashubeck-West, 2015).  The need for 
between-session homework and the reexperiencing of the trauma memory created high 
rates of treatment dropout, non-response, and non-completion for those who did seek 
PTSD treatment (Hoge et al., 2014; Kip et al., 2016; Ritchie, 2015).  Hoge et al. (2014) 
and Ritchie (2015) found that many patients did not resolve their PTSD symptoms.  This 
was significant considering that Hoge et al. (2014) and Huang and Kashubeck-West 
(2015) estimated that one in six veterans returning from the most recent conflicts met the 
criteria for PTSD.  Additionally, an estimated 70% of the combat veterans treated within 
the VA healthcare system had symptoms consistent with PTSD (Hoge et al., 2014; Huang 
& Kashubeck-West, 2015; Kip et al., 2016; Moran, Burker, & Schmidt, 2013).  This 
percentage only included veterans who sought PTSD treatment.  Unresolved PTSD is 
associated with comorbidities that include anxiety, depression, and chronic illness (Hoge 
et al., 2014; Kip et al., 2016; Moran et al., 2013). 
Unresolved PTSD was also associated with the perceived guilt combat veterans 
experienced when they killed someone or saw another service member get killed 
(Dettmer, Kappes, & Santiago, 2015).  These unresolved PTSD symptoms contributed to 
an increased rate of combat veteran suicides that have exceeded civilian suicide rates 
since 2008.  Nelson (2015) reported that in 2012 the United States Department of 
Veterans Affairs estimated that 8,000 veterans committed suicide each year—an average 
of 22 suicides per day (Nelson, 2015).  The main reason these suicides were on the rise 
was because soldiers chose to end the suffering permanently when they could not 
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separate themselves from their war memories, images, sensations, and feelings (Nelson, 
2015). Hoge et al. (2014), Mott, Hundt, Sansgiry, Mignogna, and Cully (2014), and 
Ritchie (2015) concluded that there was a need for more research to investigate other 
factors that contributed to PTSD onset and to hasten the approval and use of emerging 
interventions.   
Hernandez, Waits, Calvio, and Byrne (2016), Hoge (2015), and Kip et al. (2013, 
2016) found that accelerated resolution therapy (ART), an empirically supported, trauma-
focused intervention not yet approved by the VA, was an effective psychotherapy 
treatment for trauma and other anxiety and stressor-related disorders.  Therapists 
participating in the above studies delivered the ART protocol  in one to five 60-minute 
session(s) without the patient completing any between-session homework or repeatedly 
listening to recorded trauma accounts between session.  Researchers have, therefore, 
found that the ART protocol offers an expedient alternative to existing VA-approved 
PTSD treatment options (Hoge, 2015; Kip et al., 2016; Waits, Kip, & Hernandez, 2015).  
Hernandez et al., Hoge, and Kip et al. also found that ART included the same core in-
session components (narrative, in vivo or imaginal exposure, cognitive restructuring, and 
relaxation/stress modulation) as other proven, exposure-based PTSD interventions with 
the added differentiator that ART was equally effective whether or not the patient 
verbally shared the trauma narrative with the therapist during the session (see also 
Ritchie, 2015; Waits et al., 2015).  In a review of the literature, I found that ART 
appeared effective for PTSD symptom reduction in veteran populations (Hoge, 2015; Kip 
et al., 2013, 2014a, 2014b, 2016; Ritchie, 2015; Waits et al., 2015).  However, none of 
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the available ART research studies I reviewed included analysis of variables to predict 
which veterans most benefitted from use of ART for PTSD symptom reduction (Hoge, 
2015; Kip et al., 2013, 2014a; Ritchie, 2015; Waits et al., 2015). 
Therefore, I used secondary data in this correlational study to analyze whether the 
selected variables of interest predicted PTSD symptom reduction by use of ART in a 
veteran sample (see Field, 2013).  I also used secondary analysis of existing data to 
measure whether the variation in PTSD symptom reduction by use of ART differed 
among the three identified PTSD symptom severity groups by measuring mean PTSD 
symptom reduction (see Field, 2013; Kip et al., 2016).  Foa and Kozak’s (1986) 
emotional processing theory served as the theoretical basis of this study and aligned well 
with the underlying theory of the ART protocol.  The ART protocol focuses on 
sufficiently reactivating the trauma memory and images to then extinguish those negative 
images, cognitions, emotions, and sensations before introducing corrective information 
during a reconsolidation phase (Kip et al., 2016).  
In this study, I aimed to build the first predictive treatment-matching model for 
the use of ART, the trauma-based treatment chosen for analysis in this study. A 
predictive model offers broad social implications.  Behavioral health practitioners would 
be able to use it to assess baseline thresholds for ART intervention effectiveness in 
veteran populations (Kip et al., 2016).  This level of specificity may contribute toward 
PTSD symptom reduction or extinguishment without the need for multiple PTSD 
interventions (Hoge, 2015; Kip et al., 2016; Ritchie, 2015).  The expedient reduction of 
PTSD symptoms may also reduce the incidence of associated comorbid disorders such as 
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depression, anxiety, suicidality, medication overuse, alcohol abuse, and other life-
threatening diseases (Kip et al., 2016; Xue et al., 2015).  I also aimed to contribute to 
existing ART research in support of future consideration by the VA/DoD for inclusion of 
ART as an approved veteran PTSD intervention (Kip et al., 2016).  Other social change 
implications include raising awareness for alternate PTSD treatment interventions that 
more expediently meet the psychological needs of veterans suffering with PTSD 
symptoms and encouraging other researchers to contribute to this important field of study 
(see Kip et al., 2016; Ritchie, 2015; Waits et al., 2015).   
This chapter continues with a discussion of the background, the problem 
statement, and a discussion of the study’s purpose.  Included as well are the research 
questions and hypotheses, and an expanded summary of the theoretical framework.  
There is also detailed clarification of the study’s key terms, assumptions, limitations, and 
significance. 
Background 
The phenomenon of combat-related PTSD known by many different names before 
it was formally categorized as a psychological disorder in 1951 has existed for as long as 
soldiers have been in wars (Levinson, 2015).  This psychological condition results from 
experiencing or witnessing a terrifying event (American Psychological Association 
[APA], 1980, 1987, 1994, 2000, 2013; Levinson, 2015).  The effects of PTSD on combat 
veterans were noticeable as early as World War I (Levinson, 2015).  The disorder has 
previously been known as shell shock, battle fatigue, and gross stress reaction (Harris et 
al., 1995; Levinson, 2015; Swank & Marchand, 1946; Wilson et al., 2001).  The APA 
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eventually included the diagnosis of PTSD in its 1980 Diagnostic and Statistical Manual 
of Mental Disorders (3rd ed.; DSM-3) after the Vietnam war (APA, 1980).  The 
symptoms that support a PTSD diagnosis include the presence of intrusive thoughts, 
maladaptive avoidance behaviors, negative ruminations, and hyperarousal; all at severity 
levels that signal the need for treatment (APA, 1980, 2000, 2013; Hinton & Good, 2016; 
Huang & Kashubeck-West, 2015; Selfridge, 2014).  Selfridge (2014) explained that the 
symptoms of PTSD were elusive and manifested months or years after the traumatic 
event.  Ritchie (2015) found that veterans with unresolved trauma were at higher risk for 
developing comorbid disorders, such as depression, anxiety, chronic illness, suicidality, 
and other mental health disorders.  Adler and Castro (2014) and Phillips et al. (2016) also 
found that veterans with PTSD and comorbid disorders reported a higher incidence of 
health problems, used more healthcare services, incurred greater healthcare costs, had 
higher rates of work absenteeism, and developed maladaptive coping skills to address 
their depression and anxiety.  
Advancements in PTSD research have led to the creation of specialized 
psychotherapy treatments such as CPT, PE, and EMDR to name a few of the existing 
empirically supported PTSD treatments (Karlin, 2012; Ritchie, 2015).  Randomized 
controlled trials have shown that CPT, PE, and EMDR interventions significantly reduce 
PTSD symptoms (Karlin, 2012; Rauch, Eftekhari, & Ruzek, 2012).  However, the above 
existing therapies are lengthy, time-consuming, and include between-session homework 
and exposure exercises that risk retraumatization (Feeny & Foa, 2005).  Treatment 
dropout, non-response, and non-compliance rates are also quite high across all VA-
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approved PTSD treatment modalities, compromising treatment outcomes (Feeny & Foa, 
2005; Hembree & Foa, 2010; Kip et al., 2013).  Clear PTSD treatment guidelines were 
established by the DoD and the Veterans Health Administration (VHA); however, many 
patients remained treatment-resistant and continued to suffer with PTSD symptoms that 
worsened their disorder and led to other physiological and psychological sequelae 
(Bernardy & Friedman, 2012).  Treatment studies showed only moderate to modest 
results, signaling a need for more research to explore the factors that influence PTSD 
treatment response and inform relapse prevention efforts (Feeny & Foa, 2005).  
The varied spectrum of PTSD symptoms combined with the urgent need for 
alternative PTSD treatment options has challenged the VA and DoD to keep pace with 
demands for effective treatments (see Karlin, 2012; Ritchie, 2015; Waits et al., 2015).  
Although many empirically supported treatment options such as CPT, PE, and EMDR are 
made available to veteran populations through the DoD and VA healthcare system, 
utilization of these services remains low, and it is unclear which treatment protocols best 
serve the needs of veterans diagnosed with PTSD (Castro, 2014; Haagen, Smid, 
Knipscheer, & Kleber, 2015; Ritchie, 2015).  Therefore, Ritchie (2015) and Waits et al. 
(2015) advocated for continued research to understand the factors that better align 
treatment choice with veterans’ presenting PTSD concerns to effect timely and expedient 
PTSD symptom reduction.  
Castro (2014) found that cognitive therapies and psychopharmacology present the 
best outcomes for PTSD symptom reduction.  However, Castro also found that 
pharmacotherapy offers inconsistent relief of symptoms and ongoing clinical trials are 
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focused on the most therapeutic constructs for the use of pharmacotherapy alone or in 
combination with other empirically supported PTSD treatment modalities.  Castro, Hoge 
(2015), Ritchie (2015), and Ritchie and Nelson (2015) concluded that continued research 
is needed to explore PTSD treatment options that are expedient and do not rely on the 
adjunct of psychotropics to enhance efficacy rates. 
Kip et al. (2016), Hernandez et al. (2016), and Waits et al. (2015) found that ART 
is an effective, brief trauma-focused therapy that appears effective for the treatment of 
PTSD in veteran populations.  Kip et al., Hernandez et al., and Waits et al. further 
clarified that ART differs from other therapies because the treatment focus is on the 
patient’s trauma images rather than cognitions.  Use of imagery, metaphors, and Gestalt 
techniques helps conceptualize the trauma and associated guilt, depression, anxiety, and 
other deep emotions to dismantle the trauma and create separation between the patient’s 
sense of self and the traumatic stimuli (Kip et al., 2016; Waits et al., 2015).  This results 
in a new awareness and understanding that helps normalize the trauma by rescripting the 
metaphorical components until the patient achieves resolution of the presenting trauma 
(Kip et al., 2016; Waits et al., 2015).  The process also helps resolve associated comorbid 
sequalae that surface organically through the lens of the restructuring process (Hoge, 
2015; Kip et al., 2016; Waits et al., 2015).  Finnegan et al. (2016) found that ART offered 
brief trauma-based treatment for sustained resolution of PTSD symptoms.  Finnegan et al. 
concluded that ART should be considered a first-line treatment protocol for treatment-
resistant or comorbid PTSD.  Kip et al. (2014a) found that the theoretical base for ART 
comprises three proven trauma-focused therapy components that include imaginal 
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exposure (IE), imagery rescripting (IR), and smooth-pursuit eye movements (EM).  Kip 
et al. found that the above components support effective reduction of PTSD-related 
symptoms such as intrusive thoughts, sensations, emotions, and images.  The theoretical 
base for ART is consistent with Foa and Kozak’s (1986) emotional processing theoretical 
framework, which informed this study (Kip et al., 2014a, 2016). 
Randomized controlled trials conducted by Kip et al. (2012, 2013, 2014a) 
examined the use of ART among combat veterans.  Aggregate outcomes showed that 
ART offers meaningful results for the effective treatment of PTSD (Kip et al., 2012, 
2013, 2014a).  However, none of the published ART studies included analysis of 
variables to predict which veterans most benefit from ART for PTSD symptom reduction, 
and none of the studies included analysis to determine mean PTSD symptom reduction 
amounts by symptom severity group (Field, 2013). 
Therefore, this quantitative study informed by Foa and Kozak’s emotional 
processing theory fills the gap in the literature by analyzing selected variables to predict 
which veterans most benefit by use of ART for PTSD symptom reduction and whether 
mean PTSD symptom reduction differs by symptom severity group (Field, 2013).  In the 
study, I aimed to produce a predictive model that could be applied to any PTSD 
intervention to create a scientific treatment-matching model or algorithm that predicts 
PTSD symptom reduction. 
Problem Statement 
PTSD is the result of direct or indirect traumatic experiences that may include 
injury, sexual or physical violence, the risk of death, or witnessing actual death 
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(Bardhoshi et al., 2016).  Symptoms of PTSD include reliving components of the 
traumatic event, experiencing intrusive thoughts and flashbacks, displaying avoidant 
behaviors, self-medicating, numbing of emotional experiences, and heightened arousal 
(Bardhoshi et al., 2016).  PTSD increases the risk of suicides due to a higher prevalence 
of comorbidities between PTSD and depression, anxiety, phobias, isolation, aggression, 
homelessness, and maladaptive family systems, all culminating in overall poorer health 
outcomes (Bardhoshi et al., 2016; Huang & Kashubeck-West, 2015).  Combat veterans, 
the focus of this study, are at higher risk for PTSD, with one in six veterans of the most 
recent conflicts (Operation Enduring Freedom [OEF] and Operation Iraqi Freedom 
[OIF]) meeting the diagnostic criteria for PTSD after returning from combat (Bardhoshi 
et al., 2016; Huang & Kashubeck-West, 2015; Moran et al., 2013).  As a result, the 
estimated prevalence for PTSD in veteran populations is 20% (Bardhoshi et al., 2016).  
Advancements in PTSD research have led to the creation of specialized 
psychotherapy treatments such as CPT and PE (Karlin, 2012).  Randomized controlled 
trials have shown that CPT and PE interventions significantly reduce PTSD symptoms 
(Karlin, 2012; Rauch et al., 2012).  The above cognitive behavioral therapies and other 
therapies such as EMDR are also interventions that have resulted in statistically 
significant PTSD symptom reduction (Rauch et al, 2012).  However, these existing 
empirically-supported therapies are lengthy, time-consuming, and include between-
session homework and exposure exercises where the patient must record their trauma 
narrative in session and listen to the recording repeatedly between sessions, increasing 
the risk of retraumatization (Feeny & Foa, 2005).  Treatment dropout, non-response, and 
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non-compliance rates are high across these treatment modalities, compromising treatment 
outcomes (Feeny & Foa, 2005; Hembree & Foa, 2010; Kip et al., 2013).  For example, 
CPT requires 12 sessions including homework assignments.  The dropout rate is as much 
as 30% in some programs, and the non-response rate is as much as 48%.  Verbal and/or 
written trauma accounts are required protocol components. Researchers have found there 
is a 5% to 10% risk that symptoms will worsen and the protocol does not address 
replacement of negative trauma images (Chard et al., 2012; Hernandez et al., 2017; Kip et 
al., 2013).   
The PE protocol requires eight to 12 sessions including homework assignments, 
and the patient must provide verbal and written accounts of the trauma. The studies I 
reviewed revealed a dropout rate of up to 50%; a non-response rate of up to 67%; and a 
13% to 25% risk that symptoms might worsen.  The protocol does not replace negative 
trauma images (see Hembree & Foa, 2010: Hernandez et al., 2017; Kip et al., 2013; 
Thomas et al., 2015).   
The EMDR protocol consists of eight to 12 sessions including limited homework 
assignments and patients must complete verbal and written trauma accounts.  The studies 
I reviewed revealed a dropout rate of up to 36%; a non-response rate of up to 90%; and a 
20%  risk of symptoms worsening.  The protocol does not replace negative images (see 
EMDR Institute, Inc., 2017; Hernandez et al., 2017; Kip et al., 2013; Shapiro 2001, 
2012). Richie (2015) found that veterans suffering with chronic PTSD symptoms were 
also more treatment-resistant, and treatment studies showed only moderate to modest 
results from existing trauma-based exposure therapies such as CPT, PE, and EMDR.  
12 
 
In contrast, the ART protocol consists of one to five sessions without the need for 
homework or written patient trauma accounts, and the patient can choose whether to 
verbalize the trauma memory during the session (Kip et al., 2016). Researchers have 
found that the ART dropout rate is 6%, and the non-response rate is 30% (Hernandez et 
al., 2017; Kip et al., 2013). Researchers also found that there is a less than 2% risk of 
symptoms worsening, and the protocol does include replacement of negative images 
(Hernandez et al., 2017; Kip et al., 2013).   
Despite treatment advancements over the last 30 years, veterans continue to 
struggle with a sense of hopelessness and a loss of meaning in life due to their treatment-
resistant PTSD symptoms (Feeny & Foa, 2005; Ritchie, 2015).  Such struggles signal a 
critical need for more research to explore the factors that influence PTSD treatment 
response and inform relapse prevention efforts (Feeny & Foa, 2005; Ritchie, 2015).   
This study design, therefore, includes  secondary data from a prospective study of 
ART, an emerging trauma-focused intervention delivered in as little as one to five 60-
minute sessions without any between-session homework, the need to repeatedly listen to 
recorded trauma accounts between sessions, or the retelling of the trauma experience 
during the session if the patient is unwilling or unable to verbally share the trauma 
experience (Hernandez et al., 2016; Kip et al., 2013, 2016).  The ART intervention 
protocol is built on the core in-session components of other proven, empirically-
supported PTSD interventions to include narrative, in-vivo and/or imaginal exposure, 
cognitive restructuring, and relaxation/stress modulation (Hernandez et al., 2016; Hoge, 
2015; Kip et al., 2016).  The United States Substance Abuse and Mental Health Services 
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Administration (SAMHSA) and the National Registry of Evidence-Based Programs and 
Practices (NRE-PP) classified ART as an empirically-supported therapy effective for the 
treatment of trauma and other anxiety and stressor-related disorders, as well as depression 
(Hernandez et al., 2016; Kip et al., 2016).  In a review of the literature, I found that ART 
is an effective intervention for the treatment of PTSD symptoms in veteran populations 
(Kip et al., 2016; Ritchie, 2015; Waits et al., 2015).  More ART research may strengthen 
the merits of using ART as an exposure-based, cognitive intervention not currently 
offered within the VA/DoD behavioral health system for PTSD symptom reduction in 
veteran populations (Hoge, 2011, 2015; Hoge et al., 2014; Kip et al., 2013, 2016).  
Therefore, this study filled the gap in the literature by examining the variables that might 
predict which veterans benefit most by use of ART for PTSD symptom reduction. 
Purpose of the Study 
In this quantitative study informed by Foa and Kozak’s (1986) emotional 
processing theory, I conducted a secondary analysis of existing data from a prospective 
cohort treatment study of ART (Kip et al., 2016) registered at www.clinicaltrials.gov 
(NCT02030522).  My intent was to analyze whether number of deployments, guilt, 
depression, and anxiety predicted PTSD symptom reduction by use of ART for veterans 
who completed a course of ART (Field, 2013; Kip et al., 2016).  In addition, I assessed 
the variation in PTSD symptom reduction by PTSD symptom severity group to calculate 
mean PTSD symptom reduction differences among the low, moderate, and high PTSD 
symptom severity groups (Field, 2013). 
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Research Questions and Hypotheses 
RQ1: What is the effect of number of deployments, guilt, depression, and anxiety 
in predicting PTSD symptom reduction for veterans who complete ART? 
Ho1: Number of deployments, guilt, depression, and anxiety do not predict PTSD 
symptom reduction for veterans who complete ART. 
Ha1: At least one predictor, number of deployments, guilt, depression, and anxiety 
will predict PTSD symptom reduction for veterans who complete ART. 
RQ2: What is the variation in PTSD symptom reduction among low, moderate, 
and high PTSD symptom severity groups? 
Ho2: There is no variation in PTSD symptom reduction among low, moderate and 
high PTSD symptom severity groups.  
Ha2: There is variation in PTSD symptom reduction for at least one of the three 
(low, moderate, high) PTSD symptom severity groups.   
Theoretical Framework for the Study 
Foa and Kozak’s (1986) emotional processing theory holds that activation of fear 
structures trigger stimulus and response memory structures (Rauch & Foa, 2006).  The 
excessive response to these activated fear structures differentiate pathological fear 
structures from normal fear structures (Rauch & Foa, 2006).  These excessive responses 
cause a form of generalized fear that attribute meaning elements and trigger excessive 
stimulus and response fear structures to otherwise non-threatening structures (Rauch & 
Foa, 2006).  Symptoms persist because avoidant behaviors prevent the processing of 
traumatic experiences (Rauch & Foa, 2006; Rosen & Frueh, 2010). 
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The other constructs that the authors attributed to PTSD maintenance were that 
the world is a dangerous place and that the self is perceived incompetent and incapable 
(Rauch & Foa, 2006; Rosen & Frueh, 2010).  Foa and Kozak (1986) further proposed that 
extinguishment of PTSD-related fear structures need activation of the fear structure and 
introduction of corrective information to replace pathological constructs with realistic 
ones (Rauch & Foa, 2006; Rosen & Frueh, 2010). 
Imaginal exposure and in-vivo exposure activate the traumatic memories, 
sensations, emotional cognitions, and images associated with the trauma to rescript 
trauma-based images and sensations during a reconsolidation process (Hernandez et al., 
2015; Kip, 2012, 2013, 2014a, 2014b, 2016; Rauch & Foa, 2006).  Therapeutic 
interventions must ensure that patients sufficiently engage in the process to activate the 
fear structures, such that modification can occur (Rauch & Foa, 2006).  This theoretical 
framework was useful in understanding the processes that constitute effective exposure-
based treatment.  The theoretical framework was aligned with ART’s theoretical 
framework (Kip et al., 2016).  The ART protocol relies on sufficiently activating the fear 
structures to extinguish associated fear-based images, negative cognitions, feelings, and 
sensations and then rescripts the trauma-based images, associated feelings, and sensations 
during a reconsolidation process (Hernandez et al., 2015; Kip, 2012, 2013, 2014a, 2014b, 
2016; Rauch & Foa, 2006).  The extinguishment of the symptoms associated with 
negative images, thoughts, feelings, and sensations during the reconsolidation process is 
what forms the basis for PTSD symptom reduction by use of ART (Hoge, 2015; 
Hernandez et al. 2016; Kip et al., 2016; Waits et al., 2016).   
16 
 
Nature of the Study 
A quantitative strategy of inquiry using secondary data and informed by Foa and 
Kozak’s (1986) emotional processing theory was consistent with the study’s purpose and 
research questions.  I conducted a multiple regression analysis to examine whether 
number of deployments, guilt, depression, and anxiety predicted which veterans 
benefitted most from ART for PTSD symptom reduction (Field, 2013; Kip et al., 2016).  
An ANOVA test was computed to examine mean PTSD symptom reduction among three 
PTSD symptom severity groups at low, moderate, and high PTSD symptom severity 
levels (Field, 2013; Kip et al., 2016). Post-hoc tests showed whether significant 
differences occurred among the low, moderate, and high PTSD symptom severity groups 
(Field, 2013).  The secondary analysis of existing data from a prospective cohort 
treatment study of ART registered at www.clinicaltrials.gov (NCT02030522) included a 
sample of 108 adult male and female veterans with a history of combat deployments who 
were experiencing PTSD symptoms (Kip et al., 2016).  All participants in the sample 
completed ART intervention during the prospective cohort treatment study of ART (Kip 
et al., 2016).  In this study, I aimed to fill the gap in the literature by creating a predictive 
treatment-matching model to predict which veterans most benefit from ART for PTSD 
symptom reduction (Field, 2013; Kip et al., 2016). 
A qualitative strategy of inquiry would neither have achieved this study’s purpose 
nor answered the research questions because inferences and generalizability would not 
have been possible (Field, 2013).  I therefore used deductive inquiry to answer the 
research questions and to analyze secondary data from reliable, valid, and measurable 
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Likert scales to examine which independent variables might predict PTSD symptom 
reduction in veteran populations and whether mean PTSD symptom reduction amounts 
differed when study participants were stratified by symptom severity levels (see Field, 
2013).  
Definitions 
Veterans: Veterans in this study were identified as adult active-duty, reservist, or 
discharged United States armed forces veterans or service members with a history of 
combat deployments who were experiencing PTSD symptoms (Kip et al., 2016).   
Number of deployments: The definition of the continuous, independent variable, 
number of deployments, as measured by data from the original study’s demographics 
form (DF), was identified as the movement of military soldiers to assigned conflict areas 
(Hoge, 2011, 2015). 
Guilt: The definition of the continuous independent variable guilt, as measured by 
the original study’s Trauma-Related Guilt Inventory (TRGI) pretreatment scores was 
identified as an unpleasant or negative feeling with an associated belief that more could 
have been done to change the outcome of what occurred (Kubany et al., 1996).   
Depression: The definition of the continuous independent variable depression, as 
measured by the original study’s Center for Epidemiologic Studies-Depression (CES-D) 
scale pretreatment scores, was identified as a persistent sadness that affected thoughts, 
feelings, and behaviors (Van Voorhees, Gollan, & Fogel, 2012).   
Anxiety: The definition of the continuous independent variable anxiety, as 
measured by the original study’s State-Trait Inventory for Cognitive and Somatic 
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Anxiety (STICSA) scale pretreatment scores, was identified as a feeling of tension, 
negative cognitions, and physiological reactions, such as elevated blood pressure (Ree, 
French, MacLeod, & Locke, n.d.). 
PTSD symptom reduction: For this study, the definition of the dependent variable 
PTSD symptom reduction, as measured by the original study’s PTSD Checklist-Military 
(PCL-M) scale scores, was identified as the difference between study participants’ 
pretreatment and posttreatment scores, before and after ART. 
PTSD symptom severity group: The definition of PTSD symptom severity group, 
as measured by the original study’s PCL-M scale pretreatment scores, was identified as 
the study participants grouped into three independent groups according to a range of 
PCL-M scale pretreatment scores (Field, 2013; Kip et al.., 2016).  Group 1 consisted of 
study participants with PCL-M scale pretreatment scores at or lower than 50.  Group 2 
consisted of study participants with PCL-M scale pretreatment scores ranging from 51 to 
60.  Group 3 consisted of study participants with PCL-M scale pretreatment scores at or 
greater than 61. 
Demographics form: The DF was identified as the intake form used in the 
prospective cohort treatment study of ART to capture military demographic information 
about each study participant.  The respective number of deployments study participants 
recorded on their DF to include 1, 2, 3, or 4 or more deployments was the construct of 
interest for this study.  
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Assumptions 
I assumed that this study and its findings will be beneficial for veterans diagnosed 
with PTSD (Hoge, 2015; Kip et al., 2016; Waits et al., 2015).  The study’s constructs will 
better inform behavioral health practitioners and researchers about the needs of veterans 
diagnosed with PTSD.  I also assumed that the secondary data self-rating scales I used for 
this study and have detailed in the instrumentation section of Chapter 3 are reliable and 
valid measurements for the constructs of guilt, depression, and anxiety, which could not 
be measured directly.  The pretreatment scores on each respective self-rating scale were 
utilized to measure the level of perceived guilt, the level of symptom severity for 
depression, and the level of symptom severity for anxiety.  Finally, I assumed that 
participants in the original study responded honestly when completing their self-rating 
scales. 
Scope of Delimitations 
The scope of this study includes analysis of whether the identified predictors of 
number of deployments, guilt, depression, and anxiety predicts PTSD symptom reduction 
for veterans who completed ART and whether PTSD symptom reduction differs by 
PTSD symptom severity groups classified at low, moderate, or high PTSD symptom 
severity levels to compare mean PTSD symptom reduction differences among the three 
groups. The difference in PCL-M scale scores before and after treatment with ART will 
account for the mean PTSD symptom reduction.  I selected the ART protocol for analysis 
because the ART treatment components aligned with and supported Foa and Kozak’s 
(1986) emotional processing theory in which imaginal exposure and in vivo exposure  
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support activation of the traumatic memories, sensations, emotional cognitions, images, 
and perceptions associated with the trauma to rescript trauma-based images and 
sensations during a reconsolidation process, thus leading to PTSD symptom reduction or 
extinguishment (Hernandez et al., 2016; Kip, 2013, 2016; Rauch & Foa, 2006).  After 
reviewing the literature on the effectiveness of ART in veteran populations and the need 
for more effective and expedient PTSD treatment alternatives, I determined that it was 
important to fill the identified gap in understanding by attempting to create a PTSD 
treatment-matching model that might predict which veterans benefit most from use of 
ART for PTSD symptom reduction. This scientific treatment-matching model or 
algorithm might inform other PTSD treatment outcomes, thereby improving PTSD 
treatment efficacy outcomes in veteran populations (see Hoge, 2015; Kip et al., 2016; 
Waits et al., 2015; Ritchie, 2015). An analysis of the variables that predict which veterans 
most benefit from ART intervention for PTSD symptom reduction and which of the three 
PTSD symptom severity groups experience the greatest difference in mean PTSD 
symptom reduction might better inform behavioral health practitioners regarding which 
veterans benefit most from ART for PTSD symptom reduction (Field, 2013).  An 
important boundary of this study is the inclusion of adult combat veterans with a history 
of PTSD who completed ART.  Therefore, the results of this study are only generalizable 
to adult combat veterans suffering with PTSD.  Exclusions in the secondary data I used 
include adult veterans with suicidality, comorbid psychiatric disorders that could interfere 
with treatment, and traumatic brain injury severe enough to impede cognitive functioning 
(Kip et al., 2015). 
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Limitations 
Limitations of this study include self-assessments that, by their subjective nature, 
may result in responder bias, as well as the inability to assess the impact of participants’ 
engagement levels on the study’s statistical outcomes.  Additionally, future ART 
researchers are encouraged to consider the inclusion of study participants with suicidal 
ideation and those who are in the recovery phase of their alcohol or drug treatment.  
These inclusions might result in better assessment of the effects of ART intervention on 
PTSD symptom reduction in veteran populations with comorbid disorders such as alcohol 
and drug abuse, as well as those whose PTSD symptoms have triggered suicidal thoughts 
(see Kip et al., 2016; Ritchie, 2015).  Despite the above limitations, a correlational 
research design is appropriate because it allows for statistical inferences and serves to 
contribute to existing research on available trauma-based treatment for PTSD symptom 
reduction in veteran populations (Castro, 2014; Hoge, 2015; Kip et al., 2016). 
Significance 
In this study, I sought to produce a treatment-matching model used to predict 
PTSD symptom reduction amounts by use of ART, a brief trauma-based intervention for 
veterans seeking PTSD symptom reduction (Huang & Kashubeck-West, 2015). The same 
treatment-matching model could be applied to other constructs and other trauma-based 
interventions to determine PTSD symptom reduction amounts.  Use of a treatment-
matching model may help identify baseline thresholds that could better inform behavioral 
health practitioners treating veterans with PTSD.  The study’s findings will contribute to 
existing literature on PTSD in veterans population and may support inclusion of 
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treatment-matching algorithm analyses in current and ongoing PTSD research studies.  
The study findings may also be of interest to VA and DoD researchers, as they consider 
empirically validated brief trauma-based interventions such as ART (Kip et al., 2016; 
Waits et al., 2015).  The knowledge derived from this study may inform PTSD treatment 
choices and relapse prevention efforts in veteran populations.  The creation of a 
predictive treatment-matching model that can be applied across other PTSD treatment 
options may lead to a reduction in the PTSD-related comorbidities and suicide rates 
associated with unresolved PTSD (Hoge, 2011; Kip et al., 2016; Ritchie, 2015). 
Summary 
Documented evidence of posttraumatic stress in its many iterations existed long 
before it was formally classified as a disorder in 1951 (Levinson, 2015).  There have been 
many names for the disorder, and many theorists have debated about assessment, 
diagnosis, and treatment approaches (see Hoge, 2015; Kip et al., 2016; Levinson, 2015; 
Ritchie, 2015; Waits et al., 2015; Xue et al., 2015).  Research and treatment advances 
have occurred over the decades (Xue et al., 2015).  However, the etiology of PTSD 
remains unclear, and the symptoms and degree of recovery are unique to each individual 
(Hoge et al., 2014; Ritchie, 2015).   
Barriers to effective resolution of PTSD symptoms persist, despite empirically 
supported research on the effectiveness of available PTSD interventions such as CPT, PE, 
EMDR, traditional talk therapy, and pharmacotherapy, due to the complex nature of 
combat-related PTSD symptoms (Waits et al., 2015).  The DoD and the VHA have 
created clear treatment guidelines, yet veterans have continued suffering with treatment-
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resistant PTSD symptoms (Bernardy & Friedman, 2012; Hoge, 2015; Ritchie, 2015).  
These unresolved PTSD symptoms have led to other physiological and psychological 
sequelae (Bernardy & Friedman, 2012).  In the literature review, I found that researchers 
have advocated for continued PTSD research to examine additional factors that influence 
PTSD symptom reduction and resolution of PTSD-related comorbidities such as 
depression, anxiety, and suicidality (see Dettmer et al., 2015; Leardmann et al., 2013; 
Ritchie, 2015; Waits, Marumoto, & Weaver, 2017).  These comorbidities have become a 
critical research focus because veteran suicides exceeded civilian rates in 2008, and the 
current rate of suicide in veteran populations is 22 suicides per day (Dettmer et al., 2015; 
Leardmann et al., 2013; Ritchie, 2015). 
Although many empirically supported PTSD treatment options are available to 
veteran populations through the DoD and VA healthcare system, use of existing health 
services remains low, and it is still unclear which treatment protocols best serve the needs 
of veterans diagnosed with PTSD (Castro, 2014; Haagen et al, 2015; Ritchie, 2015).  
Hoge et al. (2014) and Waits et al. (2015) found that the low utilization and high dropout, 
non-response, and non-compliance rates are due to lengthy and time-consuming 
therapies, the inclusion of required between-session homework, and the exposure 
exercises that patients are required to complete on their own between sessions, potentially 
retraumatizing them when they are required to repeatedly recall their trauma memories, 
images, sensations, and feelings without the support of their therapist (see Feeny & Foa, 
2005; Hembree & Foa, 2010; Hernandez et al., 2016; Hoge et al., 2014; Kip et al., 2013; 
Ritchie, 2015).  Veterans suffering with symptoms of chronic PTSD are also more 
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treatment-resistant resulting in moderate to modest results (Friedman, 2016; Hernandez et 
al., 2016; Ritchie, 2015). 
A review of study findings from experts in the field of PTSD research confirmed 
the need for continued research to analyze which factors contribute to PTSD onset to 
hasten the approval of alternative and emerging PTSD treatments that address these 
factors (Hawley, Armstrong, Czarnota, & Field, 2013; Kip et al., 2016; Mott et al., 2014; 
NIMH, 2016; Ritchie, 2015). 
My review of the available literature also revealed that ART is an evidence-based 
trauma intervention not offered within the VA/DoD behavioral health system (see Hoge, 
2015; Kip et al., 2013, 2014; Ritchie, 2015; Waits et al., 2015).  Therefore, this 
correlational study using secondary data and informed by Foa and Kozak’s emotional 
processing theory fills the gap in the literature by analyzing whether number of 
deployments, guilt, depression, and anxiety predict which veterans most benefit from 
ART intervention for PTSD symptom reduction and weather mean PTSD symptom 
reduction differ by symptom severity groups at low, moderate, and high PTSD symptom 
severity levels (Kip et al., 2012, 2013, 2014a, 2014b, 2016). The outcomes of this study 
will inform practitioners regarding the potential benefits of utilizing a treatment-matching 
algorithm to predict the amount of improvement possible by use of ART for PTSD 
symptom reduction (Field, 2013; Kip et al., 2016). 
In Chapter 2, I present an overview of the available literature on PTSD, the 
literature search strategy, the theoretical foundation that informs this study, the literature 
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review specific to the constructs under investigation, and the methodology I used in this 
study. 
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Chapter 2: Literature Review  
Introduction 
PTSD onset results from direct or indirect traumatic experiences that may include 
injury, sexual or physical violence, the risk of death or witnessing the death of another 
(APA, 2013; Bardhoshi et al., 2016).  Symptoms of PTSD include reliving components 
of the traumatic event, experiencing intrusive thoughts and flashbacks, displaying 
avoidant behaviors, self-medicating, numbing of emotional experiences, and heightened 
arousal (APA, 2013; Bardhoshi et al., 2016).  A diagnosis of PTSD increases the risk of 
suicide due to a higher prevalence of comorbidities between PTSD and depression, 
anxiety, phobias, isolation, aggression, homelessness, and maladaptive family systems 
(Bardhoshi et al., 2016; Huang & Kashubeck-West, 2015).  These associated 
comorbidities culminate in overall poorer health and quality of life outcomes (Bardhoshi 
et al., 2016; Huang & Kashubeck-West, 2015).  
Combat veterans, the focus of this study, are at higher risk for PTSD (Hoge, 
2011).  Prevalence rates for combat-related PTSD have ranged from 2% to 17% in the 
veteran population since the Vietnam War. One in six veterans of the most recent 
conflicts (Operation Enduring Freedom and Operation Iraqi Freedom) met the criteria for 
PTSD after returning from military combat deployment (Bardhoshi et al., 2016; Fischer, 
2014; Huang & Kashubeck-West, 2015; Moran et al., 2013).  The overall prevalence rate 
for veteran PTSD is up to 20% (Bardhoshi et al., 2016).  Statistics on  prevalence rates 
range widely because the DoD has not systematically gathered statistical data specific to 
each war conflict, and veterans suffering with PTSD may not seek behavioral health care 
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(Bardhoshi et al., 2016).  However, the effects of combat-related PTSD pose a critical 
medical, psychological, physiological, and social crisis for veterans, their families, and 
the communities in which they live (Castro, 2014).  Advancements in PTSD research 
have led to the creation of specialized psychotherapeutic treatments such as CPT, PE, and 
EMDR (Karlin, 2012).  Randomized controlled trials have shown that CPT, PE, and 
EMDR interventions reduce PTSD symptoms (Karlin, 2012; Rauch, Eftekhari, & Ruzek, 
2012).   
However, Hoge et al. (2014), Waits et al. (2015), and Kip et al. (2016) found that 
these existing empirically-supported therapies were lengthy and time-consuming, as I 
detailed in Chapter 1.  These therapies include between-session homework and require 
patients to repeatedly listen to their recorded trauma accounts between sessions, 
increasing the risk of retraumatization (Hoge et al., 2014; Waits et al., 2015).  
Researchers found that treatment dropout, non-response, and non-compliance rates 
remained high across all treatment modalities, potentially compromising treatment 
outcomes (Feeny & Foa, 2005; Hembree & Foa, 2010; Hernandez et al., 2016; Hoge et 
al., 2014; Kip et al., 2013).  Veterans suffering with symptoms of chronic PTSD were 
also more treatment-resistant, resulting in moderate to modest results (Friedman, 2016; 
Hernandez et al., 2016; Ritchie, 2015). 
Veterans have continued to struggle with treatment-resistant PTSD symptoms 
despite treatment advancements over the last 30 years (Friedman, 2016; Morina, 
Wicherts, Lobbrecht, & Priebe, 2014).  Ritchie (2015) and Waits et al. (2015) advocated 
for continued research to find other factors that influence PTSD treatment response and 
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inform relapse prevention efforts.  The varied spectrum of PTSD symptoms combined 
with the urgent need for alternative therapy options has challenged the VA and DoD to 
keep pace with demands for effective treatments (Karlin, 2012; Ritchie, 2015; Waits et 
al., 2015).  
 Hernandez et al. (2016) and Kip et al. (2013, 2016) found that ART was an 
emerging, empirically supported, trauma-focused, intervention delivered in as little as 
one to five, 60-minute session(s) without any between-session homework, exposure 
exercises that the patient is required to complete outside of the therapy setting, or 
requirements to retell the trauma experience.  Hernandez et al., Hoge (2015), Kip et al., 
and Waits et al. (2015) confirmed that the ART intervention protocol includes core 
components consistent with other proven and empirically-supported PTSD interventions.  
The ART intervention includes narrative, in vivo or imaginal exposure, cognitive 
restructuring, and relaxation/stress modulation (see Hernandez et al., 2015; Hoge, 2015; 
Kip et al., 2013, 2016; Waits et al., 2015). However, ART does not require any between-
session homework or the need for the patient to record the trauma account and listen to it 
repeatedly between sessions (see Hernandez et al., 2015; Hoge, 2015; Kip et al., 2013, 
2016; Waits et al., 2015).   
The SAMHSA and the NRE-PP classified ART as an empirically-supported 
therapy considered effective in treating trauma and other anxiety and stressor-related 
disorders, including depression (Hernandez et al., 2016; Kip et al., 2016).  My review of 
the available literature revealed that ART was an effective PTSD intervention not yet 
offered within the VA/DoD behavioral health system (see Hoge, 2015; Kip et al., 2013, 
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2014a; Ritchie, 2015; Waits et al., 2015; Waits et al., 2017).  Therefore, I conducted this 
study to fill the gap in the literature by defining the variables that predict which veterans 
most benefit by use of ART for PTSD symptom reduction and whether the differences in 
mean PTSD symptom reduction differed among the three PTSD symptom severity 
groups classified by symptom severity levels.   
I analyzed secondary data from a prospective cohort treatment study of ART 
registered at www.clinicaltrials.gov (NCT02030522), to conduct this quantitative study.  
The correlational study design included an analysis of the selected continuous 
independent variables, as informed by the literature on PTSD in veteran populations.  The 
aim of the study was to determine whether number of deployments, guilt, depression, and 
anxiety predicted which veterans most benefitted from ART for PTSD symptom 
reduction, and whether mean PTSD symptom reduction differed among the low, 
moderate, or high symptom severity groups identified in the study (Field, 2013).  Foa and 
Kozak’s (1986) emotional processing theory served as the theoretical framework of this 
study, which I explain in detail later in this chapter. 
In Chapter 2, I offer a comprehensive literature review of the historical origins of 
PTSD in veteran populations.  The chapter also contains a review of the associated 
etiology, prevalence, symptoms, diagnostic criteria, and comorbidities associated with 
PTSD.  A review of the theoretical frameworks that informed empirically supported 
PTSD treatments is also included.  My aim in the literature review was to identify gaps in 
understanding that indicated the need for further research of emerging, empirically-
supported PTSD treatment options such as ART, the variables that predicted PTSD 
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symptom reduction, and the influence of PTSD symptom severity levels on PTSD 
symptom reduction.  
Literature Search Strategy 
The literature search consisted of a digital database review of PsycARTICLES, 
PsychiatryOnline, PsycBOOKS, ProQuest - EbooksCentral, Academic Search Complete, 
SAGE Journals, Mental Measurement Yearbook with Tests in Print, EBSCO eBooks, 
Google Books, ProQuest Health and Medical Collection, ProQuest Science Journals, 
Psychology Databases Simultaneous Search, SAGE Research Methods Online, and 
Thoreau Multiple Database Search.  I also reviewed the reference lists of journal articles 
and books for additional sources.  Keywords used to search the databases included 
posttraumatic stress disorder, history, origins, diagnosis, symptoms, prevalence, etiology, 
comorbidities, empirically supported psychotherapy treatments, combat posttraumatic 
stress disorders, predictors, veteran demographic characteristics, VA and DoD PTSD 
treatments, deployments, guilt, depression, anxiety, veterans, PTSD pharmacotherapy, 
refractory PTSD, moral injury, assessment, and emerging posttraumatic stress 
treatments.  The literature review included seminal works for PTSD self-rating scales, 
theoretical frameworks, combat-related PTSD historical origins, and empirically-
supported research studies. The literature I reviewed spanned the years 1955 through 
2018, with emphasis on the last 5 years to include current PTSD studies as well as the 
research specifically relating to ART.  The literature review offered me (a) a deeper 
understanding of the nature of the topic under investigation and the importance of 
continued research to isolate the variables that predict which veterans most benefit from 
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ART for PTSD symptom reduction, and (b) whether PTSD symptom reduction varies by 
PTSD symptom severity group.  The use of a predictive treatment-matching model to 
determine which veterans benefit most from PTSD treatment for PTSD symptom 
reduction would add a level of treatment-matching specificity that does not currently 
exist.  As the literature review showed, additional research is needed to minimize the 
need to use different intervention approaches, in a trial-and error manner, to treat 
unresolved PTSD (Hoge et al., 2014; Kip et al., 2016; Ritchie, 2015). 
Theoretical Foundation 
 Rosen and Frueh (2010) found that the brain stores and recalls traumatic 
memories in a manner that results in fragmentation.  That is, stored traumatic memories 
become fragmented in ways that are not accessible (e.g., trauma amnesia) or manifest as 
flashbacks that trigger strong sensations (Rosen & Frueh, 2010).  Eraly et al. (2014) 
theorized that traumatic memories or images are the source of PTSD symptoms that 
include intrusive thoughts, flashbacks, poor sleep, and physiological sensations.  These 
theories served to inform the development of PTSD interventions to achieve integration 
of fragmented memories or images and other nonverbal triggers associated with traumatic 
memory (Eraly et al., 2014).  Berntsen, Willert, and Ruben (2003) offered another 
perspective, arguing that the brain stores traumatic memories in the same manner as 
normal memories.  Berntsen et al. theorized that PTSD onset results from the distinct 
impact the traumatic memories make on the individual and the way the individual 
internalizes reality.  Berntsen et al. concluded that the dysfunctional memories of the 
32 
 
event, rather than exposure to the trauma event itself, explained the nature of PTSD 
onset. 
Yehuda, Neylan, Flory, and McFarlane (2013) presented a biological model 
explaining that stress hormone response creates the neurocircuitry and genetic 
predispositions for PTSD onset.  Brewin et al. (2000) proposed a psychosocial model 
explaining that exposure to life threat, violence, childhood abuse, adversities, life 
stressors, protective factors, social support, socioeconomic status, education, and social 
support all contribute to the risks or protective factors associated with PTSD onset.  
Janoff-Bulman (1992) supported a cognitive model that altered beliefs and information 
processing cause the persistent vigilance and fear.  The Janoff-Bulman theory holds that 
the shattered assumptions of the self and the world are what leads to PTSD onset.  
Learning theorists have explained PTSD onset as the activation of fear networks that 
trigger maladaptive avoidance behaviors and prevent resolution of PTSD symptoms (Foa 
& Kozak, 1986).  Emotional processing theories have pointed to hyperactivity to and 
reminders of the original traumatic event, eliciting behavioral avoidance and inability to 
resolve presenting PTSD symptoms (Foa & Kozak, 1986; Foa & Rothbaum, 1998). 
Peri, Gofman, Tal, and Tuval-Mashiach’s (2015) embodied simulation theory 
holds that exposure to traumatic memories is the underlying focus of most therapies that 
address PTSD.  However, Peri et al. found there was not enough emphasis on the impact 
of the patient-therapist alliance since much of the exposure-based work done by the 
patient occurs between sessions.  Peri et al. noticed that the modeling that occurs during 
the patient-therapist alliance serves as a vital therapeutic tool in regulating emotions and 
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reducing or extinguishing fear responses linked to non-threatening fear stimuli.  The 
projective identification of patient and therapist exchanging empathy and emotional 
awareness was instrumental in affecting desired therapeutic change.  Peri et al. advocated 
for more research to assess the impact of the patient-therapist interaction on PTSD 
symptom reduction during face-to-face sessions with less reliance on between-session 
homework.  
 The above theorists were unable to point to a specific theory to explain PTSD 
onset, but they asserted that the composite of multiple theories framed an understanding 
by which researchers could contribute new theoretical perspectives (Brewin et al., 2000; 
Eraly et al., 2014; Foa & Kozak, 1986; Foa & Rothbaum, 1998; Janoff-Bulman, 1992; 
Yehuda et al., 2013).  The conundrum identified in the literature, however, was that non-
life-threatening events such as a loss of finances, career, or friendships could all elicit 
PTSD symptoms that did not necessarily meet DSM 5 criteria making etiological 
assumptions difficult to define (Eraly et al., 2014).  
 Foa and Kozak’s (1986) emotional processing theory informs this study.  Foa and 
Kozak posited that stimulus and response memory structures triggered when fear 
structures activated.  The excessive response to these activated fear structures 
differentiated pathological fear structures from normal fear structures (Rauch & Foa, 
2006).  When applying this theoretical framework to PTSD, pathological elements added 
to the excessive stimulus and response elements (Rauch & Foa, 2006).  This caused a 
form of generalized fear that attributed meaning elements and triggered excessive 
stimulus and response fear structures to otherwise non-threatening structures (Rauch & 
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Foa, 2006).  Symptoms persisted because avoidant behaviors prevented the traumatic 
experience from processing (Rauch & Foa, 2006; Rosen & Frueh, 2010).  The other 
constructs that the authors attributed to PTSD maintenance were that the world was 
dangerous and the self was incompetent (Rauch & Foa, 2006; Rosen & Frueh, 2010). 
Foa and Kozak (1986) further proposed that extinguishment of PTSD-related fear 
structures relied on activation of the fear structure and introduction of corrective 
information to replace pathological constructs with realistic ones.  Imaginal exposure and 
in vivo exposure were thought to activate the traumatic memories, sensations, emotional 
cognitions, and images associated with the trauma to rescript trauma-based images and 
sensations during a reconsolidation process (Hernandez et al., 2016; Kip, 2013, 2016; 
Rauch & Foa, 2006).  Therapeutic interventions had to ensure that patients sufficiently 
engaged to activate the fear structures such that modification occurred (Rauch & Foa, 
2006).  This theoretical framework was useful in understanding the processes that 
constituted effective exposure-based PTSD treatment options (Rauch & Foa, 2006).   
Literature Review Related to Key Variables 
Historical Perspective  
 Combat-related PTSD, in its many iterations, meanings, and terms has existed for 
over a century (Levinson, 2015).  The historical origins of PTSD and the associated 
damaging psychological consequences of war date back to Homer’s epic work The Iliad 
and the Odyssey (Levinson, 2015).  Joseph Mendes Da Costa developed the physiological 
model known as Da Costa’s Syndrom to explain the effects of war on the cardiac 
condition of his soldiers (Levinson, 2015).  Nostalgia was the psychological term used to 
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explain combat-related PTSD (Levinson, 2015).  The syndrome signaled that soldiers 
needed to return home to familiar environments to recover (Levinson, 2015).  Shell shock 
was the term used during World War I to explain the general sense of powerlessness 
soldiers experienced (Levinson, 2015; Wilson et al., 2001).  The term contextualized how 
soldiers responded to war-fighting and artillery fire (Levinson, 2015; Wilson et al., 2001).  
Symptoms of shell shock manifested as anxiety, fear, hysteria, sleep disturbance, and the 
fight-flight-freeze stress response (Wilson et al., 2001).  Battle fatigue was the coined 
phrase for PTSD symptoms during World War II (Swank & Marchand, 1946).  Military 
leaders viewed battle fatigue as a display of military weakness and cowardice (Levinson, 
2015; Perkins, 1955; Swank & Marchand, 1946).  The APA published the term gross 
stress reaction in the 1952 diagnostic and statistical manual of mental disorders (DSM) to 
formalize the use of the term during the Korean War (APA, 1980; Harris et al., 1995; 
Levinson, 2015).   
 The APA recognized PTSD as an anxiety disorder when it published the  
DSM III in 1980 after the Vietnam War (APA, 1980; Wilson et al., 2001).  The indicators  
supporting a PTSD diagnosis at that time included the presence of intrusive thoughts, 
maladaptive avoidance behaviors, negative ruminations, and hyperarousal; all at levels of 
severity that signaled the need for treatment (Hinton & Good, 2016).   
Nelson (2015) offered the same historical perspectives of combat-related PTSD 
mentioned above but added that soldiers experienced exhaustion, the blues, and a soul-
crushing sense of self-deterioration.  Nelson also found that returning combat veterans no 
longer felt at home in their familiar surroundings nor could they share combat 
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experiences with family and friends (see Huang & Kashubeck-West, 2015; Nelson, 
2015).  Some returning soldiers viewed successful reintegration back to civilian life as an 
impossible prospect (Nelson, 2015).  Nelson concluded that available science was 
inconclusive about adaptive methods that supported reintegration (Nelson, 2015). 
PTSD Defined 
Bardhoshi et al. (2015) defined PTSD as a direct or indirect traumatic experience 
that included injury, sexual or physical violence, the risk of death, or the witnessing of 
actual death.  Selfridge (2014) defined PTSD as the damaging effects experienced by 
survivors after severe, distressing, life-altering traumatic events.  Selfridge found that 
PTSD involved enduring psychological disturbance attributed to the experience of a 
major traumatic event.   
Friedman (2016) found that traumatic stressors included combat, concentration 
camp imprisonment, military bombings, and natural and human disasters.  The traumatic 
occurrence had to also overwhelm human adaptation sufficiently to meet the stressor 
criterion for a PTSD diagnosis (Friedman, 2016).  Friedman also found that not all 
individuals who experienced traumatic events experienced PTSD.   
Selfridge (2014) reported that an estimated seven million adult Americans met the 
diagnostic criteria for PTSD every year.  The disorder often manifested after a rape, 
exposure to military combat situations, an assault, a severe automobile accident, or a 
natural disaster (Bardhoshi et al., 2016; Selfridge, 2014).   
Bardhoshi et al. (2016) and Selfridge (2014) explained that the symptoms of 
PTSD were elusive and manifested months or years after the traumatic event.  The 
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identified symptoms included reliving the traumatic experiences as nightmares, 
flashbacks, alienation, problems in social relations, an increased sense of vulnerability 
and dread, increased anxiety, frustration, anger, and worry (APA, 2000, 2013; Huang & 
Kashubeck-West, 2015; Selfridge, 2014).  Traumatic experiences can leave permanent 
physical, psychological, and physiological scars (Eraly et al., 2014; Yehuda et al., 2013).  
The research of Eraly et al. (2014) and Yehuda et al. (2013) has shown that the effects of 
trauma may permanently impair immune and memory function with hypersensitivity of 
the sympathetic nervous system, increased startle response, and sleep disturbances.  
Structural brain imaging results have revealed excessive amygdala activity and reduced 
activation of the prefrontal cortex and hippocampus (Friedman, 2016; Yehuda et al., 
2013).  The associated symptoms become chronic lasting through the life span and 
recurring when triggered by similar stimuli-response retraumatization (Freidman, 2016; 
Yehuda et al., 2013).  These negative emotional states have resulted in impaired immune 
system and cardiovascular functioning making a PTSD survivor more vulnerable to 
disease and infection (APA, 2013; Friedman, 2016; Yehuda et al., 2013).  
One in six veterans of the most recent conflicts (Operation Enduring Freedom and 
Operation Iraqi Freedom) met the criteria for PTSD after returning from combat 
(Bardhoshi et al., 2016; Huang and Kashubeck-West, 2015; Kip et al., 2016; Moran et al., 
2013).  An estimated 70% of the combat veterans treated within the VA healthcare 
system had symptoms consistent with a PTSD diagnosis, and the 70% treated within the 
VA healthcare system represented only those veterans who actually sought treatment 
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(Bardhoshi et al., 2016; Huang & Kashubeck-West, 2015; Kip et al., 2016; Moran et al., 
2013).   
PTSD Diagnostic Criteria  
The DSM first classified PTSD in 1987 after large numbers of Vietnam veterans 
experienced difficulty coping with the aftermath of their combat deployment experiences 
(APA, 1980).  Lee, Warner, and Hoge (2015) noted that the use of valid and reliable 
PTSD psychometrics helped diagnose Vietnam veterans’ mental health needs after the 
war.  Behavioral healthcare practitioners and epidemiological researchers continued using 
these same assessments to diagnose PTSD (Lee et al., 2015).  A revision to the PTSD 
diagnostic criteria occurred in 1994 when the APA published the DSM-IV and again in 
2000 when the APA published the DSM-IV-TR (APA, 1994, 2000).  The DSM-IV 
diagnostic criteria for PTSD included a history of exposure and symptoms from each of 
three symptom clusters to include intrusive recollections, avoidant/numbing symptoms, 
and hyper-arousal symptoms (APA, 1994).  Two other criteria included the symptom 
duration and level of severity for those symptoms, sufficient to cause significant distress 
and functional impairment (APA, 1994).   
The DSM-5 (2013) included significant changes with empirically supported 
conceptual and clinical impacts, moving beyond classifying PTSD as an anxiety disorder 
and instead classifying PTSD as a trauma and stressor-related disorder (APA, 2013).  
This change focused on the etiological foundation of an external traumatic event 
preceding all presenting PTSD symptomatology (APA, 2013).  The criteria added 
anhedonic/dysphoric classifiers that included negative cognitions and mood states as well 
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as anger, impulsivity, and reckless self-harming behaviors (APA, 2013).  The DSM-5 
stressor criterion (A) emphasized that the catastrophic event had to have caused a threat 
to or the witnessing of actual death, or injury or a threat to personal physical integrity 
(APA, 2013).  Indirect trauma is the witnessing or learning of a violent or accidental 
death or perpetration of sexual violence to a loved one (APA, 2013).  A criterion 
excluded from the PTSD diagnosis was the viewing of traumatic experiences via 
electronic modes (APA, 2013).  The onset of all presenting PTSD symptoms had to occur 
after exposure to the traumatic event (APA, 2013).   
The intrusive recollections criterion (B) included language that the recurring 
intrusive thoughts manifested as daytime ruminations, nightmares, flashbacks, or 
dissociative episodes (APA, 2013).  The recollections had to be powerful enough to have 
triggered mental cognitions and emotional and physiological responses to the presenting 
trauma (APA, 2013).  The avoidant criterion (C) consisted of the behavioral strategies 
that PTSD survivors used to prevent reexposure to traumatic stimuli (APA, 2013).  The 
trauma symptoms also caused faulty mental pattern matches between the trauma and 
appraisals of the self as weak, broken, inadequate, or incapable of a positive future (APA, 
2013).  Anger, guilt, shame, and lack of trust all led to faulty self-appraisals and a 
diminished sense of self-efficacy (Paul et al., 2014).  Dissociation was another factor in 
this criterion, and associated symptoms included cutting oneself off from conscious 
memories or emotions associated with the trauma (APA, 2013).  Friedman (2016) found 
that trauma survivors struggled with positive affect making it difficult for them to give or 
receive love or sustain close relations.   
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Symptoms included in the alterations in arousal reactivity criterion (E) resembled 
panic disorder or generalized anxiety disorder but also included hypervigilance and 
startle response including paranoia when stressors were extreme (APA, 2013).  The 
criterion also included expressions of aggressive, reckless, self-injurious, and suicidal 
behaviors (APA, 2013).   
The duration criterion (F) included that symptoms had to have persisted at least 
one month to diagnose symptoms as PTSD (APA, 2013).  The functional significance 
criterion (G) specified that the PTSD survivor must have experienced significant social, 
occupational, or other distress because of these symptoms (APA, 2013).  The exclusion 
criterion (H) specified that symptoms could not be due to medication, substance use, or 
other illnesses (APA, 2013). 
The above DSM-5 classification of PTSD as an actual disorder filled a knowledge 
gap that resulted in better informed behavioral health practices (APA, 2013; Friedman, 
2016).  The etiological focus of PTSD onset shifted from internal stimuli triggered by 
weakness or traumatic neurosis to that of external stimuli triggered by traumatic events 
(Friedman, 2016; Swank & Marchand, 1946).  
Friedman (2016) and Hoge et al. (2014) found that PTSD symptoms were unique 
to each trauma survivor and the symptoms often manifested in ways that did not meet 
diagnostic criteria.  Therefore, the psychological and physiological aspects of trauma 
needed individualized assessment to understand the extent of the perceived threat 
(Freidman, 2016; Hoge et al., 2014).  
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The following is a DSM-5 (APA, 2013) summary of the symptoms associated 
with a PTSD diagnosis: 
• Recurrent, involuntary, intrusive memories 
• Traumatic nightmares 
• Dissociative reactions 
• Intense or prolonged distress after exposure to traumatic reminders 
• Marked physiological inability to recall key factors of the traumatizing 
dissociative reactions 
• Persistent, distorted, negative beliefs and expectations about oneself or the 
world 
• Feeling alienated from others 
• Hypervigilance and irritable or aggressive behaviors 
• Self-destructive or reckless behaviors and sleep disturbances.   
Assessment of PTSD 
 Lee et al. (2015) felt that PTSD screening was critical to assess PTSD treatment 
options.  The importance of PTSD screening magnified when over 250,000 service 
members returned from Operation Desert Shield/Desert Storm in a well-adjusted state 
during reintegration, only to present months later with behavioral health concerns.  This 
revelation overwhelmed the military health care systems (Lee et al., 2015).  This urgent 
need gave rise to the development of surveys and protocols for clinical interviews 
conducted by primary behavioral health care providers (Lee et al., 2015).  The DoD, VA, 
and Institute of Medicine refined their standards and their survey timeframes (Lee et al., 
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2015).  Protocols were disseminated throughout the military and VA healthcare systems, 
despite the challenges posed by rapid deployment cycles (Lee et al., 2015).  The military 
reengineered the system of primary care for PTSD and depression screening (Lee et al., 
2015).  The behavioral health data portal (BHD) automated and populated screening 
protocols and ensured integration of findings to enhance continuum of care measures 
(Lee et al., 2015).  Lee et al. also noted that screening cutoffs needed to be sensitive to 
purpose and prevalence in the target population to ensure predictive value and reliable 
false negative to false positive ratios.   
Assessments, therefore, offered face validity, but repeated administrations 
produced less reliable outcomes because validity needed to detect the presence of the 
condition as well as the severity (Lee et al., 2015).  The PTSD checklist (PCL) presented 
with subjective limitations in the interpretation of the rater’s severity assignment when 
comparing one self-rater to another self-rater (Lee et al., 2015).  Data captured at 
different points in time could also confound the results of the assessments (Lee et al., 
2015).  The outcomes pointed to the need for cultivating sensitive contextual assessment 
of the results and an inherent understanding that no one instrument could meet all 
screening needs (Lee et al., 2015).  
Lee et al. (2015) found that the most prevalent assessment tools used within 
veteran populations were the Structured Clinical Interview for DSM-5 (SCID) for 
diagnosis only, the Clinician’s Administered PTSD scale (CAPS), the Short PTSD Rating 
Interview (SPRINT) and the PTSD Symptoms Scale – Interview (PSS-I).  The above 
screening tools depend on standard interviews, making administration difficult (Lee et al., 
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2015).  Thus, self-report instruments accommodate larger screening needs.  Lee et al. 
stated that when a diagnosis of PTSD is identified by a primary care practitioner, the 
PCL-M (Military) or PCL-C (Civilian) or PCL-S (Specific Stressor) is commonly used 
and a new instrument, the PCL-5 (DSM-5 compliant), was created but was not in general 
use at the time.  Lee et al. also noted that the PCL consists of 17 questions related to 
DSM-IV criteria for PTSD, as well as a Likert scale to assess symptom severity ranging 
from 1 (not at all) to 5 (extremely).  Cutoff scores depend on purpose and population 
(Lee et al., 2015). 
 A study conducted by Forbes, Creamer, and Biddle (2001) on serial 
administration of the PCL found variations in the ability to confirm the presence or 
absence of PTSD symptoms.  The study concluded that the PCL underrates improvement 
when compared to CAPS.  Monson, Gradus, Young-Xu, Schnurr, and Price (2008) found 
that the PCL is effective in the assessment of symptom changes over time.  The accuracy 
issues were concerning to military behavioral health providers because these screening 
tools are germane to all electronic matrixed data collection and archival patient 
monitoring platforms (Monson et al., 2008).  The PCL-S instrument is more sensitive to 
overlapping symptoms associated with comorbidities (Lee et al., 2015).  Cutoffs were 
another concern when assessing prevalence scores.  In general populations where 
prevalence scores are lower, higher cutoffs prevent inflation (Lee et al., 2015).  In clinical 
settings, a lower cutoff prevents false negatives (Lee et al., 2015).  This was inconsistent 
with the National Center for PTSD (2018), where PCL cutoff scores were set higher.  
Terhakopian, Sinaii, Engel, Schnurr, and Hoge (2008) reinforced the importance of 
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recalibrating cutoff points to prevent high false positive and low predictive value.  Lee et 
al. (2015) found that the most significant limitation with the PCL was the self-reporting 
nature of the instrument.  
Etiology 
 Karlin (2012) and Wells et al. (2010) theorized that the undertaking of etiological 
studies enhanced exploration of the determinants of any disorder.  Modeling helped to 
support the identification and validation of PTSD onset and associated symptoms, 
treatments, and recovery (Bryan, McNaughton-Cassill, Osman, and Hernandez (2013).  
Bryan et al., (2013) and Cabrera, Hoge, Bliese, Messer, and Castro (2007) found that 
childhood adversity, sexual or physical abuse, or other traumatic events are associated 
with PTSD onset and associated comorbid disorders such as depression and suicide.  
Yehuda et al. (2013) offered compelling research on the importance of biomarkers to aid 
in the assessment of PTSD.   
Prevalence 
The National Comorbidity Survey Replication investigated prevalence rates as the 
diagnosis criteria for PTSD underwent revisions in the DSM III, IV, IV-TR, 5 (APA, 
1994, 2000, 2013; Kessler et al., 2005).  A total of 8,098 Americans aged 15 to 54 
completed surveys (Kessler et al., 2005).  Estimated prevalence rates for PTSD were 
much higher than expected at 7.8% in the general population (Kessler et al., 2005).   
Kilpatrick (2013) reported that the lifetime prevalence rate of PTSD was at 8% of the 
adult United States population with women having a lifetime prevalence of 9.7% and 
men having a lifetime prevalence of 3.6%.  Women were at higher risk for exposure to a 
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traumatic experience such as rape and, therefore, experienced more intense symptoms 
(Kilpatrick, 2013).  LeardMann et al. (2013) estimated that one in five women 
experienced sexual assault, and the impact of sexual assault could potentially last for 
months, years, or a lifetime because survivors of sexual assault or rape coped and 
recovered in uniquely individual ways (Carlson, Stromwall, & Lietz, 2013). 
Bardhoshi et al. (2016), Huang and Kashubeck-West (2015), and Moran et al. 
(2013) found in their research that combat veterans are at higher risk for PTSD with one 
in six veterans of the most recent conflicts meeting the criteria for PTSD.  Bardhoshi et 
al. (2016) estimated that the prevalence rate for PTSD in veteran populations was 20% 
with co-occurring major depressive disorder prevalence rates at 37%.  Hoge et al. (2014) 
and Miller (2013) defined PTSD as a medical condition that affected identity.  
Additionally, the indoctrination associated with military training and the higher rates of 
exposure to trauma make combat PTSD a paradoxical problem that is much more serious 
and widespread than the military or the public realizes (Hoge et al., 2014; Miller, 2013).  
Additionally, many more soldiers return with symptoms of hyperarousal, flashbacks, and 
other symptoms that do not meet the full criteria for a PTSD diagnosis (Hoge et al., 2014; 
Huang & Kashubeck-West, 2015).  Multiple war zone deployments coupled with quick 
redeployments create further readjustment difficulties for service members and their 
families (Gerlock, Grimesey, & Sayre, 2014). 
There is documented evidence of the adverse effects of combat through World 
War I, World War II, the Korean War, the Vietnam War, and the Gulf War (Castro & 
McGurk, 2007; Harris et al., 1955; Perkins, 1955; Swank & Marchand, 1946).  The 
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United States has been engaged in combat operations in Afghanistan since 2001 and in 
Iraq from 2003 to 2010 (Castro, 2014).  More service members than ever have 
experienced multiple deployments in rapid succession (Castro, 2014).  These wars 
resulted in more than 6500 deaths, 50,000 wounded-in-action, and 118,000 cases of 
diagnosed PTSD (Castro, 2014).  Castro also found that at the peak of the war in 2012 an 
estimated 17,000 active duty service members per year met the criteria for PTSD.   
The focus of military research was and is on knowing the impact of combat and 
deployment on the mental health status of service members including risk and protective 
factors (Castro, 2014).  The military, therefore, began the Millennium Cohort 
(MILCOHORT) Study in 2014 (Castro, 2014)  The study is in progress through 2067 
(Castro, 2014).  The study included service members and veterans dating back prior to 
the September 11th terrorist incident, offering an objective research baseline (Castro, 
2014).  Wells et al. (2010) found that PTSD onset after deployment and exposure to 
combat was between 7.6% and 8.7%, compared to 1.4% to 3% for non-combat or non-
deployed personnel.  Onset of new diagnoses of depression following combat was 5.7% 
for men and 15.7% for woman, compared to 3.9% and 7.7%, respectively for men and 
women who had never deployed (Wells et al., 2010). 
 Phillips et al. (2016) found that significant advances have led to 90% survival rate 
among those injured while deployed to conflict areas.  The high rate of trauma-related 
injuries endured by this population, however, have challenged existing medical facilities 
when meeting long-term care needs (Phillips et al., 2016).  The VA has responded with 
specialized care models and the creation of a veteran registry to improve care (Phillips et 
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al., 2016).  Phillips et al. found that veterans with PTSD and comorbid disorders reported 
a higher incidence of health problems, used more healthcare services, incurred greater 
healthcare costs, had higher rates of work absenteeism, and developed maladaptive 
coping skills to address their depression, pain, and anxiety.  
Van Voorhees et al., (2012) found that returning service members experienced a 
range of mental health disorders and symptoms, most prominent of which was PTSD at 
21.8%.  Only 38% to 45% were interested in receiving help, but only 23% to 40% of 
those who expressed an interest actually received professional help (Van Voorhees et al., 
2012).  The complexity of mental health disorders combined with other situational 
disadvantages increases the risk for maladaptive transition into civilian life or impairment 
of existing military roles (Van Voorhees et al., 2012).  
Risk Factors 
The DSM-5 (APA, 2013) detailed that those at higher risk for PTSD included 
males, those less educated, those with conduct problems as children, those with a family 
history of psychiatric disorders, and those with high scores on extroversion and 
neuroticism.  African Americans were at greater risk for PTSD onset than Caucasian 
Americans (APA, 2000, 2013).  Severity, duration, and proximity of exposure to a 
traumatic event were important indicators affecting the likelihood of PTSD onset (APA, 
2000, 2013).  There was also evidence that social support, family history, childhood 
experiences, personality variables, and preexisting mental health disorders influenced 
PTSD onset, treatment, or recovery (APA, 2000, 2013).  PTSD also developed in 
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individuals without any predisposing conditions when they experienced extreme or life-
threatening stressors (APA, 2000, 2013; Hazle, Wilcox, & Hassan, 2012).   
Huang and Kashubeck-West (2015) assessed pre-trauma vulnerability factors that 
included younger chronological age, female gender, ethnic minority, being single, less 
educated, having experienced a prior trauma, and having a history of psychiatric illness 
or abuse.  Trauma vulnerability factors included the degree of severity of the stress, the 
intensity of the exposure, having less deployment preparedness, and exhibiting existing 
maladaptive coping behaviors (Huang-Kashubeck-West, 2015).  Combat exposure, 
specifically, was a strong predictor of PTSD onset (Hoge et al., 2014: Huang & 
Kashubeck-West, 2015).  Thus, the greater the exposure, the greater the severity of PTSD 
symptoms (Hoge et al., 2014; Huang & Kashubeck-West, 2015).  
Protective Factors 
Bardhoshi et al. (2016) found that protective factors included behavior 
(engagement in meaningful activities), cognitive self-efficacy (problem-solving skills), 
and interpersonal relations (enhanced social support).  Negative affect increased 
functional impairment and worsened specific symptoms especially when psychological 
intervention was not sought (Bardhoshi et al., 2016).   
Comorbidities 
 Individuals who meet DSM-5 diagnostic criteria for PTSD often meet DSM-5 
diagnostic criteria for other co-occurring disorders, such as alcohol use, substance use, 
depression, dysthymia, anxiety, or personality disorders (APA, 2013).  Goodson et al. 
(2011) and Britvic et al. (2015) found that PTSD is associated with chronic conditions 
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and diseases that include cardiovascular disease, liver disease, autoimmune disease, 
dementia, hypertension, fibromyalgia, chronic fatigue syndrome, irritable bowel 
syndrome, and chronic pain issues.  The link between PTSD and coronary disease has 
also been under scientific investigation because combat veterans are 25%to 33% more 
likely to develop cardiovascular disease than service members who have not experienced 
combat (Goodson et al., 2011).  Additionally, combat veterans experience poorer health 
despite controlling for combat-related injuries (Goodson et al., 2011).  Research has been 
focused on the link between PTSD and premature death based on the above findings 
(Goodson et al. 2011).   
Another area of research included vicarious trauma among veterans’ family 
members (Lester et al., 2013).  Lester et al. (2013) found that children under the age of 17 
experience less incidences of PTSD and that a diagnosis of PTSD was rare, only 
occurring in less than one half of one percent of children studied.  Child-related trauma, 
however, increased during single and dual-parent deployments and when families lived 
outside of a military community (Lester et al., 2013; Sensiba & Franklin, 2015).  
According to the National Center for PTSD (2018), the rates for PTSD among children of 
combat veterans varies from 3% to 100%.  Price (2013) found that these complexities 
made it difficult for behavioral health practitioners to decide whether to treat 
comorbidities sequentially or concurrently, bringing into question treatment efficacy, 
especially when symptoms do not resolve.   
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PTSD and Guilt 
Dettmer et al. (2015) found that the nature of PTSD diagnosis in military 
populations is the same as PTSD diagnosis in the general population, except for the 
inclusion of guilt and shame known as the invisible wounds of war or moral injury.  
Dettmer et al. defined moral injury as a syndrome that occurs when challenged beliefs 
cause guilt, shame, or blame, with a persistent sense of demoralization that alters self-
concept.  Dittmer et al. also found that symptoms of moral injury do not respond well to 
pharmacotherapy.  However, the patient-therapist alliance does serve as a protective 
factor in supporting more adaptive reappraisals of the self and others and the regulation 
of shame-based and guilt-inducing recollections (Bryan, Ray-Sannerud, Morrow, & 
Etienne, 2013; Dettmer et al., 2015; Hendin, 2014).  Research efforts are now more 
focused on combat veterans’ invisible wounds.  Hendin (2014) found that physical war 
injuries worsened the psychological symptoms associated with the concept of invisible 
wounds (Hendin, 2014; Vick, 2014).  The rise in combat-related suicides is due to the 
comorbidities resulting from physical and psychological war wounds (Hendin, 2014; 
Kane, Saperstein, Bunt, & Stephens, 2013; Vick, 2014).  Hendin’s (2014) research 
showed that perceived guilt is associated with increased suicides.  In fact, Hendin (2014) 
found that severe combat-related guilt is the major differentiator between veterans 
attempting suicide and veterans contemplating suicide.  The nature of the internalized 
combat experience is the determining factor in the degree of suicide risk (Hendin, 2014).   
Hendin’s research found that veterans’ perceived guilt is associated with nightmares that 
reflect their guilt.  Veterans that struggle with perceived guilt medicate their feelings with 
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drugs and alcohol (Hendin, 2014).  The burden of guilt exacerbates extinguishment of 
PTSD symptoms (Hendin, 2014).  Resolution of PTSD symptoms is closely associated 
with an understanding of the veteran’s unconscious meaning of the traumatic experience 
(Hendin, 2014; Vick, 2014). 
 Hendin (2014) noted that cognitive behavioral therapies are empirically supported 
PTSD therapies, but the treatment effectiveness of these therapies for resolving 
suicidality was unclear.  Prolonged exposure is another empirically supported therapy 
found effective for military PTSD, but the therapy has not been tested in veteran 
populations at high risk for suicide (Hendin, 2014; Vick, 2014).  Hendin stated this is 
why VA-approved therapies are not proving effective for the prevention of suicide.  This 
is a critical factor because the rate of suicide in the military from 1980 to 1992 was 11 to 
14 suicides per 100,000 per year (Anestis & Bryan, 2013; Castro, 2014; Castro & 
Kintzle, 2014).  More soldiers took their own lives than died in combat in Afghanistan or 
Iraq, and these statistics do not include drunk driving deaths due to comorbidities 
associated with military PTSD (Castro & Kintzle, 2014).  Suicide rates were stable from 
1990 to 2003  among army personnel and then nearly doubled from 2003 to 2010, with 
suicide rates estimated at 21 suicides per 100,000 per year (Ritchie, 2015).  Nelson 
(2015) cited that in 2012 the United States Department of Veteran’s Affairs (2018) 
estimated that 8,000 veterans committed suicide each year, at an average of 22 suicides 
per day.  The main reason these estimates were on the rise was because soldiers chose to 
permanently end their suffering when they could not separate themselves from their war 
memories, images, sensations, and feelings (Nelson, 2015). 
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Wanklyn et al. (2016) conducted a study of participants who experienced a 
traumatic event.  The aim of the study was to examine the predictors of PTSD and 
comorbid diagnostic status (Wanklyn et al., 2016).  Age, education, higher degree versus 
each of postsecondary degree, minority status, and partner status were identified.  These 
risk factors led to increased suicides, suicide ideations, attempted suicide, and completed 
suicides (Wanklyn et al., 2016).  PTSD increases the risk of suicide due to a higher 
prevalence of comorbidities between PTSD and depression, anxiety, phobias, isolation, 
aggression, homelessness, and maladaptive family systems; all culminating in overall 
poorer health outcomes (Bardhoshi et al., 2016; Huang & Kashubeck-West, 2015; 
Schoenbaum et al., 2013).  
PTSD and Depression  
Van Voorhees et al. (2012) found a link between PTSD and depression among 
service members exposed to trauma.  Both PTSD and depression shared common factors 
thought to increase vulnerability in three domains (1) behavior avoidance; (2) low 
cognitive bias; (3) and learning and information bias (Van Voorhees et al., 2012).  Castro 
and Kintzle (2014) and Wanklyn et al. (2016) affirmed in their research that the severity 
of combat exposure is the key predictor differentiating a comorbid diagnosis from either 
PTSD or major depressive disorder (MDD) when accounting for rank, deployment era, 
and wounded in action, while life threat is associated with PTSD.  Traumatic loss and life 
threat leads to an increased rate of diagnosed comorbidities (Wanklyn et al., 2016).  
Frequency of the severity of the traumatic event is associated with more severe PTSD 
symptoms (Wanklyn et al., 2016).  It is unclear if trauma type serves to differentiate a 
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PTSD diagnoses, or a PTSD/major depressive disorder (MDD) comorbid diagnosis, 
because available studies focused specifically on PTSD or represented cumulative 
outcomes (Wanklyn et al., 2016).  The researchers hypothesized whether deployment-
related and interpersonal traumas differentiated the diagnoses of PTSD / MDD, or PTSD-
only, or MDD-only (Wanklyn et al., 2016). 
Raab, Mackintosh, Gros, and Morland (2015) also reported that depression is a 
highly comorbid condition in veteran populations diagnosed with PTSD.  A large meta-
analysis of 57 studies across military and civilian samples concluded with a comorbidity 
rate of 52% (Raab et al., 2015).  Raab et al. reported that the reason for this high degree 
of comorbidity was unclear but pointed to a potential lack of PTSD specificity.  There 
was an association with reduced veteran quality of life defined as the state of mental, 
social, and physical wellness (Raab et al., 2015).  Raab et al. (2015) and Price 92013)  
found that PTSD negatively affected veteran quality of life, resulting in symptoms that 
included intense emotions, fear, anger, grief, and guilt.   
PTSD and Anxiety 
Soldiers receive resilience training in preparation for combat (Schweizer et al., 
2017).  However, combat exposure tests even the most resilient soldiers (Schweizer et al., 
2017).  In fact, combat exposure is a proven predictor of negative mental health outcomes 
(Schweizer et al., 2017).  One well-established risk factor is anxiety.  Russ and McNally 
(1985) defined anxiety as increased subjective stress responses, emotion dysregulation, 
and intrusive memories.  Russ and McNally also found that anxiety produced limited 
access to emotion dysregulation, increased worry, and rumination.  Schweitzer et al. 
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(2017) also noted that anxiety impeded integration and resolution of traumatic 
experiences.  Fear, helplessness, horror, negative cognitions, and ruminations were 
common responses after experiencing a trauma (Schweizer et al., 2017).  Many trauma 
survivors recovered from these intense posttraumatic symptoms (Schweizer et al., 2017).  
However, others developed stressor-related disorders such as PTSD and were more 
susceptible to trauma due to stress modulation dysfunctions (Schweizer et al., 2017).  
People diagnosed with anxiety experienced greater degrees of emotional dysregulation, 
were less resilient to stressors-related disorders, and recovered more slowly from the 
after-effects of their trauma experiences (Agorastos et al., 2013).  Anxiety was also 
associated with less fear reduction and impaired suppression of negative ruminations 
(Agorastos et al., 2013).  Severe anxiety symptoms were also associated with high 
peritraumatic behaviors leading to the development of PTSD (Agorastos et al., 2013).  
The degree of severity associated with  peritraumatic behaviors depended on the absence 
or presence of effective coping and resilience skills maintenance (Agorastos et al., 2013).   
Empirically Supported Psychotherapeutic Interventions 
More than 12,000 published PTSD studies over the last 30 years have advanced 
knowledge in the behavioral healthcare field (Rosen & Frueh, 2010).  Foa, Keane, 
Friedman, and Cohen (2009) reviewed the most successful PTSD interventions available 
at that time and concluded that cognitive behavioral therapies and medications are 
effective in the treatment of PTSD symptoms.  Specifically, Foa et al. (2009) found that 
CPT and PE are effective in treating female victims of adult sexual trauma, survivors of 
military trauma, and survivors of serious motor vehicle accidents (Foa et al. 2009).  
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Pharmacologically, sertraline (Zoloft) and paroxetine (Paxil) were the first selective 
serotonin reuptake inhibitors (SSRIs) to have received FDA approval as indicated 
treatments for PTSD (Ritchie & Nelson, 2015).  Group therapy was also indicated as a 
supportive treatment for mild PTSD symptoms, especially when group members share 
trauma experiences and empathize with each other (Foa et al., 2009; Ritchie, 2015).  Foa 
et al. (2009) concluded, however, that PTSD is a complex and debilitating disorder that 
does not always respond well to available treatments making it difficult to conclude who 
most benefits from specific PTSD treatments.  
The VA/DoD, in 2004, issued the clinical practice guidelines (CPG) for the 
treatment of PTSD to support veteran populations at the beginning of the conflicts 
(Bernardy & Friedman, 2012; Department of Veterans Affairs, 2012).  The VA mandated 
as part of a national policy that all veterans diagnosed with PTSD have access to CPT, 
PE, and EMDR interventions (Bernardy & Friedman, 2012).  A successful system-wide 
training program began in 2011, resulting in the certification of thousands of clinicians 
(Bernardy & Friedman, 2012). 
 However, Foa et al. (2009) noted that prior to the September 11 terrorist attacks 
neither CPT nor PE, the current first-line treatment options, were effective in addressing 
combat-related PTSD symptoms.  Subsequent studies focused on investigating the 
effectiveness of these PTSD treatment interventions and whether the interventions 
required modifications or inclusion of complementary psychological or pharmacological 
treatment approaches (Karlin, 2012).  Subsequent randomized controlled trials have since 
shown that CPT and PE interventions significantly reduce PTSD symptoms in veteran 
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populations (Karlin, 2012; Ritchie, 2015; Rauch et al., 2012).  However, Adler and 
Castro (2014) reported that even though these first-line therapies have been proven 
effective, behavioral health practitioners need to consider the nature, intensity, and 
severity of the traumatic events experienced by these veteran populations.  First-line 
interventions used within veteran populations include the therapeutic interventions listed 
below.  
Cognitive processing therapy (CPT).  Chard, Ricksecker, Healy, and Karlin, 
(2012) reported that Patricia Resick began researching CPT as early as 1988.  Resick, 
Nishith, Weaver, Asten, and Feuer developed a manualized, cognitive-based, trauma-
focused, PTSD intervention in 2002. The CPT intervention consists of 12 sessions 
delivered once or twice per week in structured 50-minute sessions with between-session 
homework and written trauma accounts (Chard et al., 2012).  Chard et al. (2012) found 
that CPT is an effective treatment for PTSD and comorbid disorders such as depression, 
anxiety, and guilt.  The CPT protocol accommodates individual and group sessions or 
sessions delivered in mixed settings (Chard et al., 2012; Resick & Schnicke, 1992; Resick 
et al., 2008).  Hernandez et al. (2016) confirmed that CPT includes elements of cognitive 
therapy and information processing. The aim of the intervention is the restructuring of 
trauma memories through the process of accommodation (Hernandez et al., 2016).   
Chard et al. (2012) noted that the first four sessions of CPT focus on the 
theoretical underpinnings of CPT.  This focus aids patients in building trauma narratives 
that add meaning, explore feelings, and surface resistance to integrate and reinterpret the 
trauma experience (Chard et al., 2012).  Sessions five to seven focus on cognitive therapy 
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skills and therapy-specific questionnaires to examine held beliefs impeding wellness 
(Chard et al., 2012).  Sessions eight through 12 introduce the challenging beliefs 
worksheet to examine beliefs about safety, trust, power, control, intimacy, and esteem for 
baseline-to-progress changes (Chard et al., 2012; Resick et al., 2012).  The therapist 
processes specific trauma details in written form on a case-by-case basis (Chard et al., 
2012).  The therapist introduces CPT techniques useful in challenging beliefs about 
future-focused concerns and the resulting triggers that surface (Chard et al., 2012).   
Resick et al. (2008) conducted a randomized controlled trial to compare CPT and 
PE in a sample of female rape victims.  The intent-to-treat sample experienced significant 
reduction in PTSD and depression symptoms after treatment, at three months and at nine 
months (Resick et al., 2008).  The study revealed that CPT produces modestly greater 
improvement than PE (Resick et al., 2008).  Despite the empirical evidence of CPT 
effectiveness, there is a 4% to 29% dropout rate and a 4% to 48% non-response rate for 
cognitive processing therapy (Hembree & Foa, 2010; Kip et al., 2013).  
Prolonged exposure (PE).  In October of 2010 the VA and the DoD released 
their VA/DoD clinical practice guidelines for management of PTSD and exposure 
therapies (Bernardy & Friedman, 2012: Department of Veterans Affairs, 2012).  The 
guidelines categorized prolonged exposure, which was created by Edna B. Foa, PhD, as a 
first-line treatment for PTSD regardless of the type of trauma or associated comorbidity 
(Department of Veterans Affairs, 2012; Hembree & Foa, 2010; Karlin, 2012; Rauch et 
al., 2012; Thomas, Amin, & Friedlander, 2015).  Prolonged exposure is an individual 
therapy consisting of eight to 15, 90-minute sessions with flexible approaches to meet 
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patient needs (Rauch et al., 2012; Thomas et al., 2015).  The PE intervention includes 
education, in vivo exposure of the trauma, and repeated imaginal exposure of the 
associated traumatic memories (Rauch et al., 2012; Thomas et al., 2015).  Daily, 
between-session homework, in vivo exercises, and imaginal exposure recordings are 
critical components of the protocol (see Hembree & Foa, 2010; Paul et al., 2014; Thomas 
et al., 2015).  
Thomas et al. (2015) highlighted that the first session focuses on detailing the 
trauma experience with an intake of the history and formulation of the diagnosis.  
Relaxation techniques and psychoeducation play a key role in the process (Thomas et al., 
2015).  The second session includes psychoeducation on trauma responses to aid in 
normalizing and acknowledging the trauma experiences (Thomas et al., 2015).  The topic 
of avoidance is important because of its impact on outcomes (Thomas et al., 2015).  
Between-session exposure exercises are critical components in the recovery process 
(Thomas et al., 2015). 
In the third session, imaginal exposure techniques encourage the patient to recall 
and record the trauma narrative in session and then listen to the recorded tapes between 
sessions (Thomas et al., 2015).  The subjective units of distress (SUD) scale assesses 
severity of symptoms throughout the imaginal exposure exercise (Thomas et al., 2015).  
The goal is to associate the retelling of the trauma narrative with the reality that the 
retelling will not create a catastrophic event.  However, Paul et al. (2014) noted that this 
step creates the greatest amount of non-compliance, as patients avoid the retelling of their 
traumatic experiences. 
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 Sessions four through 10 include repeated reviews of the imaginal exposure 
exercises and homework from prior sessions (Thomas et al., 2015).  The patient continues 
creating tapes and listening to them at home (Thomas et al., 2015).  Learning theory and 
classical conditioning inform the PE protocol (Thomas et al., 2015).  Exposure to the 
trauma memories through in vivo and imaginal exposure continue until extinguishment of 
the trauma occurs (Paul et al., 2014).  Paul et al. (2014) found there is less cognitive 
intervention in PE, but the assumption made are that the cognitive restructuring occurs 
with exposure to the trauma memories. 
Yuen et al. (2015) conducted a randomized controlled trial comparing the 
effectiveness of PE with in-office visits and home-based telemedicine after eight to 12 
weeks of treatment.  Yuen et al. reported no significant treatment outcome differences 
between the two forms of PTSD treatment.  However, Hernandez-Tejada, Acierno, and 
Sanchez-Carracedo (2017) reported that attrition across all empirically supported 
psychotherapies was at 30% due to stigma and logistical difficulties.   Additionally, 
home-based treatment with PE had no effect on high dropout rates (Hernandez et al., 
2017).   
Yuen et al. (2015) also surveyed 82 veterans who dropped out of their PE 
treatment.  The results showed that 50% were non-compliant with the in vivo home 
assignments and, subsequently, withdrew from the program (Yuen et al., 2015).   Kip et 
al. (2013) reported that CPT treatment dropout rates were estimated between 0% to 50% 
for PE and non-response rates varied from 20% to 67%.  
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Eye movement desensitization and reprocessing (EMDR).  Shapiro’s (2001) 
eye movement desensitization and reprocessing (EMDR) eight-phase protocol is 
premised on an adaptive information processing (AIP) model.  The model facilitates the 
accessing and processing of traumatic memories and adverse life experiences to facilitate 
adaptive resolution (Shapiro, 2001).  Shapiro detailed that EMDR consists of eight to 12, 
60 to 90-minute weekly sessions.  The number and length of EMDR sessions is unique to 
each PTSD patient offering flexibility in the management of patient needs (EMDR 
Institute, Inc., 2017).  The eight-phase protocol includes a variety of procedures that align 
with the AIP model to maximize treatment effects (Shapiro, 2001).  Procedures include 
history-taking; assessment of readiness; identification of distressing trauma memories; 
and imagery and stress reduction techniques to reduce or extinguish trauma images, 
negative self-beliefs, and related emotions and body sensations (Shapiro, 2001). 
Shapiro (2001, 2012) stated that focused attention on bilateral eye movements, 
tones, or tapping aids  help patients resurface trauma images, sensations, and triggers to 
create new insights, memories, and mental associations.  The intervention, initially 
viewed with scepticism, was endorsed by the APA in 2004, and EMDR is now a first-
line, empirically supported protocol for the treatment of PTSD (Shapiro, 2012).  
Hernandez et al. (2016) stated that the EMDR protocol relies on the theoretical premise 
that the images and sensations associated with the trauma memory are the source of 
PTSD symptoms.  Shapiro (2012) stated that EMDR therapy supports early intervention 
when trauma memories, images, sensations, and feelings are not yet fully integrated.   
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Shapiro also stated that EMDR treatment reduces hyperarousal, negative cognitions, 
intrusive memories and sensations, and the risk of retraumatization (Shapiro, 2012). 
However, Albright and Thyer (2010) examined the effects of EMDR and PTSD 
among military veterans by reviewing six randomized-controlled trials and three quasi-
experimental studies conducted between 1987 and 2008.  Albright and Thyer concluded 
that the findings were inconsistent and that EMDR did not meet the threshold for 
empirically supported PTSD treatment of combat veterans.  Albright and Thyer 
concluded that EMDR research required larger randomized-controlled-trial studies with 
credible placebo-controlled treatment to determine efficacy rates for veteran populations 
with combat-related PTSD (Albright & Thyer, 2010). 
Shapiro (2001) theorized, when EMDR was first introduced, that the protocol 
could desensitize anxiety and related trauma memories, but Shapiro also stated that 
EMDR was not intended to eliminate PTSD symptoms nor include coping techniques 
(EMDR Institute, Inc., 2017).  Hernandez et al. (2016) compared EMDR with other 
empirically supported therapies and concluded that 60% to 72% retained their PTSD 
diagnoses.  Kip et al. (2013) reported that the dropout rates for EMDR is between 0% and 
36% with a non-response rate between 7% and 92%. 
 In summary, all the above empirically supported therapies are significant in 
reducing PTSD symptoms (Rauch et al., 2012).  However, as mentioned previously, 
existing empirically supported therapies are lengthy, time-consuming, and require 
between-session homework and exposure exercises that could re-traumatize patients 
(Feeny & Foa, 2005; Rauch et al., 2012).  Treatment dropout, non-response, and non-
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compliance rates also remain high across these treatment modalities, potentially 
compromising treatment outcomes (Feeny & Foa, 2005; Hembree & Foa, 2010; 
Hernandez et al., 2016; Kip et al., 2013; Ritchie, 2015). 
Haagen et al. (2015) conducted a meta-analysis of 57 studies and concluded that 
pretreatment severity levels were associated with post-treatment outcomes, creating lower 
treatment gains at low and high severity levels when compared with the outcomes of 
those who tested at moderate severity levels prior to treatment.  The Haagen et al. meta-
analysis supported the conclusion that exposure-based therapies optimally address 
veterans’ PTSD symptoms and that future studies are suggested to analyze efficacy rates.   
However, Ritchie (2015) noted that research consensus has not been reached on 
the most optimum PTSD treatment approaches.  Some practitioners have argued for case 
formulation while others have advocated for therapist specialization and patient 
preference to determine appropriate PTSD treatment protocols (Ritchie, 2015).  More 
research is needed to investigate the factors that influence treatment response and inform 
relapse prevention efforts, despite treatment advancements over the last 30 years. (Feeny 
& Foa, 2005).  
Pharmacotherapy.  Ritchie and Nelson (2015) found that in the 1980s Thorazine 
and Valium were the only psychotropic medications used.  Medication augmentation for 
use in the field occurred in the early 1990s (Ritchie & Nelson, 2015).  Depression was 
treated with selective serotonin reuptake inhibitors (SSRI; Ritchie & Nelson, 2015).  
Additionally, Prozac (Fluoxetine) received approval for the treatment of depression 
(Ritchie & Nelson, 2015).   Paxil (Paroxetine) and Zoloft (Sertraline) were the only 
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medications that were FDA-approved for PTSD (Castro, 2014; Ritchie & Nelson, 2015).  
These medications have been helpful with non-combat-related PTSD symptoms, but they 
have not been tested for the treatment of combat-related PTSD symptoms (Castro, 2014; 
Ritchie & Nelson, 2015).  Serotonin-norepinephrine reuptake inhibitors (SNRIs) such as 
Cymbalta (Duloxetine) were effective for neuropathic pain, and Effexor (Venlafaxine) 
helped with migraines (Ritchie & Nelson, 2015).   
Ritchie and Nelson (2015) noted that deployment guidelines do not allow service 
members to deploy while taking certain prescribed medications.  Off-label, second-
generation, antipsychotics are useful but their use prevents deployment (Ritchie & 
Nelson, 2015).  Trazadone in low doses and Prazosin help manage trauma-related 
nightmares (Ritchie & Nelson, 2015).  Ambien (Zolpidem) and Lunesta (Eszopiclone) 
help but are habit-forming (Ritchie & Nelson, 2015).  Benzodiazepines are 
contraindicated because of tolerance, the potential for abuse, and the worsening of PTSD 
symptoms (Ritchie & Nelson, 2015).  Valproic acid (Depakote) and Gabapentin are 
helpful for depression and comorbid pain (Ritchie & Nelson, 2015).  Antidepressants 
such as Seroquel help to manage hyperarousal and nightmares but weight gain and 
increased triglycerides make long-term use unsustainable (Ritchie & Nelson, 2015).  
Ritchie and Nelson concluded that medication management was a trial-and-error process 
and many medications are not well-tolerated long-term or become risk-factors for 
military career ascension (Ritchie & Nelson, 2015).  Castro (2014) found that 
pharmacotherapy offers inconsistent relief of symptoms, and ongoing clinical trials are 
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focused on determining the most therapeutic constructs for the use of pharmacotherapy 
alone or in combination with other empirically supported PTSD treatment modalities.  
Barriers to Successful Treatment  
Chard et al. (2012) found that as concise, tested, and well-developed as 
empirically supported therapies are, existing barriers include therapists’ inability to meet 
veterans’ healthcare demands, availability of training time, adherence to training 
protocols, and the overall complexity and comorbid state of treating PTSD symptoms.  
The emotional toll on practitioners’ resilience and empathic reserves, when delivering 
trauma-based interventions, is another important PTSD treatment factor (Chard et al., 
2012).  The patients’ retelling of and the therapists’ continuous listening to traumatic 
experiences oftentimes leads to burnout (Chard et al., 2012).  Chard et al. found that 
some therapists do not know how to prevent countertransference, empathic drain, and 
burnout.  Chard et al. advocated for more veteran studies and replications of the same 
studies to make treatment efficacy comparisons. 
Zeiss and Batten (2012) reviewed the VA’s overall commitment to empirically 
supported psychotherapies and found the process to be interdisciplinary and 
interdepartmental.  The guidelines include evidence of diagnoses, treatment options, and 
the importance of early intervention to prevent PTSD.  The guidelines developed by the 
International Society for Traumatic Stress Studies (ISTSS) focuses on acute stress 
reaction/disorder to better assess PTSD onset (Zeiss & Batten, 2012). 
A review of the literature explored interventions with and without evidence of 
effectiveness (Zeiss & Batten, 2012).  Categorical treatment segmentation includes 
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specific evidence of pharmacotherapy, adjunctive services, somatic treatments, 
psychotherapy, and CAM approaches (Zeiss & Batten, 2012).  Symptom focus also 
includes sleep disturbance, pain, irritability, severe agitation, and anger (Zeiss & Batten, 
2012).  Many of the approaches in use, however, could not readily accommodate patient 
feedback about inclusion of the family system, dissemination of care in non-traditional 
settings, and inclusion of CAM (e.g., acupuncture, meditation) in the treatment options 
(Zeiss & Batten, 2012). 
Brown et al. (2015) found that treating returning veterans was a complicated and 
challenging task because 1,300,000 veterans lived remotely and were not near behavioral 
health networks, and 1,000,000 dependents reported deterioration in physical or mental 
health (Brown et al., 2015).  The Brown et al. research showed that veteran proximity to 
medical care facilities was associated with likeliness to seek care.  This presented a 
potential gap in the accessibility and availability of effective and consistent treatment 
(Brown et al., 2015). 
Whealin, Seibert-Hatalsky, Howell, and Tsai (2015) found that a known barrier to 
effective PTSD treatment in veteran populations is the associated stigma of needing 
behavioral health care.  Veterans avoid treatments that include re-experiencing of trauma 
memories; a hallmark step in the treatment protocol (Whealin et al., 2015).  
Hoge et al. (2004) found early on that the wars were taking a tremendous toll on 
the mental health of combat veterans.  In 2007 the government increased funding for 
medical research to a total of one billion dollars from 2007 to 2013, as a result of Hoge’s 
findings (Castro, 2014).  Castro (2014) confirmed the creation of the psychological health 
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research continuum framework to ensure availability of empirically supported treatment 
options for combat veterans in need.  Areas of research included risk and resilience, 
PTSD biomarkers, mental health training, psychological screening, psychological 
debriefing, third location decompression, combat and suicide, usefulness of 
psychotherapy and drug therapy for PTSD, role of advanced technology, telemedicine, 
virtual reality (VR), methods to reduce stigma, barriers to care, and best approaches to 
disseminate effective interventions (Castro, 2014; Eraly et al., 2014; Reger et al., 2011; 
Zamorski, Guest, Bailey, & Garber, 2012).  
 The psychological health research continuum framework, however, did not detail 
when a solution would be sought, how much the solution would cost, the level of 
evidence that existed for all solutions, or the protective or risk factors in the etiology of 
PTSD onset such as branch of service, needs, gender, culture variances, and the 
complexities of comorbidities (Castro, 2014).  
 Although the VA focused on the gold standard of therapeutic care for PTSD 
which included CPT and PE, Nelson (2015) and Paul et al. (2014) found that evidence of 
treatment efficacy was unclear.  The primary in-session therapeutic approach had patients 
repeatedly reliving the traumatic experience until there was extinguishment of the 
stimulus-response cycle and the patient experienced relief of associated PTSD symptoms 
(Nelson, 2015).  However, many patients abandoned the therapeutic process prior to 
experiencing relief of PTSD symptoms (Nelson, 2015).  Nelson (2015) and Nelson and 
Ritchie (2015) also added that SSRIs like Prozac and Zoloft are helpful for some but 
many others do not experience relief from pharmacotherapy.  Drugs used atypically like 
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Propranolol, initially developed to prevent cardiac episodes, disrupt the brain’s ability to 
track the traumatic memory (Ritchie, 2015).  The atypical use of these medications, 
however, raises ethical considerations because they alter the fight-flight-freeze human 
response to danger (Nelson, 2015).  Nelson concluded that individuals experience trauma 
in such unique and singular ways that treatment outcomes will vary. 
Behavioral health services research within the military has not led to notable 
improvements in the delivery or coordination of care for veterans with PTSD (Schnurr et 
al., 2013).  Castro (2014) and Hassan and Flynn (2012) confirmed that there was an 
urgent need for empirically supported psychotherapies that focus on reintegration and 
reducing the associated hardships for combat veterans diagnosed with PTSD.  Castro 
(2014) concluded that available PTSD healthcare systems serve more as barriers to, 
rather than facilitators of, the resolution of these social, medical, and physical hardships 
(Castro, 2014).  
Emerging PTSD Interventions 
The National Institute of Mental Health (NIMH) website includes information 
that NIMH-funded research is focused on the customization of PTSD treatments; 
understanding the mechanisms by which individuals react to trauma; how PTSD 
symptoms resolve naturally for some in acute care settings; how treatment immediately 
following a trauma impacts recovery; and what are the factors that determine whether or 
not a patient responds well to one particular intervention over another (NIMH, 2016).  
Genetic research focuses on investigating the source of PTSD onset in the brain to better 
treat or prevent PTSD (NIMH, 2016). 
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 The NIMH and DoD continue to explore and investigate other emerging treatment 
applications to assess their impact on PTSD symptom reduction (NIMH, 2016; Ritchie, 
2015).  Ritchie (2015) reported that the emerging treatments under investigation include 
meditation for combat-related mental health, transcranial magnetic stimulation, and 
acupuncture and stellate ganglion block.  Although preliminary results are promising, 
meditation for combat-related mental health is an adjunct to traditional PTSD treatments 
(Khusid, 2015).  The use of transcranial magnetic stimulation needs more research to 
tailor the therapy for PTSD use (Grammer, Cole, Rall, Scacca, 2015).  Acupuncture 
therapy also needs more research to investigate which points are associated with PTSD 
symptom reduction (Hickey & Koffman, 2015). And, the use of stellate ganglion block 
requires more research to determine PTSD treatment efficacy (Lipov, 2015).   
 Another innovative treatment modality under investigation is e-therapy (Whealin 
et al., 2015). Whealin et al. (2015) found that more than 30% of patients entering the VA 
healthcare system met the criteria for a mental health disorder of which 52% were PTSD 
cases.  However, 41% of those diagnosed with PTSD lived in rural areas.  This 
challenged the VA to create culturally diverse systems of care (Whealin et al., 2015).  E-
therapy is a viable option, especially when research reveals that veterans underuse mental 
health services.  Whealin et al. estimated that only 23% to 40% of veterans seek care in 
person and only 9.5% of newly diagnosed PTSD patients are compliant with PTSD 
treatment recommendations.    
Kuhn et al. (2014) and Rosen et al. (2013) reported that telephone-based 
interventions, telephone texting exchanges, online-web-based interventions, social 
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networking sites like Facebook, and clinical video teleconferencing are all used as 
supplement or replacement therapy tools.  Kuhn et al. found that these innovative 
approaches to effective behavioral healthcare must still include the option of clinic visits 
and face-to-face appointment scheduling.   Whealin et al. (2015) investigated predictors 
of internet-based service interest that included being female, married, possessing higher 
education, an ethnoracial minority status, travel distance, and poor quality of life.  The 
role of PTSD as a risk factor, however, remains unclear (Whealin et al., 2015).  
Predisposing factors include younger age, female, married or cohabitating, minority, and 
living in a rural area (Morland et al, 2014).  Van Voorhees et al. (2012) also advocated 
for internet-based interventions because these interventions are not stigmatizing, are 
private, are easily accessible, and CBT principles offer sound empirically-supported 
benefits.  Early intervention include structured learning of coping skills, peer-to-peer 
chats, and social worker-provided motivational interviewing (MI; Van Voorhees et al., 
2012). 
 Van Voorhees et al. (2012) conducted a pre/post design, phase-one study of 50 
veterans to assess feasibility, clinical response, and changes in attitudes relevant to 
treatment-seeking behavior.  A baseline single-group, pre/post comparison screening was 
repeated at four weeks, eight weeks, and 12 weeks (Van Voorhees et al., 2012).  
Participants were recent US veterans from any military branch who were experiencing 
distress and depression as measured by the CES-D.  The Van Voorhees et al. (2012) 
research revealed moderate improvement in PTSD symptoms.  However, the research 
concluded that although there was a 50% to 100% dropout rate in internet intervention, 
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their study showed a 100% retention rate for one follow-up with a 7% recruitment rate 
despite results.  Van Voorhees et al. did not know, however, if the participants received 
traditional care during the study.  Additionally, comorbid assessment prevented disorder-
specific statistical analyses (Van Voorhees et al, 2012).  The Van Voorhees et al. study 
did show an increase in favorable attitude toward treatment-seeking behavior, but a 
limitation was the small sample and short follow-up timeframe.  Van Voorhees et al. 
found that traditional psychotherapies translated well on an internet platform for a small 
percentage of the sample and that the protocol needed inclusion of components to 
specifically address depression and PTSD symptoms.  Van Voorhees et al. advocated for 
more treatment options including traditional and alternative therapies to address the 
diverse needs of patients with PTSD.  
Accelerated resolution therapy (ART).  Kip et al. (2016), Ritchie (2015), and 
Waits et al. (2015) found that despite treatment advancements over the last 30 years, 
veterans continue to struggle with treatment-resistant PTSD symptoms.  A critical need 
exists for more research to investigate the factors that influence PTSD treatment response 
and inform relapse prevention efforts (see Hoge, 2011; Kip et al., 2016; Ritchie, 2015; 
Waits et al., 2015). Hernandez et al. (2016), Hoge, (2011, 2015), Kip et al., and Waits et 
al. concluded that ART was an emerging, brief, trauma-focused, PTSD intervention 
delivered in as little as one to five, 60-minute sessions without any between-session 
homework, the need for adjunctive medication, or the need to record the trauma narrative 
in session and listen to it repeatedly between sessions.  The ART intervention protocol, 
created in 2008 by Laney Rosenzweig, was built on the same core components as other 
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proven, empirically supported, PTSD interventions to include a narrative component, in 
vivo and/or imaginal exposure, cognitive restructuring, and relaxation/stress modulation 
(Hernandez et al., 2016; Hoge, 2015; Kip et al., 2016).   
Kip et al. (2016) and Waits et al. (2015) found that ART differentiated itself from 
other therapies because the treatment focus is on the patient’s trauma images rather than 
cognitions.  Use of imagery, metaphors, and Gestalt techniques help conceptualize the 
trauma and associated guilt, shame, and other deep emotions to dismantle the trauma and 
create separation between the patient’s sense of self and the traumatic stimuli (Kip et al., 
2016; Waits et al., 2015).  This results in a new awareness and understanding that helps 
normalize the trauma by rescripting the metaphorical components until the patient 
achieves resolution of the presenting trauma.  The process also helps resolve associated 
comorbid sequalae that surfaces organically through the lens of the restructuring process 
(Hoge, 2015; Kip et al., 2016; Waits et al., 2015).  
Finnegan et al. (2016) found that ART provides brief and sustaining resolution of 
PTSD symptoms and Finnegan advocated for consideration of ART as a first-line 
treatment protocol for PTSD, refractory PTSD, and PTSD with comorbidities such as 
depression, anxiety, and substance use.  Finnegan et al. (2016) and Kip et al. (2016) noted 
that three proven trauma-focused therapy components which included (a) imaginal 
exposure (IE); (b) imagery rescripting (IR); and (c) smooth pursuit eye movements (EM), 
form the theoretical base for ART (Kip et al., 2014a).  Kip et al. (2014) found that the 
above components support effective PTSD symptom reduction such as intrusive 
thoughts, sensations, emotions, and images.   
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 The major components of ART include imaginal exposure where patients recall 
details of their trauma (with as much or as little verbalizing as desired) while focusing on 
the physiological thoughts, sensations, or feelings (Hoge, 2015; Kip et al., 2016).  
Exposure and reactivation of the trauma occurs for brief therapeutic periods followed by 
the diminishment or extinguishment of distressing, somatic, physiological and 
psychological discomforts (Hoge, 2015; Kip et al., 2016).  Imagery rescripting techniques 
help the patient replace the old narrative, images, sensations, and feelings with more 
adaptive appraisals of the trauma memory, images, and sensations (Kip et al., 2014a, 
2014b).   
 Kip et al. (2014b) theorized that the excessive activation of the hippocampus and 
amygdala and the decreased inhibition of the prefrontal cortex serve as barriers to 
extinguishment of emotional traumatic memories.  Kip et al. further theorized that the 
ART process could create structural malleability, desensitize fear-based memories, make 
them susceptible to change, and allow reconsolidation to occur.  Kip et al. (2014b) also 
felt that the therapeutic alliance is significant because the ART-certified behavioral health 
practitioner engages the patient in bilateral eye movements throughout the ART process.  
Metaphorical and Gestalt techniques, used throughout the process strengthen and anchor 
new memories, sensations, feelings, and images (Kip 2012, 2013, 2014a).  Kip et al. 
theorized that the ART session concludes when the patient confirms extinguishment of 
presenting trauma memories, sensations, and feelings and achieves a rescripted, 
nonthreatening, adaptive version of the original trauma event.  Kip et al. (2014a, 2014b, 
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2016) and Waits et al. (2015) found that the differentiators associated with ART, when 
compared with other evidence based first-line treatments, include:  
• Shorter therapeutic timeframes. 
• Going beyond framing and desensitizing the presenting trauma narrative to 
changing the distressing images, thoughts, and sensations of the presenting 
trauma with a resolved narrative that strengthens self-efficacy. 
• The ability to engage the patient in the therapeutic process with as little 
verbalizing of the traumatic event as desired by the patient, offers a unique 
therapeutic approach not possible with other available PTSD treatment 
options. 
• Inclusion of metaphorical use to activate the IE and IR components. 
• Use of specific sets of standardized smooth-pursuit eye movements to 
extinguish distressing images in a manner that the images could not be 
accessed mentally regardless of the patient’s deliberate intent to recall.  
ART research.  Kip et al. (2012, 2013, 2014a) and Waits et al. (2015) reviewed 
the seven federally and privately funded research efforts related to ART.  Four of the 
studies were ongoing at the time.  Three completed studies resulted in four peer-
reviewed, data-based publications and one peer-reviewed, case-based publication (see 
Kip et al., 2012, 2013, 2014a; Waits et al., 2015b). 
In the first prospective cohort study, Kip et al. (2012) evaluated ART to assess its 
effectiveness as an exposure-based PTSD intervention.  A total of 80 adults enrolled in 
the program.  They ranged in age from 21 to 60 years.  A total of 66 participants 
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completed treatment (Kip et al., 2012).  A total of 54 participants provided follow-up data 
at two months (Kip et al., 2012).  The ART intervention protocol included an average of 
three sessions (Kip et al., 2012).  The ART protocol includes a total of one to five 
sessions (Kip et al., 2012).  Administration of the PCL-C occurred at pre, post, and two-
month follow-up (Kip et al., 2012).  Delivery of the ART intervention occurred without 
any adverse effects (Kip et al., 2012).  Empirical evidence was promising for the use of 
ART as an effective treatment alternative for PTSD symptom reduction in veteran 
populations (Kip et al., 2012; Waits et al., 2015). 
A total of 29 randomly-assigned participants with symptoms of military PTSD 
received ART treatment during the controlled trial study of ART conducted by Kip et al. 
(2013).  A total of 28 randomly-assigned participants with symptoms of military PTSD 
received an attention control (AC) regimen consisting of two sessions of fitness 
counseling or career counseling (Kip et al., 2013).  All participants assigned to the AC 
group were eventually offered ART treatment and a three-month follow-up (Kip et al., 
2013).  The sample mean age was 41 ± 13 years with 19% female, 54% Army, and 68% 
with prior PTSD treatment (Kip et al., 2013).  Kip et al. reported that study participants 
completed the ART protocol in 3.7 ± 1.1 sessions with a 94% completion rate.  The Kip 
et al. study results concluded that ART when compared to AC showed a significantly 
greater mean reduction in PTSD symptoms, as well as depression, anxiety, and guilt 
symptoms (p<.001).  Kip et al. reported that results were sustained at three-month follow-
up with an added reduction in aggression (p<.0001).  Adverse effects were minimal to 
none with no serious impact (Kip et al., 2013).  Study outcomes concluded that ART 
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could be a promising alternative treatment approach for combat-related PTSD and 
treatment-resistant or refractory PTSD (Kip et al., 2013; Waits et al., 2015). 
Waits, et al, (2015) confirmed that study efforts focused on subgroup analysis for 
military sexual trauma and treatment-resistant or refractory PTSD.  Waits et al. advocated 
for more research to further support the treatment advantages by use of ART for PTSD 
symptom reduction in veteran populations.  
Benefits of ART intervention for veteran PTSD.  The above randomized 
controlled trials conducted by Kip et al. (2012, 2013) examined the use of ART among 
combat veterans.  Aggregate outcomes showed that ART offered meaningful results for 
the effective treatment of PTSD (Kip et al., 2012, 2013).  The National Registry of 
Evidence-Based Programs and Practices (NRE-PP) and SAMHSA classified ART as an 
evidence-based therapy considered effective in the treatment of trauma and other anxiety 
and stressor-related disorders, as well as for the treatment of depression and 
resilience/self-concept (see Kip, 2015, 2016; Waits et al., 2015). 
The ART intervention is a trauma-focused treatment choice not currently 
approved or widely offered to service members and veterans within the VA/DoD 
behavioral health system (Ritchie, 2015; Waits et al., 2015).  The manualized, brief, and 
directive ART intervention delivered in one to five sessions may reduce dropout and non-
response rates and more expediently resolve veterans’ debilitating PTSD symptoms 
(Ritchie, 2015; Waits et al., 2015).  The ART protocol does not include between-session 
homework, trauma narrative recordings, adjunctive medications, or prolonged exposure 
to the trauma memories, thereby reducing risk of retraumatization (Ritchie, 2015; Waits 
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et al., 2015).  The use of ART results in permanent resolution of trauma symptoms and its 
associated physical, mental, physiological, and emotional side-effects (see Hernandez et 
al., 2016; Kip et al., 2012, 2013, 2014a, 2014b; Waits et al., 2015).  Waits et al. (2015) 
also noted that, during the ART session, ART-trained clinicians reported minimal or no 
debilitating effects associated with delivery of trauma-based therapies.  
Summary 
Posttraumatic stress has existed for over a century in its many iterations.  There 
were many ways to define the disorder over the decades. Theorists have debated 
regarding assessment, diagnosis, and treatment approaches.  Research and treatment 
advances have occurred over the decades.  However, the etiology of PTSD is unclear and 
remains unique to each individual (Hoge, 2011; Hoge et al., 2014; Ritchie, 2015).   
Combat PTSD presents with many challenges and behavioral health practitioners, 
researchers, and theorists offer conflicting viewpoints about whether PTSD is an injury or 
a disorder (Ritchie, 2015).  While some researchers and practitioners conclude that PTSD 
diagnostic criteria are too broad, others conclude they are not conclusive enough (Ritchie, 
2015). 
Empirically supported research has proven there are sound therapies available for 
the treatment of PTSD such as CPT, PE, EMDR, traditional talk therapy, and 
pharmacotherapy (Ritchie, 2015).  However, these interventions present with barriers to 
effective resolution of symptoms due to the complex nature of combat-related PTSD  
(Hoge, 2011; Hoge et al., 2014; Ritchie, 2015; Waits et al., 2015).  Additionally, 
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available treatment options do not align well with the cultural, physiological, 
psychological, and social needs of veterans who do seek care (Ritchie, 2015).   
The DoD and the VHA provided clear PTSD treatment guidelines, but many 
patients remain treatment-resistant and continue to suffer with PTSD symptoms that 
worsen their disorder and lead to other physiological and psychological sequelae 
(Bernardy & Friedman, 2012).  Cultural barriers that impede effective PTSD treatment 
and outcomes include the stigma associated with asking for behavioral health care; 
avoidance of the traumatic memories and images; the challenges associated with 
treatment side-effects; continuum of care limitations; and the risk of compromising 
military career ascension (Castro, 2014; Nash & Watson, 2012; Ritchie, 2015).  
Also, the guilt and shame service members experience when they are involved in 
a killing or witness the killing of another service member impedes PTSD recovery (see 
Castro, 2014; Hoge et al., 2014; Ritchie, 2015).  The concept of moral injury needs 
further research to investigate how these factors contribute to comorbid disorders such as 
depression, anxiety, and suicide (see Dettmer et al., 2015; Leardmann et al., 2013; 
Ritchie, 2015). These comorbidities become a critical research focus because, since 2008, 
veteran suicide rates have exceeded civilian rates, and the current rate of suicide in 
veteran populations is 22 suicides per day (see Dettmer et al., 2015; Leardmann et al., 
2013; Ritchie, 2015). 
The DoD and VA healthcare system have approved CPT, PE, and EMDR for all 
veterans who present for PTSD treatment.  However, use of available behavioral 
healthcare services is low, and it is unclear which treatment protocols best serve the 
78 
 
needs of veterans diagnosed with PTSD (see Castro, 2014; Haagen et al, 2015; Ritchie, 
2015).  Hoge et al. (2014) and Waits et al. (2015) found that the low utilization rates, the 
high dropout, non-response, and non-compliance rates are all due to lengthy and time-
consuming therapies, resistance to the required between-session homework, and the 
potentially retraumatizing exposure exercises that include repeatedly recalling trauma 
memories, sensations, and feelings (see Feeny & Foa, 2005; Hembree & Foa, 2010; 
Hernandez et al., 2016; Hoge et al., 2014; Kip et al., 2013; Ritchie, 2015).  Veterans 
suffering with symptoms of chronic PTSD are also more treatment-resistant, resulting in 
modest to moderate results (Friedman, 2016; Hernandez et al., 2016; Ritchie, 2015). 
Study findings from experts in the field of PTSD research all conclude with 
urgent requests for more research to assess alternative treatment options (see Hawley et 
al., 2016; Kip et al., 2016; Mott et al., 2014; NIMH, 2016; Ritchie, 2015).  Research 
focus is on investigating the factors that contribute to PTSD onset (Hawley et al., 2016; 
NIMH, 2016; Ritchie, 2016).  Military researchers are advocating for ways to hasten the 
approval process of alternative and emerging interventions for use in clinical settings 
(Hawley et al., 2016; Kip et al., 2016; Mott et al., 2014; NIMH, 2016; Ritchie, 2015). 
The ART intervention analyzed in this study  is a brief, empirically supported, 
trauma-focused intervention that combines key components of other empirically 
supported PTSD therapies (see Hoge, 2015, Kip et al., 2016; Waits et al., 2015).  The 
ART procedure allows the patient to process the trauma experience while attending to 
sets of bilateral eye movement until the scene and sensations associated with recalling the 
trauma event desensitize (Hoge, 2015; Kip et al., 2013, 2016).  After the desensitization 
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process, the patient replaces old images of the traumatic event with new images that elicit 
sensations associated with resolution of the presenting concerns (Hoge, 2015; Kip et al., 
2013, 2016).  This process is known as voluntary image replacement (Hoge, 2015; Kip et 
al., 2016).  A review of the available literature concluded that ART is an effective PTSD 
intervention not approved or widely offered within the VA/DoD behavioral health system 
(see Hoge, 2015; Kip et al., 2013, 2014; Ritchie, 2015; Waits et al., 2015, 2017).   
Foa and Kozak’s (1986) emotional processing theory formed the basis for the 
theoretical framework of this study and the theory aligned well with the ART protocol, as 
both are based on sufficiently reactivating the trauma memory to extinguish negative 
images, emotions, and sensations before introducing corrective information during a 
reconsolidation phase (Kip et al., 2016).  
Therefore, this study filled the gap in the literature by conducting the first 
quantitative analysis to determine which variables predict the veterans who most benefit 
by use of ART for PTSD symptom reductions.  The study’s focus is also on whether the 
variation in PTSD symptom reduction is greater for one of three PTSD symptom severity 
groups to determine mean reduction amounts among the low, moderate, and high PTSD 
symptom severity groups (Field, 2013; Kip et al., 2016).  This secondary analysis of 
existing data may allow for the creation of a PTSD treatment-matching predictive model 
to enhance treatment outcomes, reduce the comorbidities and suicidality commonly 
associated with unresolved PTSD, minimize the need for multiple PTSD treatment 
approaches, and inform behavioral practitioners about the utility of a predictive 
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treatment-matching model that predicts PTSD symptom reduction amounts by use of 
ART in veteran populations.    
To answer the research questions and hypothesis, chapter 3 includes details of the 
research design, rationale, and method.  A multiple regression analysis supported 
assessment of the selected continuous variables to predict which veterans most benefit 
from ART for PTSD symptom reduction.  Informed by the literature, this was the first 
attempt to create a scientific predictive treatment-matching model to inform practitioners 
regarding which veterans benefit most from ART for PTSD symptom reduction.  An 
ANOVA test was computed to answer the second research question regarding the 
variation in mean PTSD symptom reduction among the three identified PTSD symptom 
severity groups at low, moderate, and high PTSD symptom severity levels. The study 
findings were used to determine where statistically significant mean PTSD symptom 
reduction differences existed among the three PTSD symptom severity groups.  
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Chapter 3: Research Method  
Introduction 
In this study, I used a quantitative strategy of inquiry informed by Foa and 
Kozak’s (1986) emotional processing theory.  This strategy of inquiry relied on a prior 
prospective cohort treatment study of ART registered at www.clinicaltrials.gov 
(NCT02030522), to conduct the secondary analysis (Kip et al., 2016).  The purpose of 
this quantitative study was to determine whether the continuous independent variables 
number of deployments, guilt, depression, and anxiety, as measured by secondary data 
pretreatment self-rating scales used in the original study, predict the continuous 
dependent variable PTSD symptom reduction, as measured by the difference between 
secondary data pretreatment and posttreatment PCL-M scores before and after ART, in a 
sample of combat veterans who participated in the prospective cohort treatment study of 
ART from which I drew the dataset (see APA, 2013; Edward et al., 1996; Henning & 
Frueh, 1997; Huang & Kashubeck-West, 2015; Kip et al., 2016; Kubany, 2004; Ree et 
al., n.d.; Weathers et al., 1998).  For purposes of this study, veterans are defined as 
active-duty, reservist, or discharged service members who are serving or served in any 
branch of the United States armed forces (see Huang & Kashubeck-West, 2015; Hunt, 
Burgo-Black, & Agarwal, n.d.; Xue et al., 2015).  
In this chapter, I detail the design and rationale of the study, outlining the 
dependent and independent study variables.  The chapter includes a review of the 
strengths and limitations of the design, as well as how the study design aligns with the 
research questions and hypotheses.  The method section includes descriptions of the 
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target population, the sampling strategy, the sampling frame with inclusions and 
exclusions, and sampling procedures, all as determined by the prospective cohort 
treatment study of ART conducted in 2016 from which I obtained the dataset.  
Information is provided on the procedural steps I took for approval of and access to the 
secondary data (Kip et al., 2016).  There is also a detailed review of the secondary data 
instrumentation used with reliability and validity values and relevance to their 
appropriateness in the study.  The chapter includes operationalization of variables and 
explanation of measurement strategies.  The secondary data analyses plan includes 
variables, measurement strategies, and statistical tests.  There is an explanation of the 
threats to internal and external validity specific to the use of secondary data.  I conclude 
the chapter with a discussion of any ethical concerns related to this study and a summary 
of the chapter. 
Research Design and Rationale 
In this study, I used a correlational research design (see Curtis, Comiskey, 
Dempsey, 2016; Dziak, 2016).  The research design included a secondary analysis of 
existing data from a prior prospective cohort treatment study of ART registered at 
www.clinicaltrials.gov (NCT02030522; Kip et al., 2016).  It is important to note that a 
correlational research design uncovers relationships, but correlation does not imply 
causation (Curtis et al., 2016; Field, 2013).  However, correlational research designs do 
assess the direction and strength of the relationships (Curtis et al., 2016).  This helps 
narrow the findings that support future experimental research to investigate causation 
(Curtis et al., 2016).  I did not seek to examine the relationship between or among the 
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variables of interest in this study (see Creswell, 2013).  Pretreatment scores from self-
rating scales previously used in the prospective cohort treatment study of ART supported 
the analysis of the predictor independent variables number of deployments, guilt, 
depression, and anxiety (see Bryan et al., 2013; Kip et al., 2016; Raab et al., 2015; Xue et 
al., 2015).  I used the same secondary data to measure the difference between 
pretreatment and posttreatment PTSD symptom scores before and after ART to analyze 
the dependent variable, PTSD symptom reduction.   
These variables may help predict which veterans most benefit from ART 
intervention for PTSD symptom reduction (see Kip et al., 2016).  A predictive treatment-
matching model based on a potential ART candidate’s pretreatment measures for number 
of deployments, guilt, depression, and anxiety may help predict the amount of PTSD 
symptom reduction by use of ART (see Kip et al., 2016). 
 Kip et al. (2016) used the data from the same prospective cohort treatment study 
of ART in a published study that compared ART intervention among two different 
veteran populations.  However, as informed by the literature, there are no available 
studies that have assessed predictor variables to determine which variables predict the 
amount of PTSD symptom reduction by use of ART in veteran populations.  No other 
researchers have attempted to identify a  predictive PTSD treatment-matching algorithm 
for PTSD symptom reduction by use of ART in veteran populations, and no study 
findings have identified mean PTSD symptom reduction differences among PTSD 
symptom severity groups, comparing said PTSD symptom severity groups to determine 
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statistically significant mean PTSD symptom reduction differences among the three 
groups (see Hardwick, 2016; Kip et al., 2012, 2013, 2014a, 2014b, 2016).   
As I noted in Chapter 2, Haagen et al. (2016) conducted a meta-analysis of 57 
PTSD intervention studies in veteran populations and concluded that pretreatment 
severity levels are associated with PTSD treatment outcomes.  Haagen et al. noted lower 
treatment gains at low and high severity levels when compared with the outcomes of 
those who tested at moderate severity levels prior to treatment.  Haagen et al. concluded 
that exposure-based therapies optimally address veteran PTSD symptoms but Haagen 
advocated for additional studies to analyze efficacy rates.  As noted in the previous 
chapter, Kip et al. (2012, 2013, 2014a, 2014b, 2016) have conducted randomized 
controlled trials of ART for veteran PTSD symptom reduction, and Waits, Marumoto and 
Weaver (2017) reviewed the ART research to date concluding that ART offers an 
effective alternative to existing trauma-based treatment options used within the military 
healthcare system.   
However, Kip et al. and Waits et al. concluded that additional research was 
needed to know which veterans benefited most from available trauma-based treatments 
for PTSD symptom reduction to prevent the need for multiple treatment approaches.  
Ritchie (2015) stated there is a need within the military healthcare system for more 
effective PTSD treatments and that additional research was needed to better match 
veteran PTSD symptoms with specific treatments to increase effectiveness rates.  The 
ART research findings, to date, have neither addressed predictive PTSD treatment-
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matching modeling, nor have the findings helped to determine efficacy rates among 
symptom severity levels (see Ritchie, 2015; Waits et al., 2017).  
I determined that a correlational research design was best for this study (Curtis et 
al., 2016).  This design supports investigation of the relationship between variables to 
know how they interact (Dziak, 2016).  The us of available secondary data mitigates the 
cost, low response rates, risks, and delays usually experienced with other research design 
options (Curtis et al., 2016; Kip et al., 2016).  The self-administration of each of the valid 
and reliable secondary data instruments selected from the original prospective cohort 
treatment study of ART I used for this study minimized the need for additional 
researchers and lowered the potential for interviewer bias (see Curtis et al., 2016; Kip et 
al., 2016; Witt, 2016).  I analyzed this secondary ART dataset to contribute to research on 
PTSD symptom reduction by use of ART in veteran populations (see Kip et al., 2016). 
I selected the ART intervention for analysis in this study because it is a brief, 
trauma-focused intervention for the treatment of PTSD symptom reduction in veteran 
populations (see Hernandez et al., 2016; Hoge, 2015; Kip et al., 2012, 2013, 2014a, 
2014b, 2016; Ritchie, 2015; Waits et al., 2015). There is a critical need to continue 
researching PTSD treatment options for veterans with PTSD (see Hoge, 2015; Kip et al., 
2016; Ritchie, 2015; Waits et al., 2015). The ART intervention includes a minimum of 
one to five sessions without the need for homework or the retelling of the trauma 
narrative (Hoge, 2015; Kip et al., 2016).  The brevity of the treatment protocol is 
significant when compared to other trauma-based interventions that include anywhere 
from eight to 12 sessions or more, often resulting in high dropout and non-compliance 
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rates (Kip et al., 2016).  Treatment completion rates are also quite high for the ART 
intervention, estimated at 90%.   
Methodology  
Population  
The target population from the secondary dataset consisted of veterans who 
served in any conflict area at any time and were experiencing PTSD symptoms (Kip et 
al., 2016).  This study, therefore, included male and female veterans 18 years of age or 
older with prior combat deployment who were experiencing symptoms of psychological 
trauma (Kip et al., 2016).  The United States Census Bureau (2014) estimated there were 
21.8 million United States armed forces veterans, of which an estimated 20% suffer with 
PTSD symptoms.  This percentage does not include veterans with undiagnosed PTSD 
symptoms (United States Census Bureau, 2014).  
Sampling and Sampling Procedures 
My analysis of secondary data from a prior prospective cohort treatment study of 
ART includes data from adult male and female active-duty, reservist, and discharged 
veteran United States service members with a history of veteran PTSD symptoms who 
completed ART intervention during that study (Kip et al., 2016).  The inclusion criteria 
from the prior prospective cohort treatment study of ART are  (a) U.S. service member or 
veteran; (b) over 18 years of age; (c) a military history of prior deployments to any 
conflict area; (d) a history of combat-related PTSD or military sexual trauma; (e) a score 
of  ≥ 40 on the PCL-M checklist; (f) the ability to speak and read English at a proper 
level of understanding (Hardwick, 2016; Kip et al., 2016). 
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Exclusion criteria from the prior prospective cohort treatment study of ART are 
(a) suicide ideation or intent including homicidal ideation or intent (b) psychotic behavior 
or being in psychological crisis (determined by the original study’s medical intake form 
data and at the discretion of the original study’s clinician (c) brain injury that prohibits 
the ability to speak, write, or take specific actions (d) active engagement in any other 
PTSD psychotherapy treatment protocol (e) other major psychiatric disorders (e.g., 
bipolar disorder) that could interfere with treatment; (f) active participation in any alcohol 
or drug abuse treatment program; (g) any psychological or medical conditions that place 
the participant at a higher risk for adverse emotional reactions (e.g., heart attack, 
seizures), as assessed by the original study’s principal investigator and ART clinician 
(Hardwick, 2016; Kip et al., 2016). 
The software G*Power 3.1.9.2 (2016) generated a power analysis for a multiple 
regression analysis with four independent variables and a power analysis for ANOVA 
with three independent groups at low, moderate, and high PTSD symptom severity levels 
(see Button et al., 2013).  For each analysis, the sample consisted of a minimum of 85 
study participants, providing 80% power, with a Type 1 error rate of  alpha .05, and a 
moderate effect size of .25 (see Button et al., 2013; Kip et al., 2016).   
Recruitment, Participation, and Data Collection 
The secondary analysis of existing data used for this study included study 
participants recruited from veteran membership organizations within the Tampa Bay 
area, as well as through academic programs at a local university (Hardwick, 2016; Kip et 
al., 2016).  The sampling frame consists of all study participants from the original study 
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who consented and voluntarily took part in the prospective cohort treatment study of 
ART (Hardwick, 2016; Kip et al., 2016).  The dataset for this study includes all study 
participants who completed ART treatment during the prospective cohort treatment study 
of ART (Kip et al., 2016).  The data source provider granted permission to use the 
secondary dataset and provided the deidentified dataset after Walden University’s 
institutional review board (IRB) approval (IRB 06-25-18-0020711).  The data source 
provider (the original study’s principal investigator) sought approval from the 
university’s institutional review board prior to commencement of the prospective cohort 
treatment study of ART conducted in 2016 (Kip et al., 2016).  An executed Walden 
University Data Source Agreement, the study title and purpose, as well as my curriculum 
vitae, and proof of completion of the National Institute of Health Office of Extramural 
Research (n.d.) NIH web-based training course, Protecting Human Research Participants 
(for their records only, since secondary data was used for this study) was submitted to the 
data source provider, to comply with stated requirements for use of data.  The proposal 
was approved by the Walden University IRB and the approval documentation from the 
Walden University IRB was submitted to the data source provider in order to receive the 
deidentified secondary dataset to conduct the study analyses (NIH, 2016).  
ART Intervention Administration 
ART, the trauma-based intervention created by Laney Rosenzweig in 2008 and 
selected for analysis in this study, was selected because it is a trauma-based 
psychotherapy that uses the same components found in other empirically supported, 
trauma-focused psychotherapies (see Hernandez et al., 2016; Hoge, 2015: Kip et al., 
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2016; Waits et al., 2015).  The components include narrative components, in vivo and 
imaginal exposure, cognitive restructuring, and relaxation/stress modulation (see 
Hernandez et al., 2016; Hoge, 2015; Kip et al., 2012, 2013, 2014a, 2014b, 2016).  The 
ART procedure differs from other first-line, trauma-focused treatments in several 
important ways (Kip et al., 2016).  ART includes a minimum of one to five treatment 
sessions (Kip et al., 2016).  The ART protocol is effective with or without the retelling of 
the trauma narrative (Hoge, 2015; Kip et al., 2016). The ART intervention does not 
include any homework (Hernandez et al.; Hoge, 2015; Kip et al., 2016).   
An average of less than four ART treatment sessions has resulted in clinically 
meaningful veteran PTSD symptom reduction in prior ART research findings (Kip et 
al.2016).  Amelioration of PTSD symptoms in less than four sessions is significant when 
compared to prolonged exposure (PE) at eight to 12 sessions, cognitive processing 
therapy (CPT) at 12 sessions, and eye movement desensitization and reprocessing 
(EMDR) at 8 to twelve sessions (see Foa et al., 2009; Kip et al., 2016; Resick et al., 2008; 
Shapiro, 2001).  Trauma-focused interventions with a greater number of treatment 
sessions result in higher treatment dropout rates (see Haagen, et al., 2015; Hernandez-
Tejeda et al., 2017; Kip et al., 2012, 2013, 2014a, 2014b, 2016).  The dropout rate is up 
to 50% for PE, up to 30% for CPT, up to 36% for EMDR, and up to 6% for ART (see 
Foa et al., 2009; Kip et al., 2016; Panchen, Blankenship, Yarvis, & Resick, n.d.; Shapiro, 
2001).  Existing veteran PTSD ART treatment study findings show a reduction in PTSD 
symptoms and comorbid disorders such as depression and anxiety (Kip et al., 2016).  
However, none of the published ART research studies to date have included an analysis 
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of predictor variables with the aim of building a scientific PTSD treatment-matching 
algorithm to inform behavioral practitioners regarding which PTSD treatment candidates 
most benefit from ART intervention for PTSD symptom reduction in veteran populations 
(Field, 2013; Kip et al., 2016).  Additionally, none of the available ART studies include 
analysis of the variation in mean PTSD symptom reduction by symptom severity groups 
to measure mean PTSD symptom reduction differences when groups are stratified by 
PTSD symptom severity levels (Haagen et al., 2015).  This study, therefore, analyzed 
which of the four identified variables predict which veterans most benefit from ART 
intervention for PTSD symptom reduction and whether the variation in mean PTSD 
symptom reduction, by use of ART, differs among PTSD symptom severity groups after 
examining mean PTSD symptom reduction amounts by PTSD symptom severity levels 
(Kip et al., 2016). 
Participants in the original prospective cohort treatment study of ART received 
individual one-hour ART treatment sessions (Kip et al., 2016).  Licensed ART-trained 
behavioral health clinicians conducted the ART treatment sessions (Hardwick, 2016; Kip 
et al., 2016).  The ART treatment sessions took place in private offices and each office 
was reserved for one study participant and one ART-trained clinician (Hardwick; Kip et 
al., 2016).  The ART sessions took place weekly, and each patient completed ART 
sessions within a one-month timeframe (Kip et al., 2016). 
Hoge (2015) and Kip et al. (2016) reported that the ART protocol includes the 
same trauma-focused therapeutic components used in existing empirically supported, 
first-line trauma-based interventions.  The therapist supports the process by moving a 
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hand back and fourth for a series of forty bilateral smooth-pursuit left-to-right eye 
movements, during each phase of the ART process (see Hardwick, 2016; Kip et al., 2016; 
Waits et al., 2015).  The veteran “watches” the original or new trauma memory while 
simultaneously following the therapist’s hand from left to right (see Hardwick, 2016; Kip 
et al., 2016; Waits et al., 2015).  The ART protocol is effective whether the veteran does 
or does not choose to retell the trauma experience to the therapist during the ART process 
(Kip et al., 2016).  This is an important differentiation when comparing ART with other 
trauma-based interventions because most other PTSD interventions require that patients 
retell their trauma narrative despite the risk of retraumatization (Foa & Kozak, 1986; 
Hoge, 2015, Kip et al., 2016). 
The first phase of ART also includes imaginal exposure whereby the veteran 
recalls details of the traumatic event while simultaneously focusing attention on the 
sensations, feelings, and thoughts that surface (see Hardwick, 2016; Hoge, 2015; Kip et 
al., 2012, 2013, 2014a, 2014b, 2016).  As the veteran briefly experiences reactivation of 
the presenting trauma memories, the period of reactivation that follows supports 
extinguishment of any presenting somatic or emotional symptoms (see Hoge, 2015; Kip 
et al. 2016; Waits et al., 2015).  Reactivation of the presenting trauma memories repeats a 
second time followed each time by diminishment or extinguishment of presenting 
somatic or emotional symptoms (Kip et al., 2016). 
The ART imagery rescripting phase allows the veteran to change or replace 
negative images and cognitions with new more positive images and cognitions (see 
Finnegan et al., 2016; Hoge, 2015; Kip et al., 2016; Waits et al., 2015).  A more positive 
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narrative that diminishes or extinguishes intrusive negative thoughts and images replaces 
the negative traumatic narrative, whether sensory or emotional (Hernandez et al., 2016; 
Hoge, 2015; Kip et al., 2012, 2013, 2014a, 2014b, 2016).  This was consistent with 
memory reconsolidation theories where theorists thought that the trauma-focused 
memories embedded themselves in the images (see Hernandez et al., 2016; Hoge, 2015; 
Kip et al., 2012, 2013, 2014a, 2014b, 2016).  Therefore, processing and rescripting these 
trauma-focused images is the preferred approach to memory reconsolidation and 
reduction or extinguishment of veteran PTSD symptoms (Foa & Kozak, 1986).  The ART 
protocol consists of one to five ART treatment sessions depending on the presenting 
trauma symptoms (Kip et al., 2016).  Kip et al. (2016) explained that successful 
completion of an ART treatment session is consistent with the veteran able to recall the 
trauma memory without any associated physiological arousal and able to visualize the 
more positive rescripted narrative rather than the original traumatic narrative.  
Secondary Data  
Th study design included a dataset derived from a prospective cohort treatment 
study of ART registered at www.clinicaltrials.gov (NCT02030522; Kip et al., 2016).  All 
processes were followed and approval was secured from the Walden University IRB as 
well as the data source provider’s IRB, as referenced in the recruitment and data 
collection section of this chapter, before acquiring the dataset and conducting the 
analyses (IRB Number 06-25-18-0020711). 
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Instrumentation 
Listed below are the reliable and valid secondary data self-rating scales from 
which the data was sought for this study’s analyses (see Hardwick, 2016; Kip et al., 2013, 
2014a, 2014b, 2016; Waits et al., 2015).  
Demographics form.  Secondary analysis of existing socio-demographic data 
produced descriptive statistics of the makeup of the secondary data study participants to 
include age, gender, marital status, race, and education (Kip et al., 2016).  Continuous 
variables appear as mean ± standard deviation (SD), and categorical variables appear as 
frequencies and percentages (Field, 2013).   
PTSD Checklist-Military (PCL-M).  The posttraumatic stress disorder 
checklist-military (PCL-M) is a self-report measure used to screen, diagnose, and 
rescreen for PTSD symptom changes before, during, and after treatment (Weathers et al., 
1998).  The 17-item checklist measures the 17 PTSD symptoms reported in the DSM-IV 
(American Psychiatric Association, 1994).  A Likert scale from 1 (not at all) to 5 
(extremely) is used to score the 17 items (Weathers et al., 1998).  The PCL-M is an 
effective tool for assessment of veteran PTSD symptoms because it includes questions 
related to stressful military experiences (see Dickstein et al., 2015; Hardwick, 2016; Kip 
et al., 2016; Waits et al., 2015).  Completion of the PCL-M takes five to ten minutes 
making it a convenient and widely-used tool in veteran PTSD research studies (see 
Dickstein et al., 2015; Weathers et al., 1998).  All published ART studies have included 
the PCL-M (see Hardwick, 2016; Kip et al., 2012, 2013, 2014a, 2014b, 2016).   
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The PCL-M score is the sum of the total symptom severity scores from 17 to 85 
from each of the 17 items (Weathers et al., 1998).  A licensed therapist should interpret 
the results of the PCL-M (Kip et al., 2016; Weathers et al., 1998).  The higher the PCL-M 
score the higher the level of PTSD symptom severity (Weathers et al., 1998).  The PTSD 
prevalence rate in the target population informs cutoff scores for assessment of PTSD 
symptoms (see Dickstein et al., 2015.; Kip et al., 2016; Weathers et al., 1998).   
Test-retest reliability for the PCL-M is .96.  Internal consistency (alpha 
coefficient) is .97 for all 17 symptoms (Dickstein et al., 2015; Kip et al., 2016; Weathers 
et al., 1998).  Strong correlations between the PCL and the Mississippi Scale accounted 
for strong convergent validity at .93 (Weathers et al., 1998).   Measurement of the 
dependent variable PTSD symptom reduction occurred by analyzing secondary data 
scores to calculate the difference between pretreatment and posttreatment PCL-M scores 
before and after ART to determine the amount of  PTSD symptom reduction (Kip et al., 
2016).  
Trauma-Related Guilt Inventory (TRGI).  Measurement of the predictor 
independent variable guilt occurred by analyzing the raw pretreatment scores from the 
TRGI scale used in the original prospective cohort treatment study of ART (Kip et al., 
2016).  Kubany et al. (1996) created the TRGI to assess trauma survivors’ experiences of 
guilt.  Kubany et al. defined guilt as an unpleasant feeling with an accompanying belief 
that one should have thought, felt, or acted differently.  Trauma-related guilt is often 
associated with PTSD in veteran populations (Kubany et al., 1996; Kubany, 2004).  The 
guilt can vary and be associated with cognitive themes such as guilt for having survived 
95 
 
the traumatic incident, not having done more at the time of the traumatic incident, and not 
having saved those who died during the traumatic event (Kubany et al., 1996).  Paul et al. 
(2014), Popiel (2014), and Bryan et al. (2013) have reported a positive relationship 
between guilt and post-trauma psychopathology contributing to the maintenance of PTSD 
symptoms.  
The TRGI consists of three scales and three subscales (Kubany et al., 1996).  The 
scales include (a) the four-item global guilt scale (b) a six-item distress scale and (c) a 22-
item guilt cognition scale (Kubany et al., 1996).  The three subscales which correspond to 
the cognitive factors include (1) a hindsight-bias/responsibility subscale (7 items) (b) a 
wrongdoing subscale (5 items) and (c) a lack of justification subscale (4 items).  The 
TRGI measures blame, cognition, distress, emotional trauma, guilt, hindsight bias, 
responsibility, and trauma (Kubany et al., 1996).  Kubany et al. (1996) used a 5-point 
Likert scale ranging from 4 (extremely true) to 0 (not at all true), or from 4 (always true) 
to 0 (never true).  Subscale coefficient alpha range from .66 to .94.  Test-retest reliability 
coefficient range from .73 to .86.   
Center for Epidemiologic Studies-Depression (CES-D) Scale.  Measurement of 
the predictor independent variable depression occurred by analyzing the raw pretreatment 
scores from the CES-D scale used in the original prospective treatment study of ART 
(Kip et al., 2016).  The CES-D is a 20-item, brief, self-report measure that assesses 
symptoms of depression (in the prior week) in the general population (Radloff, 
Lewinsohn, Seeley, Roberts, & Allen, 1997).  Radloff et al. (1997) created response 
options ranging from 0 to 3 defined as follows: 0 (rarely or not at all); 1 (some or little of 
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the time); 2 (moderately or much of the time); 3 (most or almost all of the time).  Scores 
range from 0 to 60 with higher scores indicative of greater depressive symptoms (Radloff 
et al., 1997).  The standard cutoff score suggesting depression is ≥ 16 (sensitivity = .95 
and specificity = .29). The CES-D was found reliable with a high internal consistency 
reported with Cronbach’s alpha at .79 (Radloff, 1977).  The CES-D includes common 
factors found across other measures of depression including the Beck Depression 
Inventory (BDI), the Hamilton Rating Scale for Depression (HRSD), and the Zung Self-
Rating Scale (see Ben Barnes, Hayes, Contractor, Nash, & Litz, 2018; Worboys, 2013; 
Zung et al., 1998). Wanklyn et al. (2016) found that higher depression scores impeded 
PTSD symptom resolution.  
State-Trait Inventory for Cognitive and Somatic Anxiety (STICSA).  
Measurement of the predictor independent variable anxiety occurred by analyzing the 
raw pretreatment scores from the STICSA scale used in the original prospective cohort 
treatment study of ART (Kip et al., 2016).  Ree et al. (2000) designed the STICSA to 
assess cognitive and somatic symptoms of anxiety pertaining to one’s mood in the 
moment (state) and in general (trait).  Ree et al. created the STICSA to include somatic 
and cognitive subscales.  The STICSA cutoff score is ≥ 43 (sensitivity of .73 and 
specificity .74).     
Operationalization  
PTSD symptom reduction.  For this study, the dependent variable PTSD 
symptom reduction is the difference between pretreatment and posttreatment PCL-M 
scores, before and after use of ART to determine the amount of PTSD symptom 
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reduction (Kip et al., 2016). The aim of the study analysis is to define the predictors that 
predict PTSD symptom reduction by use of ART (the PTSD intervention selected for this 
analysis) to create a PTSD treatment-matching algorithm that informs practitioners which 
veterans benefit most by use of ART for PTSD symptom reduction.  This predictive 
treatment-matching model offers potentially broad implications for effectively selecting 
ART candidates who may most benefit from ART intervention for PTSD symptom 
reduction.  
Number of deployments.  The continuous independent variable number of 
deployments is the movement of military soldiers to assigned conflict areas (Hoge, 2011, 
2015). Many soldiers deployed to combat areas return with polytraumas (Hoge, 2011, 
2015).  The polytraumas are often single-event injuries caused by improvised explosive 
devices (Xue et al., 2015).  An estimated 27% to 36% of veterans returning from the most 
recent conflict areas in Afghanistan and Iraq met the criteria for mental health disorders 
and an estimated 11% to 20%of those veterans met the criteria for PTSD (Xue et al., 
2015).  
Xue et al. (2015) estimated that as the number of deployments increased so did 
the potential for PTSD onset and maintenance.  Therefore, for the purposes of this study, 
measurement of the continuous independent variable number of deployments occurred 
using numerical data from the original study’s Demographics Form (Kip et al., 2016).  
The Demographics Form included question number 12 asking study participants to 
numerically list the total number of tours of duty defined as deployment to a conflict area 
(Kip et al., 2016).  Numerical data for the continuous independent variable number of 
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deployments supported a multiple regression analysis to assess the effect of number of 
deployments on veteran PTSD symptom reduction (Curtis et al., 2016).  The resulting 
model attaches a coefficient to this variable to predict which veterans most benefit from 
ART for PTSD symptom reduction. 
Guilt.  Guilt is an unpleasant or negative feeling with an associated belief that 
more could have occurred to change the outcome of what happened (Kubany et al., 
1996).  Guilt has been positively correlated with PTSD onset and maintenance (Bryan et 
al., 2013).  The disorder most commonly associated with combat guilt is PTSD (Kubany 
et al., 1996).  Guilt is a consistent factor in veteran PTSD research (Xue et al., 2015).   
Guilt is associated with avoidance, a risk factor in PTSD symptom reduction and 
recovery (Henning & Frueh, 1997).   Kubany et al. (1996) and Xue et al. (2015) also 
found that combat related guilt is the most significant predictor of suicide, specifically in 
veterans with combat exposure (Huang & Kashubeck-West, 2015; Xue et al., 2015).   
Kubany et al. (1996) designed the TRGI to assess trauma survivors’ experiences 
of guilt.  The TRGI consists of three scales and three subscales (Kubany et al., 1996). The 
scales include (a) the four-item global guilt scale (b) a six-item distress scale and (c) a 22-
item guilt cognition scale (Kubany et al., 1996).  The three subscales which correspond to 
the cognitive factors include (a) a hindsight-bias/responsibility subscale (7 items) (b) a 
wrongdoing subscale (5 items) and (c) a lack of justification subscale (4 items).  
Measurement of the continuous independent variable guilt occurred by calculating study 
participants’ pretreatment scores from the TRGI scale, administered during the 
prospective cohort treatment study of ART (Kip et al., 2016).  A multiple regression 
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analysis using pretreatment scores from the TRGI will support assessment of the effect of 
guilt on veteran PTSD symptom reduction (Kip et al., 2016; Kubany et al., 1996). The 
resulting model attaches a coefficient to this variable to predict which veterans most 
benefit from ART for PTSD symptom reduction. 
Depression. Depression is a persistent sadness that affects thoughts, feelings, and 
behaviors (Radloff et al., 1997; Van Voorhees et al., 2012).  This can lead to increased 
risk of suicide and other comorbid disorders (Van Voorhees et al., 2012).  Van Voorhees 
et al. (2012) found a link between depression and PTSD among service members exposed 
to trauma.  Both depression and PTSD share common factors thought to increase 
vulnerability in three domains; behavior avoidance, low cognitive bias, and learning and 
information bias (Van Voorhees, 2012).  Avoidance is associated with PTSD 
maintenance (Van Voorhees et al., 2012). 
The CES-D is a 20-item, brief, self-report measure that assesses symptoms of 
depression (in the prior week) in the general population (Radloff et al., 1997).  Radloff et 
al. (1997) created response options ranging from 0 to 3 for each item (0=rarely or not all 
of the time; 1=some or little of the time; 2=moderately or much of the time; and 3=most 
or almost all of the time). Scores range from 0 to 60 with high scores indicative of greater 
depressive symptoms (Radloff et al., 1997).  Measurement of the continuous independent 
variable depression occurred by using the pretreatment CES-D scale scores from the 
prospective cohort treatment study of ART (Kip et al., 2016).  A multiple regression 
analysis using pretreatment scores from the CES-D will support assessment of the effect 
of depression on veteran PTSD symptom reduction (Kip et al., 2016; Radloff et al., 
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1997).  The resulting model attaches a coefficient to this variable to predict which 
veterans most benefit from ART for PTSD symptom reduction (Curtis et al., 2016; Field, 
2013; Kip et al., 2016).  
Anxiety. Anxiety is defined as a feeling of tension, the presence of negative 
cognitions, and physiological reactions such as elevated blood pressure (Ree et al., n.d.). 
The STICSA is used to assess probable cases of clinical anxiety (Ree et al., n.d.).  Studies 
reveal that higher anxiety scores impede PTSD symptom resolution (Kip et al., 2016).  
Measurement of the continuous independent variable anxiety occurred by using the 
pretreatment STICSA scale scores from the prospective cohort treatment study of ART 
(Kip et al., 2016).  A multiple regression analysis supported assessment of the effect of 
anxiety on veteran PTSD symptom reduction (Kip et al., 2016; Ree et al., n.d.). The 
resulting model attaches a coefficient to this variable to predict which veterans most 
benefit from ART for PTSD symptom reduction (Curtis et al., 2016; Field, 2013; Kip et 
al., 2016).  
Data Analysis Plan  
Software application.  The IBM’s Statistical Package for the Social Sciences 
(SPSS) 23 (2015) software application supported the statistical analyses for this study.  A 
password-protected laptop kept in a secure and locked location ensured protection of the 
SPSS software application and the associated study data and statistical output (Frankfort-
Nachmias & Nachmias, 2008; Piotrowski, 2013).  
Data cleaning and screening procedure.  Secondary analysis of existing data is 
an expedient and cost-efficient research design choice (Cheng & Phillips, 2014).  The 
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secondary data used for this study was derived from a prospective cohort treatment study 
of ART (Kip et al., 2016).  The strength of the dataset was ensured by obtaining the 
original study’s purpose, available documentation, data codebooks, and sampling criteria 
(Cheng & Phillips, 2014).  Analysis of the dataset confirmed internal and external 
validity (Cheng & Phillips, 2014).  This ensured the generation of meaningful data results 
(Cheng & Phillips, 2014).  
Adherence to the above data cleaning and screening procedures occurred after 
Walden University IRB approved for commencement of the study (Cheng & Phillips, 
2014).   Frequency tables and cross-tabulation of all proposed variables ensured data 
accuracy and confirmed any missing data (Cheng & Phillips, 2014).  The data was 
analyzed to identify outliers. Normality was tested for skewness (data distribution) and 
kurtosis (flat or peaked distribution). 
Research questions and hypotheses.  The research questions and hypotheses 
selected for this study are as follows: 
RQ1: What is the effect of number of deployments, guilt, depression, and anxiety 
in predicting PTSD symptom reduction for veterans who complete ART? 
Ho1: Number of deployments, guilt, depression, and anxiety do not predict PTSD 
symptom reduction for veterans who complete ART. 
Ha1: At least one predictor, number of deployments, guilt, depression, and anxiety 
will predict PTSD symptom reduction for veterans who complete ART. 
RQ2: What is the variation in PTSD symptom reduction among low, moderate, 
and high PTSD symptom severity groups? 
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Ho2: There is no variation in PTSD symptom reduction among low, moderate and 
high PTSD symptom severity groups.  
Ha2: There is variation in PTSD symptom reduction for at least one of the three 
(low, moderate, high) PTSD symptom severity groups.   
Descriptive statistics. Informed by the literature review in chapter 2, the socio-
demographic characteristics of age, gender, race, marital status, and education describe 
the makeup of the study sample (Cheng & Phillips, 2014; Curtis et al., 2016; Kip et al., 
2016). 
Multiple regression analysis. As a predictive analysis, a multiple regression 
analysis and specifically its findings helped answer the first research question and test its 
hypotheses.  The analysis supports choosing and fitting a PTSD treatment-matching 
model to predict PTSD symptom reduction based on the multiple independent variables 
of number of deployments, guilt, depression, and anxiety (Frankfort-Nachmias & 
Nachmias, 2008; Witt, 2016).  Multiple regression allows the researcher to analyze the 
overall fit (variance explained) of the model and the relative contribution of each of the 
predictors to the total variance explained (Field, 2013; Witt, 2016).  In summary, the 
regression analysis findings supported assessment of which factors predict veteran PTSD 
symptom reduction, as well as the validity of the model (Field, 2013; Green & Salkind, 
2014). 
Confirmation of a set of assumptions were necessary to ensure proper use of a 
multiple regression analysis (Field, 2013: Laerd Statistics, 2015; Witt, 2016). There must 
be a continuous dependent variable (Field, 2013).  The continuous dependent variable for 
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this study is PTSD symptom reduction.  There are two or more independent variables 
measured at the continuous or nominal level.  This study includes four continuous 
independent variables defined as number of deployments, guilt, depression, and anxiety 
(Field, 2013; Kip et al., 2016; Witt, 2016).  There should be independence of errors or 
residuals (Field, 2013).  There should be a linear relationship between the predictor 
variables (and composite) and the dependent variable (Field, 2013).  Linearity assumes 
each of the predictors is linearly related to PTSD symptom reduction, and this study 
design used scatterplots to assess this assumption (Field, 2013). There should be 
homoscedasticity of residuals explained as equal error variables (Field, 2013).  Visual 
inspection of a plot of studentized residuals versus unstandardized predicted values  
confirmed homoscedasticity of residuals (Field, 2013).  There should be no 
multicollinearity (Field, 2013).  Observation of the variance inflation factor or VIF  
confirmed absence of multicollinearity (Field, 2013).  Any VIF values less than 10 
confirms the assumption is valid (Field 2013).  There should be no significant outliers, 
high leverage points, or highly influential points (Field, 2013). The errors (residuals) 
should be normally distributed (Field, 2013).  A limitation with all regression analyses is 
that relationships can be correlated, but uncertainty regarding causality remains (Curtis et 
al., 2016; Field, 2013). 
The aim of this type of multivariate analysis is to assess how much the 
independent variables number of deployments, guilt, depression, and anxiety account for 
the variation in the dependent variable PTSD symptom reduction (Field, 2013; Kip et al., 
2016).  For example, if the predictor independent variable depression results in being a 
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significant predictor, for every one-unit increase in the predictor depression, the 
dependent variable PTSD symptom reduction will decrease or increase by the number of 
unstandardized beta coefficients (Field, 2013).  Analysis to determine a predictive PTSD 
treatment-matching algorithm was attempted to better inform behavioral health 
practitioners and researchers regarding which veterans benefit most from ART for PTSD 
symptom reduction. 
Multiple regression models supported this correlational studies and R2, also 
known as the coefficient of determination, supported evaluation of the model fit (Field, 
2013; Laerd Statistics, 2015).  The  R2 is 1 minus the ratio of residual variability (Field, 
2013; Laerd Statistics, 2015).  Thus, when the variability of the residual values around 
the regression line is small in relation to the overall variability, the predictions from the 
regression equation are good (Field, 2013; Laerd Statistics, 2015).  The R2 value is an 
indicator of how well the model fits the data (Field, 2013; Laerd Statistics, 2015).  When 
R2 is close to 1.0, the specified variables in the study explain most of the variability 
(Field, 2013; Laerd Statistics, 2015). 
ANOVA. Group comparison tests and associated findings helped answer the 
second research question and test its hypotheses (Field, 2013; Laerd Statistics, 2015).  
ANOVA tests supported this study because the aim was to assess the differences in the 
scale-level dependent variable PTSD symptom reduction by the nominal-level variable 
PTSD symptom severity (Field, 2013; Laerd Statistics, 2015).  The nominal-level 
variable PTSD symptom severity consisted of three groups defined as low PTSD 
symptom severity group (group participants with pretreatment PCL-M scores from 40-
105 
 
50); moderate PTSD symptom severity group (group participants with pretreatment PCL-
M scores from 51-60); and high PTSD symptom severity group (group participants with 
pretreatment PCL-M scores at or greater than 61).  This ANOVA test helped to determine 
the variation in mean PTSD symptom reduction and the mean reduction amount for each 
of the three symptom severity groups (Field, 2013).  
The assumptions associated with ANOVA are that the dependent variable is a 
continuous (interval or ratio) level of measurement (Field, 2013; Laerd Statistics, 2015). 
The dependent variable in this study PTSD symptom reduction is a continuous level of 
measurement.   The independent variable is a categorical (nominal or ordinal) variable 
(Field, 2013; Kip et al., 2016; Laerd Statistics, 2015).   The independent variable for this 
ANOVA test is PTSD symptom severity with a low, moderate, and high symptom 
severity group (Field, 2013; Laerd Statistics, 2015).  ANOVA, a parametric test, assumes 
there is normal distribution of the data (Field, 2013; Laerd Statistics, 2015). The ANOVA 
test also assumes homogeneity of variance which means that the variance among the 
identified PTSD symptom severity groups (low, moderate, high) will be about equal 
(Field, 2013; Laerd Statistics, 2015).   The ANOVA test also assumes the observations 
are independent of each other (Field, 2013; Laerd Statistics, 2015).  The ANOVA test is 
not robust to the assumption of independence violations (Field, 2013; Laerd Statistics, 
2015).  The findings are trustworthy if violations to the assumptions of normality and 
homogeneity are present and if there are equally-sized groups and sufficiently large 
samples (Field, 2013; Laerd Statistics, 2015).  However, the ANOVA test is invalid if 
violation of the independence assumption exists (Field, 2013; Laerd Statistics, 2015). 
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Post-hoc tests (t tests) helped analyze the mean differences among the three PTSD 
symptom severity groups at low, moderate, and high severity levels to assess which of the 
three PTSD symptom severity groups were statistically significantly different from each 
other (Field, 2013).   
Threats to Validity 
Secondary analysis of existing data mitigates many potential threats to validity 
(Cheng & Phillips, 2014).  A potential threat to internal validity for the original study 
design could have been maturation defined as natural occurrences that happen over time 
potentially influencing participants (Cheng & Phillips; Salazar, Crosby, & DiClemente, 
2015).  Another potential threat to internal validity could be statistical regression defined 
as regression to the mean on similar tests due to extreme study participant scores (Field, 
2013; Salazar et al., 2015).  There are no other threats anticipated for this study. 
Ethical Procedures  
The original prospective cohort treatment study of ART from which the dataset 
was sought was originally approved by the data source provider’s IRB to ensure that risks 
to participants in the original study were minimized when compared with anticipated 
benefits; that the participant selection process was equitable; that informed consent was 
sought and properly documented; that the data collection process was  supervised to 
ensure continued participant safety throughout the course of the research study; and that 
the privacy of the research participants was maintained (Creswell, 2009; Kip et al., 2016).   
For purposes of this study, the use of a password-protected personal laptop for the 
storage of the deidentified secondary data ensured further privacy and confidentiality of 
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the deidentified study participants contained in the dataset (Creswell, 2009; Hardicre, 
2014; Kip et al., 2016; Piotrowski, 2013).  Deletion of all applicable electronic 
information associated with the secondary data will occur five years from approval of the 
completed dissertation (Hardicre, 2014; Piotrowski, 2013).  There are no other 
anticipated ethical issues (Creswell, 2009; Piotrowski, 2013). 
Dissemination of Findings 
The approved dissertation will be available on the ProQuest database. at 
https://www.proquest.com, for public access. 
Social Change Implications 
The research implications of this quantitative study are broad.  The ability to use a 
predictive PTSD treatment-matching model to predict which veterans most benefit from 
ART for PTSD symptom reduction may reduce the need to attempt different types of 
PTSD interventions to achieve PTSD resolution; may reduce associated comorbidities 
such as guilt, depression and anxiety; may reduce associated suicidality; and may prevent 
medication overuse and alcohol and drug dependence (Kip et al., 2016; Xue et al., 2015).  
Additionally, analyzing the variation in mean PTSD symptom reduction by low, 
moderate, and high PTSD symptom severity groups will better inform practitioners about 
ART treatment efficacy (see Hoge, 2015; Kip et al., 2016; Waits et al., 2015). Therefore, 
this correlational study introduces the importance of a predictive treatment-matching 
model that may inform ART intervention practices to address the PTSD symptom 
severity needs of the 21.8 million veterans diagnosed with PTSD.  There is a need for 
108 
 
further experimental research to assess causation (see Hoge, 2015; Kip et al., 2016; Waits 
et al., 2015). 
Other social change implications associated with this study include raising 
awareness for alternate PTSD treatment interventions that meet the psychological needs 
of veterans suffering with PTSD symptoms and to encourage further research that 
supports more expedient and targeted PTSD treatment approaches in veteran populations 
(see Kip et al., 2016; Ritchie, 2015; Waits et al., 2015).  The ART intervention is a 
trauma-focused treatment protocol administered in a minimum of one to five sessions that 
does not include homework or between-session exercises (Kip et al., 2016; Ritchie, 2015; 
Waits et al., 2015).  The ART protocol is effective whether the veteran does or does not 
retell the trauma experience during the ART intervention, thereby reducing the risk of 
retraumatization (Kip et al., 2016; Waits et al., 2016).  The findings in this study will 
contribute to ongoing ART research within veteran populations. 
Summary 
A quantitative strategy of inquiry informed by Foa and Kozak’s (1986) emotional 
processing theory supports this correlational study (Curtis et al., 2016; Field, 2013).   A 
secondary analysis of existing data from a prospective cohort treatment study of ART 
registered at www.clinicaltrials.gov (NCT02030522) informed this strategy of inquiry 
(Kip et al., 2016).  The purpose of this study is to determine whether any of the predictor 
independent variables informed by the literature review and identified as number of 
deployments, guilt, depression, and anxiety predict the dependent variable PTSD 
symptom reduction.  The analysis also shows the variation in mean PTSD symptom 
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reduction by PTSD symptom severity group at low, moderate, and high PTSD symptom 
severity levels (Field, 2013). The study aims to develop a predictive PTSD treatment-
matching algorithm that determines which veterans benefit most from ART for PTSD 
symptom reduction.  In addition, the study will analyze variations in  mean PTSD 
symptom reduction amounts by symptom severity groups stratified at low, moderate, and 
high PTSD symptom severity levels as well as determine statistically significant 
differences in mean PTSD symptom reduction among the three PTSD symptom severity 
groups. The conceptual framework of a  predictive PTSD treatment-matching model can 
be applied to other variables and PTSD treatment interventions as well. 
Measurement of the dependent variable PTSD symptom reduction occurred by 
calculating the difference between pretreatment and posttreatment PCL-M scores 
obtained from secondary data derived from a prospective cohort treatment study of ART 
(Field, 2013; Kip et al., 2016).  
To measure the independent predictor variables number of deployments, guilt, 
depression, and anxiety, the study relied on pretreatment scale scores derived from a prior 
prospective cohort treatment study of ART (Kip et al., 2016).  The number of 
deployments listed in the Demographics Form, the pretreatment TRGI scores to measure 
guilt, the pretreatment CES-D scale scores to measure depression, and the pretreatment 
STICSA scale scores to measure anxiety all supported the use of a multiple regression 
analysis (Field, 2013).  An ANOVA test supported analysis of the variation in PTSD 
symptom reduction by PTSD symptom severity group at low, moderate, and high PTSD 
symptom severity levels. Post hoc tests were also performed to assess statistically 
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significant mean PTSD reduction differences among the three PTSD symptom severity 
groups (Field, 2013). 
The ART intervention selected for analysis in this study is a brief, trauma-focused 
intervention for the treatment of PTSD symptom resolution in veteran populations (see 
Hoge, 2015; Kip et al., 2012, 2013, 2014a, 2014b, 2016; Ritchie, 2015; Waits et al., 
2015). The ART intervention includes a minimum of one to five sessions without the 
need for homework or the retelling of the trauma experience (Hoge, 2015; Kip et al., 
2016). The brevity of the treatment protocol is significant when compared to other 
trauma-based interventions that include anywhere from eight to 12 sessions or more, 
often resulting in high dropout and non-compliance rates (Kip et al., 2016).  Treatment 
completion rates are also high for the ART intervention, estimated at 90%.  This study 
was informed by the literature showing there is a critical need for continued  PTSD 
research to determine the factors that influence PTSD symptom reduction (see Hoge, 
2015; Kip et al., 2016; Ritchie, 2015; Waits et al., 2015).  This study fills the gap in 
understanding by developing the first predictive PTSD treatment-matching model to 
predict which veterans most benefit from ART for PTSD symptom reduction. 
Although other research designs such as true experimental and pretest-posttest 
quasi-experimental designs were considered, a correlational study supports this strategy 
of inquiry (Field, 2013).  The secondary data obtained for this study mitigated the cost, 
low response rates, risks, and delays associated with original studies (Cheng & Phillips, 
2014; Field, 2013).  The three secondary data self-rating scale scores used in this study 
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were from valid, reliable instruments widely-used in PTSD research within veteran 
populations (Hardwick, 2016; Kip et al., 2016). 
Veterans, defined as active duty, reservist, or discharged service members who 
served or are serving in any branch of the United States armed services define the target 
population (Hoge et al., 2014; Kip et al., 2016). The sample consists of adult male and 
female service members with prior deployments to conflict areas and a history of combat-
related PTSD or military sexual trauma who consented, were enrolled as study 
participants, and completed ART treatment during the prospective cohort treatment study 
of ART (Kip et al., 2016). 
Descriptive statistics include the socio-demographic characteristics of age, 
gender, race, marital status, and education (Kip et al., 2016).  These socio-demographic 
characteristics describe the makeup of the study’s sample (Field, 2013).  Multiple 
regression analysis is used to determine whether number of deployments, guilt, 
depression, and anxiety predict PTSD symptom reduction by use of ART to build a 
PTSD treatment-matching model that predicts which veterans benefit most from ART for 
PTSD symptom reduction.  An  ANOVA test supports analysis of the variation in mean 
PTSD symptom reduction by PTSD symptom severity group stratified by low, moderate, 
and high PTSD symptom severity levels.  Post hoc tests were used to assess which of the 
three groups experienced statistically significant mean PTSD differences when compared 
to each other.   
Adherence to ethical standards consistent with the use of secondary data were 
maintained throughout the study to include confirmation of informed consent, equitability 
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in the sample selection process, confidentiality and privacy of all study participants, as 
well as security of the dataset and eventual proper disposal of all electronic secondary 
data within five years of dissertation completion (Piotrowski, 2013).   
The research implication of this quantitative strategy of inquiry are broad. A 
predictive PTSD treatment-matching model that predicts which veterans most benefit 
from ART for PTSD symptom reduction may lead to a more specific and expedient way 
to administer the ART treatment protocol. This approach may support timely and targeted 
ART treatment for veterans who need it most, thereby reducing the incidence of 
refractory PTSD, and associated comorbidities, chronic illnesses, and suicides (see Hoge 
et al., 2014; Kip et al., 2016; Ritchie, 2015; Waits et al., 2015). The creation of this 
predictive PTSD treatment-matching model may be applicable across other identified 
variables and PTSD interventions to predict PTSD symptom reduction. 
Chapter 4 includes the results of the analysis outlined in this chapter. Baseline 
descriptive and demographic characteristics of the sample support the analysis (Field, 
2013).  The chapter includes statistical assumptions (Walden University, n.d.).   Study 
findings organized by research question and associated hypotheses include statistics, 
associated probability values, confidence intervals, and effect sizes (Field, 2013).  The 
study also include post-hoc analysis to support ANOVA testing (Field, 2013).  
Applicable tables and figures also show statistical results (Field, 2013). 
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Chapter 4: Results 
Introduction 
In Chapter 3, I detailed the quantitative strategy of inquiry I used, which was 
informed by Foa and Kozak’s (1986) emotional processing theory.  The approved 
deidentified dataset I used to conduct this analysis of secondary data was drawn from a 
prior prospective cohort treatment study of ART registered at www.clinicaltrials.gov 
(NCT02030522; Kip et al., 2016).   
The purpose of this study was to show whether the independent variables number 
of deployments, guilt, depression, and anxiety predicted the dependent variable PTSD 
symptom reduction (Kip et al., 2016). The sample consisted of combat veterans who 
participated in the prospective cohort treatment study of ART, from which the secondary 
data was drawn (Kip et al., 2016).  I also aimed to assess whether mean PTSD symptom 
reduction differed among the three identified PTSD symptom severity groups classified 
at low, moderate, and high PTSD symptom severity levels (Kip et al., 2016).  
Additionally, for the purpose of this study, veterans were defined as active-duty, 
reservist, or discharged service members who served in any branch of the United States 
armed forces (Hoge, 2011). 
I sought to develop a predictive PTSD treatment-matching model based on 
potential ART candidates’ self-rated pretreatment measures of  the number of 
deployments, guilt, depression, and anxiety, and whether these variables are predictive of 
the amount of PTSD symptom reduction in response to the use of ART (see Kip et al., 
2016).  The identified gap in the literature was that there were no existing research 
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studies that analyzed predictor variables to predict which veterans benefit most from 
ART for PTSD symptom reduction.  Further, no other researchers have attempted to 
identify a predictive PTSD treatment-matching model for effective use of ART, and no 
other researchers have determined mean PTSD symptom reduction amounts among 
PTSD symptom severity groups stratified by PTSD symptom severity levels (see 
Hardwick, 2016; Kip et al., 2012, 2013, 2014a, 2014b, 2016).   
The research questions and hypotheses selected for this study were as follows: 
RQ1: What is the effect of number of deployments, guilt, depression, and anxiety 
in predicting PTSD symptom reduction for veterans who complete ART? 
Ho1: Number of deployments, guilt, depression, and anxiety do not predict PTSD 
symptom reduction for veterans who complete ART. 
Ha1: At least one predictor, number of deployments, guilt, depression, and anxiety 
will predict PTSD symptom reduction for veterans who complete ART. 
RQ2: What is the variation in PTSD symptom reduction among low, moderate, 
and high PTSD symptom severity groups? 
Ho2: There is no variation in PTSD symptom reduction among low, moderate and 
high PTSD symptom severity groups.  
Ha2: There is variation in PTSD symptom reduction for at least one of the three 
(low, moderate, high) PTSD symptom severity groups.   
In Chapter 4, I provide an overview of the purpose, research questions, and 
hypotheses as detailed above.  Data collection techniques are briefly outlined.  
Descriptive statistics are presented to characterize the study participants.  Statistical 
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assumptions and detailed results of a multiple regression analysis and ANOVA test with 
post hoc analysis are presented.  The chapter concludes with a summary of the findings 
and an introduction to Chapter 5. 
Data Collection (Secondary Data) 
My use of an approved deidentified dataset eliminated the need to recruit study 
participants (see Curtis et al., 2016; Field, 2013).  The additional benefits of using 
secondary data include the reduced turnaround timeframes, costs, low response rates, 
risks, and delays associated with other research design options (see Curtis et al., 2016)  
The secondary data I analyzed included study participants recruited from veteran 
membership organizations within the Tampa Bay area of Florida, and from academic 
programs at a local university (Hardwick, 2016; Kip et al., 2016).  The sampling frame 
consisted of all study participants from a prospective cohort treatment study of ART who 
consented to and voluntarily completed ART (Kip et al., 2016).  The data source provider 
granted me permission to use the secondary data and provided the deidentified dataset 
after the Walden University IRB approval (IRB Number 06-25-18-0020711).  The 
deidentified dataset included adult male and female active-duty, reservist, and discharged 
veteran United States service members over 18 years of age with a history of combat-
related PTSD symptoms who completed ART intervention during that study (Kip et al., 
2016).   
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Results 
Data Cleaning and Screening 
 An approved deidentified dataset was received as an electronic IBM SPSS data 
file.  The data file was loaded into a password-protected laptop maintained in a locked 
office (see Button et al., 2013; Frankfort-Nachmias & Nachmias, 2008; Kip et al., 2016; 
Piotrowski, 2013).  I conducted a data cleaning and screening procedure to remove any 
cases with missing data (see Cheng & Phillips, 2014).   
Baseline Demographic Statistics 
Informed by the literature review in Chapter 2, I used the socio-demographic 
characteristics of age, gender, race, marital status, and education to describe the makeup 
of the study participants (see Cheng & Phillips, 2014; Curtis et al., 2016; Kip et al., 
2016).  Figure 1 shows there were a total of 108 study participants ranging in age from 23 
to 76,  with a mean age of 43 (SD = 12.67).  Males comprised 92% (n = 100) of the study 
participants, and females comprised 8% (n = 8) of the study participants (Figure 2).  
The breakdown of the study participants by race (Figure 3) showed that 85% (n = 
92) identified as White, 11% (n = 12) identified as Black or African American, 2.8% (n 
= 3) identified as Asian, and .9% (n = 1) identified as American Indian/Alaskan Native.  
Figure 4 shows that 44% (n = 47) of the study participants were married, 32% (n = 34) 
were divorced or separated, 19% (n = 21) were never married, 3% (n = 3) were living 
with someone, and 3% (n = 3) were widowed.  Figure 5 shows that the study participants’ 
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education in years ranged from 9 to 28 years, with a mean of 14.5 years of education (SD 
= 2.68). 
 
 
 
 
 
Figure 1. Histogram—age in years. 
Figure 2. Frequency table—gender. 
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Figure 3. Frequency table-race. 
Figure 4. Frequency table - marital status. 
Figure 5. Histogram-education in years. 
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Multiple Regression Analysis 
I selected a multiple regression as a predictive analysis to answer the first research 
question and test its hypotheses (see Field, 2013).  The aim of the analysis was to support 
choosing and fitting a treatment-matching model that would predict PTSD symptom 
reduction based on the independent variables of number of deployments, guilt, 
depression, and anxiety (see Frankfort-Nachmias & Nachmias, 2008; Witt, 2016).  
Multiple regression allowed for the analysis of the overall fit (variance explained) of the 
model and the relative contribution of each of the predictors to the total variance 
explained (see Field, 2013; Witt, 2016).   
I used a standard multiple regression to predict the amount of PTSD symptom 
reduction (the difference between each study participant’s pretreatment and posttreatment 
PCL-M scale scores) in a sample of 108 study participants (Kip et al., 2016; Weathers et 
al., 1998).  The participants were derived from an approved secondary dataset obtained 
from a prospective cohort treatment study of ART (Kip et al., 2016).  The dataset 
included each study participant’s (a) total number of deployments (1, 2, 3, and 4 
representing 4 or more deployments); (b) pretreatment level of guilt, as measured by the 
mean TRGI score; (c) the pretreatment level of depression, as measured by      CES-D 
score; and (d) the pretreatment level of anxiety, as measured by the STICSA score 
(Edwards et al., 1966; Kip et al., 2016; Kubany et al., 1996; Radloff et al., 1997; Ree et 
al., n.d.).  
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Multiple regression assumptions.  The assumptions associated with a multiple 
regression were tested to determine if the selected model was valid (Field, 2013; Laerd 
Statistics, 2015).  The eight assumptions tested were as follows: 
1. There must be a continuous dependent variable.  PTSD symptom reduction 
was a continuous dependent variable (Field, 2013; Laerd Statistics, 2015). 
2. There are two or more independent variables measured at the continuous or 
nominal level.  Number of deployments, guilt, depression, and anxiety were 
all measured at the continuous level (Field, 2013; Laerd Statistics, 2015). 
3. There should be independence of errors (residuals).  The Durbin-Watson 
statistic can range from 0 to 4, but a value of approximately 2 indicates that 
there is no correlation between residuals (Field, 2013; Laerd Statistics, 2015).  
As shown in Table 1, there was independence of residuals assessed by a 
Durbin-Watson statistic of 1.698. 
Table 1 
 
Model Summary 
Model R R Square Adjusted R Square Std. Error of the Estimate Durbin-Watson 
1 175a .031 -.007 15.77491 1.698 
 
Note. Predictors: (Constant),Number of Deployments, Guilt- TRGI-Pre-ART, Depression-CESD-PreART, 
Anxiety-STICSA-PreART.   Dependent Variable: PTSD Symptom Reduction 
 
4. There should be a linear relationship between the predictor variables number 
of deployments, guilt, depression, anxiety (and composite) and the dependent 
variable PTSD symptom reduction.  The plots (Figure 6 through 9) indicate 
there was a linear relationship (Field, 2013; Laerd Statistics, 2015). 
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Figure 6. Partial regression plot – number of deployments. Dependent variable: PTSD symptom reduction. 
Figure 7. Partial regression plot – guilt-TRGI-preART. Dependent variable: PTSD symptom reduction. 
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5.   There should be homoscedasticity of residuals (equal error variables).       
Figure 10 does show a random pattern.  This is indicative of homoscedasticity, as 
Figure 8. Partial regression plot – depression-CESD-preART. Dependent variable: PTSD symptom reduction. 
Figure 9. Partial regression plot – anxiety-STICSA-preART. Dependent variable: PTSD symptom reduction. 
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assessed by  inspection of a plot of studentized residuals versus unstandardized       
predicted value (Field, 2013; Laerd Statistics, 2015).    
 
 
6. There should be no multicollinearity. Table 2 showed VIF values were below 10. 
Tolerance values were all well above .2, confirming absence of multicollinearity 
(Field, 2013; Laerd Statistics, 2015). 
 
 
Figure 10. Plot of studentized residuals versus unstandardized predicted values. 
  
Table 2 
 
Coefficients 
                             Unstandardized  Standardized                95.0% Confidence Interval for B Correlations                      Collinearity Stats. 
                                             Coefficients 
 
Model 
 
B 
 
 
Std. 
Error 
 
Beta 
 
t 
 
Sig. 
 
 
Lower 
Bound 
 
 
Upper 
Bound 
 
 
Zero 
Order 
 
Partial 
 
Part 
 
Tolerance 
 
VIF 
1 (Constant) 21.042 6.658  3.161 .002 7.839 34.246      
# of Deployments -1.653 1.273 -.126 -1.298 .197 -4.179 .872 -.123 -.127 -.126 .999 1.001 
Guilt/TRGI -1.113 2.226 -.051 -.500 .618 -5.527 3.301 -.016 -.049 -.049 .899 1.112 
Depression/CESD .131 .190 .098 .688 .493 -.246 .508 .110 .068 .067 .460 2.175 
Anxiety/STICSA .049 .190 .038 .261 .795 -.327 .426 .093 .026 .025 .439 2.280 
   Note. Dependent Variable PTSD Symptom Reduction 
 
     1
2
4
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7. There should be no significant outliers, high leverage points, or highly influential 
points. The SPSS case wise diagnostic table output will show participants’ 
standardized residuals greater than ±3 standard deviations when the SPSS software 
identifies outliers.  There were no outliers.  Therefore, the SPSS output did not 
produce a case wise diagnostics table.   The dataset was inspected for high leverage 
and influential points.  High leverage points  were inspected by reviewing the LEV_1 
variable in the data to identify any cases greater than .2.  None were found.  
Influential points were inspected by reviewing the COO_1 variable in the dataset to 
identify any cases with a Cook’s Distance value greater than 1.  None were found 
(Field, 2013; Laerd Statistics, 2015). 
8. The errors (residuals) should be approximately normally distributed.  The histogram 
in  Figure 11indicates that the normality of errors assumption was met (Field, 2013; 
Laerd Statistics, 2015).  
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The normal P-P plot in Figure 12 also verifies that the normality of errors 
assumption was met because the dashed line did not deviate from the straight line (Field, 
2013). This data concluded that the model was reliable (Field, 2013). 
 
 
Figure 11. Histogram. regression srandardized Residual - Dependent variable: PTSD symptom reduction 
Figure 12. Normal p-plot of expected versus observed cumulative probability. Dependent vaariable: PTSD symptom 
reduction.          
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Computing a Multiple Regression 
A standard multiple regression was computed to assess if the predictor variables 
number of deployments, guilt, depression, and anxiety predicted the amount of PTSD 
symptom reduction (Field et al., 2013; Kip et al., 2016).  The model was also assessed for 
its validity (Green & Salkind, 2014). The data used for this analysis were found in the 
approved deidentified secondary data derived from a prospective cohort treatment study 
of ART (Kip et al., 2016).  The null hypothesis was that no predictors predicted the 
amount of PTSD symptom reduction.  The alternative hypothesis was that at least one 
predictor, number of deployments, guilt, depression, or anxiety predicted the amount of 
PTSD symptom reduction after ART treatment.  The significant level alpha was set at 
.05.  A sample size of 108 participants (Table 3) with four predictors, number of 
deployments, guilt, depression, and anxiety was appropriate, as this would detect a 
moderate effect size of .25 (Field, 2013). 
Table 3 
 
Descriptive Statistics 
 Mean Std. Deviation N 
PTSD Symptom Reduction    21.6184    15.72095    108 
Number of Deployments     2.28    1.198    108 
Guilt-TRGI PreART     1.3919    .72263    108 
Depression-CESD PreART     28.1382   11.83403    108 
Anxiety-STICSA- PreART     44.7516   12.13736    108 
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Table 4 shows that the adjusted R Square value is -.007.  The negative value 
occurred because the model contained terms that did not help to predict the dependent 
variable, PTSD symptom reduction (Field, 2013).   
Table 4 
 
Model Summary b 
Model R Square Adjusted R Square Std. Error of Estimates Durbin-Watson 
1 .175a            .031 -.007 15.77491 1.698 
 
Note. a. Predictors: (Constant), Number of Deployments, Guilt-TRGI-PreART, Depression-CESD-
PreART, Anxiety-STICSA-PreART. b. Dependent Variable: PTSD Symptom Reduction. 
 
Based on the ANOVA results in Table 5, the study failed to reject the null 
hypothesis, F(4, 103) = .817, p=.517.  
Table 5 
 
ANOVAa 
Model Sum of Squares df Mean Squares F Sig. 
1   Regression   
 
    813.548  4 203.387 .817 .517b   
     Residual     25631.325 103 248.848   
     Total     26444.874 107    
Notes. a. Dependent Variable: PTSD Symptom Reduction 
b. Predictors: (Constant), Number of Deployments, Guilt-TRGI-PreART, Depression-CESD-PreART, 
Anxiety-STICSA-PreART. 
 
ANOVA Test 
Group comparison tests answered the second research question and its hypothesis 
(Field, 2013; Laerd Statistics, 2015).  The aim of conducting an ANOVA test was to 
assess the differences in the scale-level dependent variable PTSD symptom reduction by 
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the nominal-level variable PTSD symptom severity consisting of three symptom severity 
groups (Field, 2013; Laerd Statistics, 2015).  The three groups were defined as low PTSD 
symptom severity group (group participants with pretreatment PCL-M scores at or below 
50); moderate PTSD symptom severity group (group participants with pretreatment PCL-
M scores between 51-60); and high PTSD symptom severity group (group participants 
with pretreatment PCL-M scores at or greater than 61).   
Post-hoc tests (t tests) were conducted to analyze the mean differences among the 
three PTSD symptom severity groups at low, moderate, and high PTSD symptom 
severity levels to assess which of the three PTSD symptom severity groups were different 
from each other (Field, 2013).   
ANOVA Test Assumptions 
The assumptions associated with ANOVA were as follows: 
1. The dependent variable is a continuous (interval or ratio) level of 
measurement (Field,  
2013; Laerd Statistics, 2015). The dependent variable PTSD symptom 
reduction was a continuous level of measurement.    
2. The independent variable is a categorical (nominal or ordinal) variable 
(Field, 2013; Laerd Statistics, 2015).   The independent variable for this 
ANOVA test was PTSD symptom severity with a low, moderate, and high 
symptom severity group (Field, 2013; Kip et al., 2016; Laerd Statistics, 
2015).   
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3. The ANOVA test assumes the observations are independent of each other 
(Field, 2013; Laerd Statistics, 2015).  The participants were classified by 
symptom severity levels to create three independent groups. 
4. There are no significant outliers in the groups of the independent variable 
in terms of the dependent variable (Field, 2013; Laerd Statistics, 2015).  
This was confirmed as assessed by box plots (Figure 13) and mean plots 
(Figure 14).  
 
 
 
Figure 13. Box plots. 
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5. ANOVA, a parametric test, assumes there is normal distribution of the 
data (Field, 2013; Laerd Statistics, 2015). Table 6 shows that PTSD 
symptom severity was normally distributed for the low, moderate, and 
high level of symptom severity, as assessed by Shapiro-Wilk’s test            
(p > .05). 
Table 6 
 
Test of Normality 
  
 
Symptom Severity Group 
             Shapiro-Wilk 
Statistics          df           Sig. 
PTSD Symptom 
Reduction 
≤ 50              
 
.931 28 .066 
 51-60 .954 26 .282 
 ≥ 61 .971 55 .213 
 
                 
Figure 14. Mean plots. 
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6. The ANOVA test assumes homogeneity of variance which means that the 
variance among the identified PTSD symptom severity groups (low, 
moderate, high) will be about equal (Field, 2013; Laerd Statistics, 
2015).  The assumption of homogeneity of variance was violated (p< .05), 
as assessed by Levene’s test of homogeneity of variances (Table 7).  
Table 7 
 
Test of Homogeneity of Variance 
Dependent Variable: PTSD Symptom Reduction 
Levene Statistic df1 df2 Sig. 
    10.500                2              105                .000 
 
Computing A One-Way Welch ANOVA 
 
To correct the violation of the assumption of homogeneity of variance, a one-way 
Welch ANOVA was required to compute whether the mean difference in the dependent 
variable PTSD symptom reduction was different for groups with different PTSD 
symptom severity levels.  Table 8 shows that study participants were classified into three 
groups: low (n = 27), moderate (n = 26), and high (n = 55) levels of PTSD symptom 
severity (Laerd Statistics, 2015). 
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Table 8 
 
Descriptive Statistics 
Dependent Variable: PTSD Symptom Reduction 
Symptom 
Severity 
Group 
N Mean Std. 
Deviation 
Error Lower            Upper 
Bound 
Min Max 
Low ≤ 50 27 14.4977 9.33930 1.79735 10.8032 18.1922 -3.00 30.00 
 
Moderate 
51-60 
26 19.5002 11.62894 2.28062 14.8031 24.1972 -5.00 37.00 
 
High ≥ 61 55 26.1153 18.35775 2.47536 21.1525 31.0781 -18.00 60.00 
 
Total 108 21.6184 15.72095 1.51275 18.6195 24.6172 -18.00 60.00 
 
As stated previously in the assumptions section, the ANOVA assumptions 
confirmed there were no outliers and the data was normally distributed for each group, as 
assessed by box plot, mean plot, and Shapiro-Wilk test (p=.066, p=.282, p=.213) 
respectively. The assumption of homogeneity of variance was violated, as assessed by 
Levene's test of homogeneity of variance (p=.0005). To correct the violation, a one-way 
Welch ANOVA test was computed. For the dependent variable, the mean PTSD 
symptom reduction was statistically significantly different among the different PTSD 
symptom severity groups, Welch's F(2, 63.875) = 7.204, p = .002, as shown in Table 9. 
Therefore the analysis failed to accept the null hypothesis. 
Table 9 
Robust Tests of Equality of Means 
 Statistica    df1 df2 Sig. 
Welch        7.204           2       63.875          .002 
Note.  a. Asymptotically F distributed; Dependent Variable PTSD Symptom Reduction. 
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The mean PTSD symptom reduction score differed from the low PTSD symptom 
severity group (M = 14.5, SD = 9.3) to the moderate PTSD symptom severity group (M = 
19.5, SD = 11.6), to the high PTSD symptom severity group (M = 26.1, SD = 18.4) in that 
order (Laerd Statistics, 2015).  Games-Howell post hoc analysis revealed that the mean 
difference from the low to high PTSD symptom severity group (11.62, 95% CI [4.31, 
18.92]) was statistically significant (p = .001), as shown in Table 10.  Figure 15 shows a 
graphical representation of the Welch ANOVA results.  Additionally, there was a 
moderate to large effect size of .38 for the statistically significant low to high PTSD 
symptom severity groups (www.webpower.psychstat.org). 
Table 10 
 
Games-Howell Multiple Comparisons 
 (I) 
Symptom 
Severity 
Group 
(J) 
Symptom 
Severity 
Group 
Mean 
Difference 
(I-J) 
Std.  
Error 
 
Sig.      95% Confidence 
            Interval 
    Upper        Lower 
    Bound       Bound      
Games 
Howell 
  ≤ 50             
 
51-60 
  ≥ 61 
  -5.00248 
-11.61762 
2.90374 
3.05906 
.207 
.001 
-12.0255 
-18.9232 
 2.0205 
-4.3120 
 51-60   ≤ 50 
  ≥ 61 
   5.00248 
  -6.61514 
2.90374 
3.36580 
.207 
.728 
   2.0205 
-14.6694 
12.0255 
  1.4392 
   ≥ 61   ≤ 50    
51-60 
           
 11.61762* 
   6.61514 
3.05906 
3.36580 
.001 
.128 
   4.3120 
  -1.4392 
18.9232 
14.6694 
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Summary 
Summary 
A deidentified secondary dataset was used to conduct a quantitative strategy of 
inquiry (Kip et al., 2016).  The purpose of the study was to assess if the independent 
variables number of deployments, guilt, depression, and anxiety predicted the dependent 
variable PTSD symptom reduction in a sample (n=108) of combat veterans who 
completed ART (Kip et al., 2016).  The study also aimed to show whether mean PTSD 
symptom reduction amounts differed among the three PTSD symptom severity groups 
classified at low, moderate, and high symptom severity levels (Field, 2013). 
 A predictive treatment-matching model for PTSD symptom reduction was sought 
based on study participants’ secondary data that included total number of deployments 
and pretreatment self-rating scale scores for guilt, depression, and anxiety (Kip et al., 
2016).  This quantitative strategy of inquiry, informed by the literature, was the first of its 
kind to assess whether predictors of PTSD symptom reduction by use of ART could be 
identified. 
Figure 15. Graphical representation of Welch ANOVA results. 
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 The deidentified data was received in SPSS format (Kip et al., 2016).  The dataset 
was stored in a password-protected laptop (Piotrowski, 2013).  The data was screened 
and cleaned prior to producing the output (Field, 2013). 
 Descriptive statistics defined the socio-demographic characteristics of the 108 
study participants (Field, 2013). The majority of the study participants (n=92) were 
married White males with a mean age of 43 and an average of 14.5 years of education 
(Kip et al., 2016).   
 A multiple regression analysis was conducted to answer the first research question 
regarding whether number of deployments, guilt, depression, and anxiety could predict 
PTSD symptom reduction after use of ART (Field, 2013).  All eight assumptions 
associated with a multiple regression were met (Laerd Statistics, 2015). The study failed 
to reject the null hypothesis F(4, 103) = .817, p=.517 (IBM Corp, 2015).  
 Group comparison tests answered the second research question regarding whether 
mean PTSD symptom reduction amounts differed among the low, moderate, and high 
PTSD symptom severity groups (Laerd Statistics, 2015).  The ANOVA assumptions 
confirmed there were no outliers and the data was normally distributed for each group 
(Laerd Statistics, 2015).  The assumption of homogeneity of variance was violated 
(p=.0005).  In order to correct the violation for the assumption of  homogeneity of 
variance, a Welch ANOVA test was conducted (Field, 2013; Laerd Statistics, 2015).  The 
results of the Welch ANOVA were significant F(2, 63.875)=7.204, p=.002. The study 
failed to accept the null hypotheses. 
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 Games-Howell post hoc analysis revealed that the mean differences from the low 
to high PTSD symptom severity group (11.62, 95% CI [4.31, 18.92]) was statistically 
significant (p=.001).  The statistically significant low to high PTSD symptom severity 
groups showed a moderate to large effect size of .38 (www.webpower.psychstat.org). 
 The results of the analyses presented in this chapter are synthesized in Chapter 5 
to formulate a discussion of the study findings and detail how the findings in this study 
contributed to the body of available literature presented in the literature review found in 
Chapter 2.  A theoretical analysis of the findings address generalizability, validity, and 
reliability of the findings to recommend opportunities for possible future research 
grounded in the results of this study. 
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Chapter 5: Discussion, Conclusions, Recommendations 
Introduction 
 Chapter 5 includes a synopsis of the purpose and nature of this study.  A summary 
of the key findings supports the salient components of the correlational study design, 
analysis, and outcomes.  The multiple regression, ANOVA, and post hoc analyses are 
presented herein along with recommendations for future research.  Additionally, I present 
the socio-demographic characteristics of the study participants.  The findings are further 
categorized by each of the predictor variables number of deployments, guilt, depression, 
and anxiety as measured by secondary data scores from valid and reliable self-rating 
scales used in the prospective cohort treatment study of ART from which I drew the 
deidentified dataset (Kip et al., 2016).  I also present the study’s theoretical implications 
for future research consideration, and I discuss implications for social change at the 
individual, family, organizational, and social levels.  I offer a conclusion at the end of the 
chapter to encapsulate the study’s impact on and contributions to the available literature. 
Purpose of the Study 
 The purpose of this correlational study was to determine whether the independent 
variables number of deployments, guilt, depression, and anxiety predicted the dependent 
variable PTSD symptom reduction by use of ART (Kip et al., 2016).  The ART 
intervention is an empirically validated brief trauma-based intervention (Kip et al., 2016).  
The study sample consisted of veterans defined as active duty, reservist, and discharged 
service members with a history of deployments and associated PTSD symptoms (see 
Huang & Kashubeck-West, 2015; Hunt et al., n.d.; Kip et al., 2016; Xue et al., 2015).  I 
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also aimed to assess whether mean PTSD symptom reduction differed among three 
identified PTSD symptom severity groups classified at low, moderate, and high levels of 
PTSD symptom severity (Field, 2013; Kip et al., 2016; Laerd Statistics, 2015).   
 My aim was to develop a predictive PTSD treatment-matching model for PTSD 
symptom reduction by use of ART.  The deidentified dataset I used included study 
participants’ self-reported number of deployments, and pretreatment self-rated measures 
for (a) guilt as measured by the TRGI; (b) depression as measured by the CESD; and (c) 
anxiety as measured by the STICSA, to predict the amount of PTSD symptom reduction  
by use of ART (Edwards et al., 1996; Kip et al., 2016; Kubany et al., 1996; Ree et al, 
n.d.).   
I conducted the study to address a gap in the literature.  Specifically, my review of 
existing research revealed that there were no existing studies focused on identifying 
predictors of PTSD symptom reduction by use of ART (see Hardwick, 2016; Kip et al., 
2012, 2013, 2014a, 2014b, 2016).  My review also revealed there were no other studies 
that attempted to identify a predictive PTSD treatment-matching model for PTSD 
symptom reduction by use of ART (see Hardwick, 2016; Kip et al., 2012, 2013, 2014a, 
2014b, 2016).   My review of available studies also showed there were no other studies 
that determined mean PTSD symptom reduction by symptom severity groups stratified 
by low, moderate, and high symptom severity levels (see Hardwick, 2016; Kip et al., 
2012, 2013, 2014a, 2014b, 2016). 
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Nature of the Study 
I conducted a multiple regression analysis to assess whether number of 
deployments, guilt, depression, and anxiety, as measured by self-rated pretreatment scale 
scores, predicted which veterans benefitted most from ART for PTSD symptom reduction 
(see Kip et al., 2016, Laerd Statistics, 2015).  The dependent variable PTSD symptom 
reduction was measured by calculating the difference between participants’ pretreatment 
and posttreatment PCL-M scale scores (Kip et al., 2016).  An ANOVA test was 
conducted to compare the mean PTSD symptom reduction among three symptom 
severity groups at low, moderate, and high PTSD symptom severity levels (see Field, 
2013; Kip et al., 2016).  Post-hoc tests showed which of the three PTSD symptom 
severity groups experienced statistically significant mean PTSD symptom difference 
when compared to each other (see Field, 2013).  The secondary analysis of existing data 
derived from a prospective cohort treatment study of ART registered at 
www.clinicaltrials.gov (NCT02030522) included a sample of 108 adult male and female 
veterans with a history of combat deployments and associated PTSD symptoms who 
completed ART (Kip et al., 2016).   
Summary of Key Findings 
The purpose of this correlational study was to assess if the independent variables 
number of deployments, guilt, depression, and anxiety predicted the dependent variable 
PTSD symptom reduction in a sample of combat veterans (N = 108) who completed ART 
(Kip et al., 2016).  I also aimed to show whether mean PTSD symptom reduction 
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amounts differed significantly among the three PTSD symptom severity groups classified 
at low, moderate, and high PTSD symptom severity levels (see Field, 2013). 
 This quantitative study, as informed by the literature review, was the first of its 
kind to assess whether predictors of PTSD symptom reduction could be identified prior to 
commencing ART.  I received the deidentified data from the data source provider in 
SPSS format and stored the data in a password-protected laptop.  The data was screened 
and cleaned prior to producing the output. 
Descriptive Statistics   
Descriptive statistics were produced to define the socio-demographic 
characteristics of the 108 study participants.  The majority (n = 100) of the 108 study 
participants were males (92.6%).  A total of 92 (85.2%) study participants identified as 
White, and 47 (43.5%) identified as married (Kip et al., 2016).  The mean age of the 
participants was 43 (SD = 12.7) with the mean years of education at 14.5 years (Kip et 
al., 2016).   
Multiple Regression   
I conducted a multiple regression analysis to answer the first research question 
regarding whether number of deployments, guilt, depression, and anxiety predicted the 
amount of PTSD symptom reduction by use of ART (see Field, 2013; Kip et al., 2016).  
All eight assumptions (Field, 2013; Laerd Statistics, 2015) associated with a multiple 
regression were met.  The study failed to reject the null hypothesis, F(4, 103) = .817, p = 
.517.  
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ANOVA Test   
I used group comparison tests to answer the second research question regarding 
whether mean PTSD symptom reduction amounts differed among the low, moderate, and 
high PTSD symptom severity groups (Laerd Statistics, 2015).  The ANOVA assumptions 
confirmed there were no outliers and the data was normally distributed for each symptom 
severity group (Laerd Statistics, 2015).  The assumption of homogeneity of variance was 
violated (p = .0005).  In order to correct the violation for the assumption of homogeneity 
of variance, I conducted a Welch ANOVA test.  The results of the Welch ANOVA test 
were significant F(2, 63.875) = 7.204, p = .002.  The study failed to accept the null 
hypothesis.  
Post hoc Analysis   
Games-Howell post hoc analysis revealed that the mean difference from the low 
to high PTSD symptom severity group (11.62, 95% CI [4.31, 18.92]) was statistically 
significant (p = .001) with a moderate to large effect size of .38 
(www.webpower.psychstat.org, 2018). 
Interpretation of the Findings and Recommendations for Future Studies 
Combat veterans were the focus of this study.  The literature showed that combat 
veterans are at higher risk for PTSD onset with prevalence rates ranging from 2% to 17% 
when accounting for all wars (see Bardhoshi et al, 2016; Fischer, 2014; Hoge, 2011; 
Huang & Kashubeck-West, 2015; Moran et al., 2013).  The effects of combat-related 
PTSD cause medical, psychological, physiological, and social hardships for veterans, 
their families, and the communities in which they live (Castro, 2014).  Proven PTSD 
143 
 
interventions exist such as CPT, PE, and EMDR as detailed in Chapter 2 (see Chard et 
al., 2012; EMDR Institute, 2017; Rauch et al., 2012; Shapiro, 2001, 2012).  However, 
Hoge et al. (2014), Kip et al. (2016), and Waits et al. (2015) found that these existing 
therapies are lengthy and time-consuming, resulting in high dropout and noncompliance 
rates.  Combat veterans continue suffering with PTSD symptoms as a result.  Ritchie 
(2015) and Waits et al. (2015) have advocated for continued research to find other factors 
that influence PTSD treatment response and inform relapse prevention efforts.  In this 
study, I aimed to address the need for additional research by introducing a PTSD 
treatment-matching algorithm analysis to determine who benefits most from a particular 
PTSD treatment approach, before commencing treatment. 
The development of a similar predictive treatment-matching model was attempted 
in the medical community by Nauert (2018).  Nauert conducted a study to develop a 
statistical algorithm to predict which patients responded best to antidepressants prior to 
commencing a course of treatment.  I aimed to accomplish something similar by 
identifying which predictor variables predicted the amount of PTSD symptom reduction 
by use ART and whether symptom severity levels influenced the amount of PTSD 
symptom reduction when comparing mean PTSD symptom reduction differences among 
three groups with different PTSD symptom severity levels.  Developing a more effective 
treatment-matching model to predict PTSD symptom reduction and determining how 
symptom severity levels impact the amount of PTSD symptom reduction could possibly 
reduce or eliminate the number of trauma-based interventions attempted and the number 
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of treatment sessions needed to resolve PTSD and its associated comorbidities (see Kip et 
al., 2016).  
Socio-Demographic Characteristics  
 The socio-demographic characteristics of age, gender, race, marital status, and 
education were selected to define the makeup of the study sample. These socio-
demographic characteristics were not considered as predictor variables for this study 
because I aimed to identify predictor variables that could be measured and could predict 
PTSD symptom reduction.  Informed by the literature review, the predictor variables 
number of deployments, guilt, depression, and anxiety were selected for this study 
because they directly influenced PTSD onset and the associated PTSD-related 
comorbidities that complicate PTSD resolution. 
Number of Deployments   
 A review of the literature showed that combat exposure was a significant 
predictor of PTSD onset, and the greater the exposure the greater the severity of PTSD 
symptoms (Hoge et al., 2014; Huang & Kashubeck-West, 2015).  The study findings 
showed that number of deployments was a nonsignificant predictor of PTSD symptom 
reduction (IBM Corp, 2015).  However, the secondary data used for this analysis listed 
the choices for number of deployments on the Demographics form data derived from the 
dataset as 1, 2, 3, or 4 or more (Kip et al., 2016).  The predictor variable number of 
deployments, therefore, requires further research scrutiny by including all possible 
number of deployments, as well as the dates of each deployment to determine the amount 
of time between deployments and the associated length of time of each deployment in 
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order to better analyze the impact of this data on the study outcomes (Hoge et al., 2014). 
Although number of deployments did not significantly predict the amount of PTSD 
symptom reduction in this study, this predictor variable merits more refined research 
analysis to determine the effects of deployments on PTSD symptom reduction. 
Guilt 
 Dettmer et al. (2015) found that the nature of PTSD diagnosis in military 
populations was the same as in civilian populations except for the inclusion of guilt 
(Bryan et al., 2013).  A review of the literature showed that perceived guilt associated 
with combat-related PTSD caused a persistent sense of demoralization that altered self-
concept (Dettmer et al., 2015).  Guilt was an important predictor variable because of its 
association with increased suicides (Anestes & Bryan, 2013; Hendin, 2014).  Hendin 
(2014) found that severe combat-related guilt was the major differentiator between 
veterans who attempted suicide and veterans who contemplated suicide (Anestes & 
Bryan, 2013).  Veterans struggling with guilt had greater incidences of self-medicating 
with drugs and alcohol, thereby prolonging their PTSD symptoms (Hendin, 2014).  As 
clear as the literature was regarding the association of guilt and PTSD, associated 
comorbidities, and suicide guilt was a nonsignificant predictor of PTSD symptom 
reduction by use of ART in this study.  It is suggested that researchers include 
pretreatment and repeated posttreatment measures of perceived guilt in future studies to 
determine the impact of ART on depression and associated comorbidities over time and 
their relevant impact on PTSD symptom reduction.  The dataset used in this study 
measured perceived guilt with the TRGI.  Researchers are encouraged to determine 
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which assessment best measures perceived guilt and whether physiological assessment of 
guilt, if possible, may produce more sensitive results regarding how guilt may predict 
PTSD symptom reduction. 
Depression 
 Raab et al. (2015) reported that depression was a highly comorbid condition in 
veteran populations diagnosed with PTSD.  Depression was selected as a predictor 
variable because of its association with PTSD onset, treatment-resistant PTSD, and the 
persistence of other comorbid disorders (Raab et al., 2015).  The study findings showed 
that depression was a nonsignificant predictor of PTSD symptom reduction (IBM Corp, 
2015).  It is suggested that researchers include pretreatment and repeated posttreatment 
measures of depression in future studies to determine the impact of ART on depression 
and associated comorbidities over time and how those measures may predict PTSD 
symptom reduction.  Additionally, although the secondary data measured depression with 
the CES-D researchers are encouraged to determine which assessment protocol best 
measures depression symptoms, as this predictor variable merits further research to 
determine its impact on PTSD and whether it can predict the amount of PTSD symptom 
reduction after introduction of a specific trauma-based intervention. 
Anxiety 
 Anxiety was selected as a predictor for PTSD symptom reduction because it was a 
proven predictor of negative mental health outcomes (Schweizer et al., 2017). Schweizer 
et al. (2017) noted that anxiety impedes integration and resolution of traumatic 
experiences.  Schweizer noted that although many trauma survivors recover from their 
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posttraumatic symptoms, others develop stressor-related disorders such as PTSD and are 
more susceptible to trauma due to stress modulation dysfunction (Schweizer et al., 2017).  
People diagnosed with anxiety experience greater degrees of emotional dysregulation, are 
less resilient to stressor-related disorders, and recover more slowly from the after-effects 
of their trauma experiences (Agorastos et al., 2013).  Although the literature review 
revealed that anxiety could be a strong predictor of PTSD onset, it was a nonsignificant 
predictor of PTSD symptom reduction (IBM Corp, 2015).  There are, however, 
implications for future study.  For example, individuals who score high on anxiety 
measures may experience more heightened levels of trauma especially during the peri-
trauma phase of a life-threatening event (Agorastos et al., 2013; Schweizer et al., 2017).  
Researching the impact of anxiety during the peri-trauma phase and its association with 
PTSD onset may advance available knowledge of potential barriers to PTSD resolution 
(see Agorastos et al., 2013; Schweizer et al., 2017).  It is suggested that researchers 
include pretreatment and repeated posttreatment measures of anxiety in future studies to 
determine the impact of ART on anxiety over time and how that influences prediction of 
PTSD symptom reduction.  Additionally, studies that compare PTSD and the symptom 
severity levels associated with both PTSD and anxiety may help determine whether  
higher levels of perceived anxiety as well as higher levels of PTSD symptom severity 
impede PTSD resolution and, therefore, PTSD symptom reduction.  
Implications of Symptom Severity Levels on PTSD Symptom Reduction 
 To answer whether the dependent variable, PTSD symptom reduction differed 
among groups with different symptom severity levels, Welch ANOVA test results 
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showed significant findings and the study failed to accept the null hypothesis F(2, 
63.875)=7.204, p=.002.  Games-Howell post hoc analysis revealed that the mean PTSD 
symptom reduction difference from the low to high PTSD symptom severity group 
(11.62, 95% CI [4.31, 18.92]) was statistically significant (p = .001).  It is also important 
to note that each PTSD symptom severity group at the low, moderate, and high PTSD 
symptom severity levels experienced a mean difference greater than 10 points (IBM, 
2015).  The PCL-M self-rating scale threshold when measuring improvement as clinically 
significant is between 10 and 20 points.  An improvement of 5 points is considered a 
minimum threshold for patient response to a treatment, and 10 points of improvement is 
considered clinically meaningful improvement (Weathers et al., 2013).  The low 
symptom severity group (n=27) with a total pretreatment PCL-M score at or lower than 
50, showed a mean PTSD symptom reduction of 14.5.  The moderate PTSD symptom 
severity group (n=26) with a total pretreatment PCL-M score between 51 and 60 showed 
a mean PTSD symptom reduction of 19.5.  And, the high PTSD symptom severity group 
(n=55) with a total pretreatment PCL-M score at or greater than 61 showed a mean PTSD 
symptom reduction of 26.1.  Therefore, patients who present with higher pretreatment 
PCL-M scores may experience greater amounts of PTSD symptom reduction.  
Additionally, it is important to conduct further research on the makeup of study 
participants who score at or greater than 61 on the PCL-M scale at pretreatment to 
determine what other factors influence PTSD symptom reduction in order to possibly 
isolate statistically significant predictors of PTSD symptom reduction.  This study 
included this important second research question to determine not only whether groups at 
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different PTSD symptom severity levels differed significantly in their mean PTSD 
symptom reduction, but actually which groups were significantly different and what were 
the mean PTSD symptom reduction amounts.  It is recommended that future research 
studies stratify participants by PTSD symptom severity levels to determine the makeup of 
the group and the factors that influence PTSD symptom reduction.  These findings did 
show that immediate relief of PTSD symptoms was possible with a course of one to five 
sessions of ART, regardless of the length of time a patient suffered with PTSD 
symptoms. To date, ART offers the most expedient treatment for PTSD symptom 
reduction in the least amount of sessions and the Welch ANOVA test showed results that 
support use of ART at every level of PTSD symptom severity, but statistically significant 
results were evident between the low and high PTSD symptom severity groups. 
The Theoretical Implications of the Study Findings 
 Rosen and Frueh (2010) found that the brain stores and recalls traumatic 
memories in a manner resulting in fragmentation.  Yehuda et al. (2013) presented a 
biological model explaining that stress hormone response creates the neurocircuitry and 
genetic predisposition for PTSD onset.  Foa and Kozak’s (1986) emotional processing 
theory pointed to hyperactivity to and reminders of the original traumatic event which 
elicits behavioral avoidance and inability to resolve presenting PTSD symptoms.  
Although the literature review showed that the predictor variables number of 
deployments, guilt, depression, and anxiety were isolated as potential predictors of  
PTSD onset, the study revealed that PTSD onset may be a very complicated, 
multifactorial phenomenon unique to each individual (Kip et al., 2016).  Just as no single 
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theoretical framework has fully contextualized PTSD onset, the findings in this study 
show that no one predictor predicted the amount of improvement or PTSD symptom 
reduction prior to commencement of a particular PTSD treatment intervention, in this 
case ART. 
Limitations of the Study 
The Study Sample 
 The dataset contained a sample of 108 study participants derived from a prior 
prospective cohort treatment study of ART (Kip et al., 2016).  A limitation when using an 
available dataset is that the researcher must utilize the sample identified in the dataset and 
the variables contained therein (Cheng & Phillips, 2014).  The majority (92.6%) of the 
sample consisted of males (n=100).  A total of 92 (85.2%) participants identified as 
White.  A total of 12 (11.1%) participants identified as Black or African American.  A 
total of 3 (2.8%) participants identified as Asian.  A total of 1 (.9%) participant identified 
as American Indian/Alaskan Native.  Although the participants in this study are 
representative of a combat veteran population, it is important to note that PTSD is 
underreported  within the military population (see Hoge, 2015; Waits et al., 2015). 
The government classifies race as White, Black or African American, American 
Indian/Alaskan Native, Asian, Native Hawaiian or other Pacific Islander, Multiracial, and 
Other (Reynolds & Shendruk, 2018).  Additionally, the government views ethnicity as 
separate from race and includes the category of either Hispanic or Latino or not Hispanic 
or Latino under the classification of ethnicity (Reynolds & Shendruk, 2018).  This study 
did not include the socio-demographic characteristic of ethnicity to define the makeup of 
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the study sample.  Since Hispanic or Latino is classified by the government as ethnicity 
rather than race, statistics on participants who identified their ethnicity as Hispanic or 
Latino were not included in this study’s socio-demographic characteristics (Reynolds & 
Shendruk, 2018).  It is suggested that future studies include both race and ethnicity and 
that the classifications be distinct and clear in order to effectively stratify study 
participants.  Additionally, the secondary data included active duty, reservist, and 
discharged service members who served in any branch of the United States armed forces 
(Hoge, 2011).  It is unclear if the duration of the PTSD symptoms or the particular branch 
of military service influences PTSD symptom reduction.  Therefore, researchers are 
encouraged to consider stratifying these different classifications to refine the study 
analyses.   
Generalizability 
The study findings are generalizable to US Armed Forces veterans with a history 
of combat deployment who experienced PTSD symptoms.  However, the construct of a 
predictive PTSD treatment-matching model used to predict the amount of PTSD 
symptom reduction by use of a treatment intervention is generalizable to any identified 
population, any predictor variables, and any PTSD-related interventions (Nauert, 2018).  
Use of Self-Rating Scales 
 The predictor variables guilt, depression, and anxiety were measured indirectly by 
the self-rating scale scores contained in the dataset (Kip et al., 2016).  Self-rating scales 
by their nature are subject to self-perception of the severity level of the constructs 
measured.  It is suggested that researchers consider the use of practitioner-administered 
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measures in future studies to reduce self-rater bias (Hoge, 2015). Additionally, 
consideration should be given to physiological measures of the constructs guilt, 
depression, and anxiety.  For example, measuring saliva samples to determine the level of 
cortisol as representative of the level of anxiety may better predict PTSD symptom 
reduction for patients with PTSD symptoms. 
Implications for Social Change 
 At the individual level, researchers are encouraged to determine whether the 
number of pretreatment assessments that study participants complete support better 
understanding of the treatment outcomes.  For example, the secondary data for this study 
included multiple pretreatment assessments that measured perceived guilt, depression, 
and anxiety (Kip et al., 2016).  However, none of these measures were predictors of 
PTSD symptom reduction.  Evaluation and refinement of the pretreatment assessment 
process may result in better alignment with the constructs under analysis.  Additionally, it 
is suggested that researchers focus equally on predictive PTSD treatment-matching 
algorithm analysis for PTSD symptom reduction (Nauert, 2018).  A valid predictive 
PTSD treatment-matching model can support analysis of any combination of predictor 
variables and treatment intervention types (Nauert, 2018).  Application of a predictive 
treatment-matching model may reduce the need for patients to endure multiple PTSD 
intervention attempts as well as excessive numbers of treatment sessions in a trial-and-
error manner to achieve PTSD symptom resolution (see Kip et al., 2016; Ritchie, 2015; 
Waits et al., 2015). Pretreatment scales can also be targeted toward identification of 
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predictive PTSD treatment-matching algorithms to strengthen the merits of pretreatment 
assessments and refine future research efforts. 
 At the family level, providing educational programs that help family members 
understand the PTSD treatment-matching model and why a particular intervention is 
selected will best serve the family system in adapting to the needs of the individual 
diagnosed with PTSD.  A PTSD treatment-matching model approach can better tailor the 
process so family members understand the timeframe within which treatment efficacy 
may be anticipated and know specifically how to support the family member through the 
process of change. 
 At the organizational level, researchers are encouraged to consider studies that 
target the creation of algorithms that predict the amount of improvement possible prior to 
administration of a particular intervention (Nauert, 2018).  There are many studies that 
focus on treatment efficacy but fewer studies that focus on predicting the amount of 
improvement possible by use of algorithms to match a patient with a treatment to provide 
the most effective path to  PTSD symptom resolution (Hardwick, 2016; Kip et al., 2012, 
2013, 2014a, 2014b, 2016).   
 At the societal level, the use of a PTSD treatment-matching algorithm may 
support a more targeted approach in matching a patient with an intervention resulting in 
more expedient resolution of their PTSD symptoms (see Ritchie, 2015; Waits et al., 
2015). This, in turn, may reduce the complexities and comorbidities associated with 
PTSD (Lester, 2013). 
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Conclusion 
 This study attempted to identify the first predictive PTSD treatment-matching 
model to statistically predict the amount of PTSD symptom reduction possible prior to 
commencement of a trauma-based intervention.  This study chose ART as the treatment 
of choice for analysis (Kip et al., 2016). As identified in the literature review in Chapter 
2, researchers have not concluded whom benefits most from any specific PTSD treatment 
intervention (see Kip et al., 2016; Ritchie, 2015; Waits et al., 2015).  This study’s 
nonsignificant findings for predictors of PTSD symptom reduction may be indicative of 
the complex nature of PTSD diagnosis and treatment and why myriad study findings 
show inconclusive results when attempting to determine which trauma-based treatments 
work best.   
Although number of deployments, guilt, depression and anxiety were 
nonsignificant predictors of PTSD symptom reduction in this study, much was learned 
from this study’s findings.  The study findings, informed by what is known in the 
literature, revealed that number of deployments guilt, depression, and anxiety are 
important variables that require further research with different assessment scales, more 
stratified samples, and more specific information regarding, for example, length and 
number of deployments and duration of PTSD symptoms, as well as differentiating 
between active duty, reservist, and retired service members when conducting study 
analyses. 
 The study findings also showed that the predictor variables anxiety and 
depression, specifically, require more research refinement to determine how the peri-
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trauma phase is impacted by anxiety symptoms and the influence of this co-occurring 
phenomena on PTSD symptom reduction.  Depression and its relationship with guilt and 
suicide requires further research to determine how guilt influences PTSD symptom 
reduction.  The predictor variables guilt, depression and anxiety are influenced by PTSD 
symptom severity levels, as evidenced in the Welch ANOVA test results and Games-
Howell post hoc analysis.  Stratifying participants by symptom severity levels and 
examining the make-up of each group may yield additional factors that predict PTSD 
symptom reduction, especially in PTSD symptom severity groups experiencing 
significant mean PTSD symptom reduction differences. 
 The study also revealed that ART, the brief trauma-based intervention selected for 
analysis in this study, resulted in clinically meaningful mean PTSD symptom reduction 
of 10 or more points as measured by the PCL-M scale scores of all three PTSD symptom 
severity groups at  low, moderate, and high levels of PTSD symptom severity.  This study 
also contributed to the validity of ART as a meaningful intervention for PTSD symptom 
reduction in veteran populations.  The use of an intervention that can offer immediate 
relief of PTSD symptoms in as little as one to five sessions is significant when an average 
of 22 veterans per day continue to choose suicide over living with their PTSD symptoms 
(see Nelson, 2015: Ritchie, 2015). 
The study’s findings support the urgent need for continued research to explore 
predictive PTSD treatment-matching models that may lead to more expedient and 
sustained resolution of PTSD symptoms and the comorbidities associated with this 
disorder, potentially eliminating the need for multiple PTSD intervention attempts as well 
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as excessive numbers of treatment sessions to achieve PTSD symptom resolution (Kip et 
al., 2016; Ritchie, 2015; Waits et al., 2015). Veterans suffering with PTSD survived 
combat. They are  now relying on behavioral health practitioners and researchers to help 
them survive their PTSD (see Kip et al., 2016; Nelson, 2015; Ritchie, 2015; Wanklyn et 
al., 2016).   
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